Glutamine supplementation and renal health by Ahmad, Daniel et al.
ABSTRACT 
 
Title of Document: GLUTAMINE SUPPLEMENTATION AND 
RENAL HEALTH  
  
 Daniel Ahmad, Megha Bansal, Elizabeth Dillon, 
Shauna Dorsey, Aysha Jawed, Perry Katz, Andy 
Newton, Ashley Palagois, Anita Sahu, Curtis 
Sharkey, Devang Sharma, Sarah Tostanoski, 
Gemstone Thesis, 2009 
  
Directed By: Dr. Marc Rogers, Kinesiology 
 
Team Juiced designed a multi-faceted research project surrounding the potential risk of 
college students using protein supplements developing kidney disease. Survey research 
showed that participants taking protein supplements were ingesting double the 
recommended allowance based on literature values for average American dietary protein 
intake. Participants predisposed to kidney disease were no less likely to take protein 
supplements. Kidney cell modeling showed the molecular response to glutamine, an 
important protein building block. A significant increase in the gene expression of low-
density lipoprotein receptor and two sclerotic markers was found in response to 
glutamine exposure. Gene expression was time- and dose-dependent. Enzymatic 
degradation and high performance liquid chromatography showed that three popular 
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Chapter 1: Introduction 
The University of Maryland, College Park (UMD) sponsors a unique Honors 
undergraduate research program called Gemstone in which students of all majors work 
together to design and execute an original investigative study. This thesis describes the 
work of Gemstone Team Juiced and its multi-faceted project regarding the potential risk 
for the development of chronic kidney disease among college-aged athletes that use 
protein and/or glutamine supplements. Glutamine is a building block of protein or an 
amino acid. It can be taken in the form of a pill or a powder with the intent of increasing 
normal exercise capabilities. This project is divided into three branches that, when 
examined together, reveal a great deal about glutamine‟s effects on specialized cells in 
the kidney and the implications of the use of glutamine and protein supplements among 
college students. This thesis explores the protein supplementation patterns of the UMD 
athletic community, molecular pathways by which glutamine may affect kidney function, 
and the actual glutamine content of popular supplements as compared to their labels. 
Team Juiced was interested in addressing the topic of dietary supplements after 
observing the rapid rise of the use of these products among the college population. A 
dietary supplement can be defined as a product intended to supplement diet that contains 
one or more of the following ingredients: a vitamin, a mineral, an herb or other botanical 
product, an amino acid, a concentrate, a metabolite, a constituent, an extract, or a 
combination of these ingredients (United States Food and Drug Administration, 1994). 
Dietary supplements can reduce the risk of disease, improve recovery from severe 
illnesses, and enhance exercise capabilities. The Food and Drug Administration (FDA) 




Supplement Health and Education Act (DSHEA) of 1994, dietary supplements have not 
been required to undergo the strict pre-market testing of drugs, thus allowing dietary 
supplements to enter the market with limited regulation (United States Food and Drug 
Administration, 1994). Supporters of the legislation argued that the new law would 
inspire more independent scientific research and consumer education, as well as give 
buyers greater access to the products. Although some dietary supplements have been 
studied in detail, the information on safety and efficacy of many of the supplements 
available to consumers is limited. Considering that related literature has discussed the 
high percentage of college students and athletes taking dietary supplements, uncertainty 
concerning the safety and efficacy of these products leaves a growing number of 
consumers at risk.  
The goal of this study is to provide current and accurate information regarding 
glutamine to both the scientific community and consumers. There are thousands of 
supplements available on the market but a gap in the knowledge of how these products 
affect the body, especially in the long term. In addition, there is limited sociological 
information regarding the demographics of supplementation. It is the responsibility of 
researchers to make information regarding health concerns involving supplements 
available to the public so that they can make educated and informed decisions. The 
dietary supplement industry is a business whose intention is to make profit. In creating a 
product regulated as a food by the FDA, it is important that the scientific community 
work to investigate such risks for consumers. Recently, the consequences of the relaxed 
government regulation have had a significant impact upon American citizens. In an 




dietary supplement StarCaps, intended to aid in weight loss, was laced with unclaimed 
chemical additives (Singer, 2009). These additives were drugs that include several 
serious side effects. StarCaps were imported from China and have been readily available 
to consumers at major supplement retailers in the United States. The vulnerability of 
supplement consumers, as shown by such findings and the original research of Team 
Juiced, brings forward the issue of education for supplement use.  
The dietary supplements chosen for this study were protein and glutamine 
supplements. Glutamine is one of twenty amino acids that, in unique combinations, form 
all proteins. Glutamine is a naturally occurring amino acid that is produced and used by 
muscle cells, especially during prolonged exercise. Glutamine-containing supplements 
are classified as dietary supplements and are therefore regulated by the FDA. Glutamine 
is a prolific moneymaker, topping the lists of the most popular supplements. Finally, 
while glutamine has many proven physiological benefits to athletes and patients of 
certain pathology, there is evidence from in vitro studies that suggests the potential for 
adverse effects in renal (kidney) health (Lagranha, et al., 2005, Lagranha, Doi, Pithon-
Curi, Curi, & Sellitti, 2008).  
Excess protein has been proven harmful to patients with kidney disease. The 
kidneys normally function to filter the blood and rid the body of harmful toxins, 
metabolic waste products, and excess nutrients, however the kidneys can become 
damaged and scarred in pathological conditions. Chronic kidney disease is irreversible, 
often leading to renal failure, which requires dialysis and kidney transplantations. 




family history of any combination of these factors with kidney disease. High protein 
intake worsens the progression of chronic kidney disease toward loss of function.  
While excess protein intake is known to exert a deleterious effect on patients with 
chronic kidney disease, the effect of high protein consumption on healthy individuals is 
uncertain. The effects of specific amino acids are better defined, yet few researchers are 
concerned with their effects in regard to renal health. Some of the most current research 
involves the study of glutamine in a mouse mesangial cell model. The kidney is 
composed of several discrete units called nephrons. The glomerulus is the filtration unit 
of the nephron. Three major cells types are found within the glomerulus: podocytes, 
endothelial cells, and mesangial cells. Of these cells, the mesangial cells are critical in 
supporting the capillary beds where filtration occurs. The mesangial cells excrete an 
extra-cellular matrix (ECM) of proteins that acts as a mesh between the capillaries. In 
instances where mesangial cells begin to proliferate and excrete too much matrix protein, 
the capillaries collapse and therefore the glomerulus loses the filtration capabilities. The 
extracellular matrix proteins harden the tissue and decrease the glomerular function in a 
process called glomerular sclerosis. Lipids can also accumulate in the sclerotic 
glomerulus through a mechanism similar to that of an atherosclerotic plaque, especially 
when the patient exhibits high blood levels of cholesterol. Low-density lipoprotein (LDL) 
is the main type of particle that circulates in the blood carrying cholesterol, and that 
infiltrates atherosclerotic plaques and sclerotic kidneys. Evidence suggests that the 
presence of lipids in glomeruli accelerates the scaring process in chronic kidney disease. 
In order to address these research concerns, the current research conducted by 




glutamine analysis. An additional branch of the study, urinalysis, was added after the 
thesis proposal with the aim of further interlinking the results of survey research and 
kidney cell modeling branches. The team used survey research to gather information 
regarding the patterns of protein and glutamine supplementation among the target 
population, the athletic community at the University of Maryland, College Park. For the 
purposes of this study, the athletic community consisted of individuals who used the 
campus exercise facilities, participated in the Reserve Officer Training Corp (ROTC), or 
were members of an athletic club or team. Anonymous survey research of the target 
community addressed the following questions: 
1) What proportion of participants taking protein supplement also take pure 
glutamine supplements? 
2) What is the average supplemental protein intake among participants that use 
protein supplements? 
3) How long do the participants exercise each week? 
4) Do participants have individual or family histories of diabetes, hypertension, 
obesity, or kidney disease? 
It was particularly important to know if participants at risk for kidney disease 
were any less likely to take protein supplements than low risk participants due to the link 
between protein and kidney disease. In addition to these survey questions, several 
respondents participated in a follow-up urinalysis study. Both individuals who had and 
had not reported that they actively used protein supplements had their urine tested for the 
level of albumin excretion, which can be an early indicator of kidney disease if elevated. 
By testing participants‟ urine, it was possible to provide more applicable knowledge to 




The goal of the kidney cell modeling branch of the project was to discover how 
glutamine affects specialized kidney cells that function in glomerular filtration, with 
specific attention to the expression of low-density lipoprotein receptor (LDL-r). 
Collaboration with Sonia Q. Doi, M.D., Ph.D., Director of Nephrology Research 
Laboratory, Department of Medicine, Uniformed Services University (USU), Bethesda, 
MD, helped address the following sub-questions:  
1) What is the time dependent (up to 24h) behavior of LDL-r expression in mouse 
mesangial cells exposed to a supraphysiological level of 2.0 millimolar (mM) 
glutamine? 
2) What is the dose dependent behavior of LDL-r expression in cells exposed to 
increasing concentrations of glutamine up to 20.0 mM at the peak time of 
expression from the time course study? 
3) What effect does glutamine have in a chronic setting, after 48 hours of exposure, 
with respect to the expression of in vitro markers of glomerular sclerosis, 
(collagen I, fibronectin, and collagen IV)? How does LDL-r expression respond to 
various concentrations of glutamine after 48 hours? 
The primary goal of this branch of the project was to define the time- and dose-
dependency of LDL-r in response to glutamine. This knowledge would be valuable to the 
scientific community, specifically molecular biologists in the field of nephrology. Future 
research building on this knowledge could include the elucidation of specific pathways 
by which glutamine affects kidney function. In addition to advancing the knowledge base 
in the scientific community, this information would be critically important for athletes 
taking protein supplements that have predisposing factors for kidney disease. 
The third branch of this project aimed to assess the purity of glutamine 
supplements and glutamine content of protein supplements. Biochemical analysis of 




Bioanalytical Chemistry, Center for Food Safety and Applied Nutrition (CFSAN), FDA, 
College Park, MD, helped address the following questions:  
1) What is the glutamine content of pure glutamine supplements? Does the content 
match the amount stated on the product label? 
2) What is the glutamine content of protein and amino acid supplements that contain 
glutamine? Does the content match the amount stated on the product label? 
Prior to the execution of this research project, a thorough literature review was 
conducted. Scientific literature puts the present study in context, defines its niche, and 
provides information to aid in analysis of data. Sources regarding DSHEA were 
especially important in the early stages of the project. Understanding the legislation 
helped to clarify the motivations underlying the structure of the research. It also shed 
light on the government‟s definition of a dietary supplement and the methods by which 
they are regulated. Literature about surveys conducted about supplementation among 
college populations was reviewed to assess what was already known. No literature was 
found that linked predisposing conditions of kidney disease to protein supplementation.  
Literature outlining the physiological benefits of glutamine was also reviewed. 
Glutamine has been shown to boost the immune system and aid in muscle recovery and 
tissue re-growth (Lagranha, et al., 2005). Glutamine supplementation was found to be 
especially beneficial during intense exercise and endurance training. In vitro research 
suggested the potential for adverse effects. One study demonstrated that glutamine might 
induce mesangial cells to synthesize matrix proteins in vitro, the equivalent to the 
development of chronic kidney disease in vivo (Meek, et al., 2003). 
Various biochemical analysis methods were also reviewed in the literature. A 




performance liquid chromatography (HPLC) was researched with applications to the 
determination of glutamine concentration. Information regarding enzymatic degradation 
of proteins was also necessary to develop a method to test glutamine content in popular 
protein supplements.  
The methodology for the current research was defined within the three branches. 
A survey was used to collect quantitative data from a purposive sample active individuals 
on the UMD campus. A short questionnaire was administered to gym-goers using the 
Geary F. Eppley Recreation Center or Ritchie Coliseum, intramural sports players, 
varsity athletes, and members of the Reserve Officers‟ Training Corps (ROTC). A total 
of 947 surveys were collected. A four-digit number was used to maintain the anonymity 
of participants. Participants were asked how much protein they consumed, and how often 
they consumed it, as well as how long they used the product. An option was also given to 
report protein products previously used by the participants. Other questions addressed 
what other supplements they had been taking, how long they exercised each week, their 
gender and age, and what their individual and family histories were regarding diabetes, 
hypertension, clinical obesity, and kidney disease. All data was entered into an SPSS 
statistics file and analyzed accordingly.  
The final page of the survey asked participants if they would be interested in 
participating in a follow-up study. Several respondents volunteered to give a urine sample 
to measure urinary albumin excretion, which is used as a screening test for deficient 
kidney filtration. Participants were asked to provide a sample of urine obtained through 
the “clean catch” method. The samples were sent to the National Institutes of Health 




urinary albumin excretion of participants using protein supplements to those that were 
not. It also served as a free testing for a possible early indication of kidney disease. 
Participants were told that they would be contacted if their urinary protein was elevated, 
recommending that they speak with their physicians. 
The methodology for the second branch of study used mouse mesangial cells to 
model the effects of glutamine on the kidneys. Standard cell culture methods, RNA 
extraction, and one-step reverse transcription and polymerase chain reaction was used to 
quantify the genes of interest, notably LDL-r. LDL-r was important to study because of 
its role in bringing what is commonly known as “bad cholesterol” or LDL cholesterol 
into cells. The first set of experiments was designed to determine the time course of LDL-
r expression to a supraphysiological level of 2.0 mM glutamine over a period of 24 hours. 
The time of exposure when LDL-r expression was found to be optimal was used to 
elucidate the dose-dependent behavior of LDL-r expression. Establishing such knowledge 
in the field of molecular nephrology was critical in designing the final set of experiments 
that used 48 hours of glutamine exposure to simulate conditions of chronic glutamine 
over-use to assess how glutamine may affect pro-fibrotic matrix proteins, collagen I, 
fibronectin, and collagen IV.  
In the glutamine analysis branch of the project, the glutamine supplements and 
glutamine-containing protein supplements most frequently used by survey respondents 
were gathered. After much methodological development, enzymatic degradation, phenyl 
isothiocyanate (PITC) derivitization, and HPLC were used to determine glutamine 




Each branch of the project contributed to the understanding of various aspects of 
protein and glutamine supplementation. The results from kidney cell modeling have 
provided the scientific community a detailed and intricate framework from which the 
course of chronic kidney disease can be further studied. By determining the time- and 
dose-dependent behavior of LDL-r expression in response to glutamine, further 
experiments can be performed to see how the increased LDL-r affects lipid uptake and 
pro-fibrotic excretion of matrix proteins. It is hypothesized that the up-regulation of 
LDL-r could play a role in pro-fibrotic excretion of matrix proteins. Our current in vitro 
research provided the groundwork for further studies in vivo.  
Results from survey research provided a qualitative and quantitative 
understanding of protein supplementation patterns of the UMD athletic community. 
Information collected regarding supplemental protein intake gave substantiating evidence 
for the study of glutamine‟s effects on the kidneys. It also provided a unique insight into 
the behavioral patterns of supplement use amongst the college age population.  
Results from glutamine analyses at CFSAN will hopefully inspire the 
development of a more accurate method for determining glutamine concentration in 
protein samples, as well as draw attention to the regulation and effects of long-term use 
of glutamine. It is the aim of this thesis to offer a multi-dimensional and in-depth look at 
the protein supplementation patterns among the UMD athletic community, the potential 
for adverse side effects from kidney cell exposure to glutamine, and the integrity of 




Chapter 2: Literature Review 
2.1 Complete Literature Review Summary 
In designing this current research project, much investigation needed to be done 
regarding glutamine. First, literature regarding the regulation and sale of protein 
supplements, a major source of glutamine intake, was examined. The DSHEA legislation 
and its effects proved to be the primary source in understanding the social and political 
implications of dietary supplement regulation in American society. After reviewing the 
regulation of glutamine products, it became important to determine an age cohort that 
was engaged in glutamine supplementation. There was a void in the literature 
surrounding protein supplementation and renal health that this research team could fill. 
The literature displayed that college-age individuals commonly participated in protein 
supplementation but that there was a significant gap in the public body of knowledge 
regarding glutamine use and risk factors for the development of kidney disease. This void 
helped shape the survey of the current research. More literature was used in helping to 
write an effective survey, target a useful and specific subset of a population, and 
meaningfully analyze the data.  
Once the survey had taken shape, it became important to review the link between 
protein and renal health, as known by literature. Research regarding glutamine‟s normal 
biological function, the relationship between high levels of protein and kidney disease, 
the benefits of protein use in athletes, the expression of certain genes when in the 
presence of glutamine, and the potential for excess glutamine to harm mesangial cells, 
was reviewed to help design experiments to study the expression of low-density 




the effects of glutamine on kidney cells was used, hoping to lay the groundwork for 
animal studies and eventually human subject research. 
Because literature indicated the importance of glutamine dose when studying 
mesangial cells in culture, it was assumed that glutamine intake would be a key factor of 
understanding the effects of glutamine in vivo. While the current research could not 
address in vivo studies, it does target an important source of glutamine intake- 
supplementation. Literature showed the problems with the current system of regulation in 
regards to consumer safety, directing the current research to focus on the actual glutamine 
content of various protein and amino acid supplements. Literature regarding high 
performance liquid chromatography (HPLC) and enzymatic digestion was used to 
develop a method for glutamine isolation and quantification. The absence of a validated 
method for analyzing glutamine content in foods or supplements left much room for the 
current research to advance the field of biochemical analysis.  
The possibility of high supplemental glutamine contents and a link between 
glutamine and glomerular scarring led to the team‟s study of urinalysis methods- a 
noninvasive method commonly used to assess early signs of kidney disease. Literature 
concerning urinary protein excretion was thoroughly reviewed. Overall, the literature 





2.2 Survey Research Literature 
2.2.1 Executive Summary of Survey Research Literature Review  
As research has shown, the regulation of dietary supplements, including protein 
supplements is a field worth examining. Literature has shown the presence and 
prevalence of non-vitamin, non-mineral supplements to be a common occurrence 
amongst university students. These protein supplements are often ingested by a subset of 
the university‟s population who exercise on a regular basis, and preliminary research has 
shown that those who take protein supplements for muscle recovery after rigorous 
exercise could possibly face detrimental side effects. In particular, L-glutamine is one 
amino acid that is often contained in protein supplements and is used to supplement 
recovery and cell growth in humans. The current research has aimed to relate the results 
of a questionnaire regarding supplement usage with in vitro tests to determine the effects 
of certain dosages, time exposures, and concentrations of L-glutamine on mesangial cells. 
2.2.2 Dietary Supplement Health and Education Act (DSHEA) 
Dietary supplements are not under strict regulation from the United States Food 
and Drug Administration (FDA) following the Dietary Supplement Health and Education 
Act (DSHEA) of 1994. The manufacturers of a dietary supplement must adhere to the 
following rules in order for their products to be regulated as foods and not drugs by the 
FDA: 
1. "The statement claims a benefit related to a classical nutrient deficiency 
disease and discloses the prevalence of such disease in the United States, 
describes the role of a nutrient or dietary ingredient intended to affect the 
structure or function in humans, characterizes the documented mechanism by 
which a nutrient or dietary ingredient acts to maintain such structure of 





2. The manufacturer of the dietary supplement has substantiation that such 
statement is truthful and not misleading, and 
3. The statement contains, prominently displayed and in boldface type, the 
following: „This statement has not been evaluated by the Food and Drug 
Administration. This product is not intended to diagnose, treat, cure, or 
prevent any disease‟" (United States Food and Drug Administration, 1994).  
As long as manufacturers follow these three guidelines, their products will be 
regulated as foods, even though consumers do not take most dietary supplements in the 
same way as they do foods. This suggests that dietary supplements may have potentially 
dangerous side effects since they do not undergo the strict clinical testing of drugs. To 
eliminate any possible lawsuits, dietary supplements must contain a statement that notes 
that the FDA has not evaluated the performance claims about the product before it has 
entered the market. 
The law itself was passed after the manufacturers of said products engaged in 
intensive lobbying of the United States Congress. President Clinton, who signed the act 
into law, said the act came about as a result of the “efforts [of] manufacturers, experts in 
nutrition and…consumers at the grassroots level” (Woolley & Peters, 1994). Clinton 
went on to say that DSHEA “balances [the producers‟] interests with the Nation's 
continued interest in guaranteeing the quality and safety of foods and products available 
to consumers (Woolley & Peters, 1994). The act was sponsored by Senators Orrin Hatch 
and Tom Harkin as well as Representative Bill Richardson, and passed in large measure 
due to the efforts of Senator Edward Kennedy, Congressman John Dingell, and 
Congressman Henry Waxman. 
To illustrate how the process works, one can look back to the recent banning of 




demonstrated and documented list of serious issues surrounding the product, including 
many deaths directly related to the use and abuse of ephedra. In 2001, two professional 
football players died as a direct result of ephedra use, prompting Congress to hold 
hearings regarding ephedra‟s safety and efficacy. In the end, the FDA banned dietary 
supplements containing ephedra because it posed an unnecessarily high risk to consumers 
(Phillips, 2004).  
The act provides a very loose and broad definition as to what constitutes a dietary 
supplement. According to DSHEA, a dietary supplement: 
1. “Is a product (other than tobacco) that is intended to supplement the diet that 
bears or contains one or more of the following dietary ingredients: a vitamin, a 
mineral, an herb or other botanical, an amino acid, a dietary substance for use 
by man to supplement the diet by increasing the total daily intake, or a 
concentrate, metabolite, constituent, extract, or combinations of these 
ingredients, 
2. Is intended for ingestion in pill, capsule, tablet, or liquid form, 
3. Is not represented for use as a conventional food or as the sole item of a meal 
or diet, 
4. Is labeled as a „dietary supplement‟, 
5. Includes products such as an approved new drug, certified antibiotic, or 
licensed biologic that was marketed as a dietary supplement or food before 
approval, certification, or license (unless the Secretary of Health and Human 
Services waives this provision)” (United States Food and Drug 
Administration, 1994). 
In large measure due to the lack of oversight in protein and glutamine supplement 
use, this current project will test glutamine-containing dietary supplements for their 
content to be compared against the content claims by manufacturers. Both the dosage and 




match the actual content in the supplement bottles determined using high-performance 
liquid chromatography (HPLC).  
In 2007, the FDA issued a Final Rule that established exactly how the dietary 
supplement needed to be manufactured, labeled, and tested. According to the ruling, 
manufacturers were required to analyze their products to identify the strength, purity, 
composition, and identity of dietary supplements. If the products were contaminated or 
did not contain the supplements that they claim to contain, the FDA has to consider these 
products adulterated or misbranded (NewsRX, 2007). However, there is no mention as to 
how the FDA would go about confirming the purity or content of any of these products 
which are not tested before they enter the market. 
A large problem with DSHEA is that unlike highly regulated prescription 
medications, the burden of proof to demonstrate whether or not the dietary supplement 
poses an unreasonable risk of illness or injury lies solely on the manufacturer of the 
dietary supplement. This takes the burden of proof away from the United States 
Government and allows for most dietary supplements to be put on the market without 
significant testing. Though the FDA has the authority to conduct random spot checks of 
products on the market, they have little incentive to do so unless an event such as the 
aforementioned ephedra incidents shed light on the need for regulation. Therefore, these 
products could pose a risk to consumers. 
According to DSHEA (1994), almost 70% of Americans take a dietary 
supplement, begging the question of why they go unregulated before their provision to 
consumers (United States Food and Drug Administration, 1994). The ephedra incident 




research is focused on products, such as glutamine, that have gone relatively unregulated 
and untested for almost fifteen years.  
Though no empirical data was found on the economic impact of DSHEA, one can 
infer its significance. As previously mentioned, approximately 70% of Americans 
currently take dietary supplements. Because of the relatively free entry into the 
marketplace, consumers are flooded with choices ranging from multivitamins to protein 
powders to obscure herbs. More competition drives down prices, making these products 
more readily available to people of all socioeconomic classes. This therefore increases 
the access of consumers to a wide variety of potentially unregulated products. 
No empirical data was found for a societal impact either, but some speculations 
have been made. According to the Coalition to Preserve DSHEA, the ready availability of 
supplements, mainly multivitamins, should improve the health of the average American. 
By increasing the general health of Americans, people will save money on health care. 
For example, if the elderly community increased their doses of calcium with vitamin D, 
supplements that are readily available in most drug stores, seniors would save over $13.9 
billion over five years (CPDSHEA, 1994). The growing presence of protein 
supplementation in the general market especially in the context of fad diets and 
bodybuilding efforts, therefore implies an increase in dietary and protein supplement 
usage amongst the younger generation. 
2.2.3 Presence of Supplementation in the Younger Generation 
 In a 2006 study, it was shown that about 80% of teenagers had used a form of 
contemporary or alternative medicine at some point in their lives, and almost 50% of the 




sometime within the past month (Wilson, et al., 2006). Because contemporary and 
alternative medicines are defined as including both herbal and dietary supplements, this 
implies that supplement usage is a growing trend amongst the young population. Several 
studies have been conducted on the topic of supplementation specifically on college 
campuses which suggest that it is a prominent activity amongst the student population 
especially amongst young athletes. The types of supplements used by the college-aged 
population have ranged from general dietary and protein supplements to specific amino 
acids for a variety of reasons mostly revolving around physical enhancement. 
2.2.4 Non-Vitamin, Non-Mineral Supplement Usage on College Campuses 
Generally, the studies have demonstrated the prevalence of students using 
supplements characterized as non-vitamin, non-mineral (NVNM). NVNM supplements 
have been defined in a broad sense to include dietary supplements, herbal supplements, 
protein or amino acid supplements, or other supplements that are used to enhance 
behavior such as memory, metabolism, energy, exercise, muscle recovery, etc. In a 
comparison study at Washington State University, researchers suggested that the use of 
NVNM supplements is more common in college students than in the general population 
(Newberry, Beerman, Duncan, McGuire, & Hillers, 2001). Other studies have 
documented the prevalence of NVNM supplement usage on various college campuses, 
especially in relation to the amount of exercise subjects may be involved in during some 
increment of time. In a 2004 study at a Turkish university, a stratified random sample of 
approximately 1,900 students completed a questionnaire regarding NVNM and dietary 
supplement usage including questions about types of products used, frequency of usage, 




from this research yielded a positive relationship between exercising and NVNM 
supplement usage which suggested possible other implications.  
In a 2002 study that aimed to determine the usage of NVNM supplements 
amongst a 1,000 person sample of college students, researchers found that approximately 
a quarter of the students were using NVNM supplements most of whom were using 
protein powders or amino acid supplements. This study also indicated a strong correlation 
between supplement usage and physical activity more than three times per month and 
discussed further research as necessary for educating the supplement-using population on 
implications of usage (Perkin, Wilson, Schuster, Rodriguez, & Chabot, 2002).  
These findings have suggested that supplementation on college campuses 
deserves more attention as a research area since it appears to be a common activity 
amongst the younger generation. Additionally, these studies indicated a positive 
correlation between increased exercise time and supplement usage which begs further 
research given the potential health implications of using and possibly over-using and 
abusing these supplements in conjunction with rigorous exercise training. Data from 
these experiments also indicated that students may not be fully educated or informed 
about the consequences of supplement usage and may be under the wrong impressions 
about the benefits of supplement usage which increase their consumption. These all 
indicate that further research needs to be conducted in order to address these various 
findings and concerns. 
2.2.5 Protein and Amino Acid Supplementation on College Campuses 
The increase of NVNM supplement usage in the general market and on college 




amongst the supplement-using population. Echinacea, ginseng, gingko biloba, and 
protein/amino acid supplements were all amongst the most frequently used NVNM 
supplements given their perceived benefits on mental and physical enhancement 
(Ayranci, et al., 2005; Perkin, et al., 2002). Protein and amino acid supplements seem to 
be used more often in regards to assisting physical attributes such as weight gain and 
muscle recovery. The following research concerning the use of protein and amino acid 
supplements with regards to physical enhancement has been conducted which supports 
the idea that further research on implications of usage needs to be explored. 
In a 2004 study at a Division I university that specifically surveyed college 
athletes, approximately 88% of the subjects reported previous or current use of dietary 
supplements, 10% of whom specifically stated that they used the amino acid glutamine as 
a form of their supplement intake. Glutamine was found to be ingested in order to 
enhance athletic ability or expedite recovery from rigorous exercise (Froiland, Hingst, 
Kopecky, & Koszewski, 2004). Additionally in a 2007 study, approximately 600 high-
performance Canadian athletes responded to a survey that addressed protein supplement 
usage, reasons for supplementation, sources of supplementation information, and 
concerns with inherent risks associated with usage (Erdman, Fung, Doyle-Baker, 
Verhoef, & Reimer, 2007). Data showed that the majority of participants reported taking 
one or more protein supplements in the previous six months of completing the survey. 
Additionally, protein drinks were the most frequently used protein supplements across the 
population sampled. 
These studies support the conclusion that protein and amino acid supplementation 




especially amongst young athletes in recent years. The majority of these studies that have 
focused on exploring the issue of supplementation on college campuses have been in the 
form of survey research focusing mainly on self-reporting and anonymous response 
collecting. With any large-scale survey, it is important to ensure high-quality 
methodology and survey construction in order to produce reliable results.  
2.2.6 Qualitative and Quantitative Research 
The current research team constructed their survey using a combination of 
qualitative and quantitative research methods. When studying human subjects, it is not 
always advantageous to solely use quantitative methods which may prove impossible for 
obtaining the desired results. Qualitative research methods focus on phenomena and 
events that happen in natural, real-world settings which allow various factors all to meet 
and interplay, thereby creating complexity (Leedy & Ormrod, 2005). 
Non-random sampling helps to explain more complex inquiries into human 
behavior even though the results cannot necessarily generalize to an entire population as 
is possible with random sampling. First, if a truly random sample were taken, the specific 
characteristics applicable to the study must be known. Second, random sampling will 
only produce useful results if beliefs and attitudes of the population are normally 
distributed. There is little evidence to show that the opinions and values that are crucial to 
the success of the study will be normally distributed. It is instead more likely that they 
will be concentrated in non-random subgroups. Lastly, some potential respondents in a 
population are more knowledgeable about the matter under study and will provide 
deeper, more useful information that is pertinent to the study (Marshall, 1996). It is more 




related to the studied behavior. This allows information to be garnered about a specific 
subset of a population concerned with the research area of interest. 
2.2.7 Purpose of Using Survey Research 
Almost all types of research share the similar goal of providing basic information 
describing both the topic and the respondents involved (Nardi, 2003). The only way to 
achieve this with 100% accuracy would be to contact and study each and every member 
of the population of interest. In most cases, it would be impossible to possess either the 
time or resources to achieve this goal. If done carefully, it is possible to take a small 
sample of that population and generalize the findings from that sample to the entire 
population. This is the basis for survey research methods. For example, in the current 
study of protein supplement usage on the University of Maryland, College Park campus, 
it would not be possible to track down and study every single student at the university. 
Instead with a written questionnaire, a smaller, targeted sample of this population can be 
studied for habits, trends, behaviors, and attitudes concerning a particular research area. 
This idea is supported by Peter Nardi in the text Doing Survey Research when he says, 
“Questionnaires are more efficient tools for surveying large samples of respondents in 
short periods of time than interviews or other research methods, and with less expense 
than interviews” (Nardi, 2003). For a project with stringent financial and time constraints, 
a self-administered survey targeting a specific subset of the college population was the 
best methodology choice for gaining a deeper understanding of the specific research area. 
Properly conducting survey research requires several aspects to ensure quality results. In 
all of the literature reviewed, several similar steps must have been taken in order to 




2.2.8 Survey Research Methods 
The first step for the reviewed studies as well as the current study was usually to 
determine what specifically will be studied in order to decide on specific research 
questions. In research efforts, it is critical to come up with a set of well-defined research 
questions because this governs what will be asked in the survey. The next step was to 
decide the method for survey administration. Structured interviews, postal/e-mail 
surveys, and in-person surveys all have their own advantages and disadvantages. 
However, administering written surveys in person has important advantages over the 
other types. First of all, unlike personal interviews, one researcher can administer the 
survey to many respondents at once which saves time. Next, it adds to the reliability of 
the study to allow respondents to read and answer the items of a survey on their own. It 
would be less likely that the researchers would affect the outcome of the study either 
through their presence, phrasing of questions, or asking leading questions (Nardi, 2003). 
Additionally, even though the researcher is not actually reading each question to the 
respondents, it is helpful that a researcher be present to clarify the questions if necessary; 
this is not the case with postal or e-mail surveys. 
After deciding which questionnaire method to use, the next and probably most 
critical step is writing the actual survey questions to address the study‟s specific research 
questions. The wording and structure of questions can have a great influence on the 
results, and often one of the most important aspects of conducting survey research is 
being able to succeed in “the construction of well-written and manageable 
questionnaires” (Nardi, 2003). Literature provides guidelines for how to best formulate a 




should be relatively short and simple, usually twenty words or less. It also poses a 
problem to ask people to recall information that happened more than six months in the 
past. Since in the case of the current study this was unavoidable, it was important to at 
least provide reference information to help the respondents recall the information. For 
example, when asking about a specific brand of a protein supplement product that an 
individual had used in the past, it was determined helpful to provide a list of popular 
brands for respondents to consult if needed. 
Even after all of the questions have been written and the researchers have decided 
that the questions cover all the information they wish to learn, the organization of the 
questions within the survey is very important. Literature suggested that the most effective 
way to start the survey was to ask general, factual questions which would relax the 
respondents. Next, the more difficult questions would follow including those that ask the 
respondent to recall information that occurred in the past. Lastly, identifiable personal 
questions that were easy to remember would come towards the very end of the survey 
since this was easily accessible information (Nardi, 2003). 
The potential advantages of evaluating and revising the first draft of a 
questionnaire before distributing it to the targeted population have been discussed in the 
scientific literature. It is not enough for the researchers to simply read and revise the 
survey on their own. Researchers who have constructed the survey are most likely 
already very experienced in the subject matter so there may be questions or directions 
that seem obvious to them but may cause confusion in respondents. One very effective 
method of revising survey drafts is to utilize focus groups through cognitive interviewing 




out the survey and provide feedback. They can help identify potentially problematic or 
ineffective questions. The major benefits of using focus groups are that the opinions of a 
wide range of respondents can be collected at the same time. Additionally, interaction 
between participants does not happen while people are filling out the survey in a real 
setting but can help to identify new problems during focus groups. 
2.2.9 Purposive (Judgmental) Sampling 
A combination of qualitative and quantitative research encompasses several 
different sampling techniques. For the current study, the research team used purposive, or 
judgmental, sampling. In purposive sampling, the sample is selected by the researcher for 
a specific purpose (Leedy & Ormrod, 2005). The subgroup is selected based on attributes 
it possesses that will help the researcher answer the research question(s) (Marshall, 
1996). The researcher should be able to explain exactly why the specific subgroup was 
chosen (Leedy & Ormrod, 2005). The current study chose to examine a targeted 
population of students engaged in physical activity as a hobby and/or a requirement. It 
was presupposed that these students would have more knowledge and experience 
regarding protein supplementation than students who do not actively engage in physical 
activity. In addition, the selection of a subgroup should be based on the researcher‟s 
previous knowledge of the characteristics of the population and knowledge gained 
through literature (Marshall, 1996). It was presumed that students who participate in 
physical activity use protein supplements to enhance their performance. This presumption 
was later confirmed in several studies that this phenomenon was present on other college 
campuses especially in a population of students who partake in physical activity (Biemer 




Purposive sampling is advantageous for several reasons. First, when the study is 
being conducted under time restraints, purposive sampling allows the researcher to reach 
the targeted sample quickly (Trochim & October, 2006). The university research program 
under which this current study was conducted did limit the time for collecting and 
analyzing data. Second, this type of sampling is inexpensive (Ackoff, 1953). A student 
research team with minimal university funding does not have the means to conduct 
research that requires large sums of money to be successful. Purposive sampling is a 
satisfactory way to achieve results consistent with the academic inquiry by undergraduate 
students with a university budget. Most importantly, purposive sampling provides 
directed, valid, and useful information for the researcher because the subgroup has 
specific interest and/or relevant experience in the topic(s) under scrutiny (Biemer & 
Lyberg, 2003). This was essential simply because the time and money restraints created 
pressure to complete efficient yet high-quality research. 
Although purposive sampling has its drawbacks, the limitations were not serious 
enough in nature to pose serious implications for the current study‟s results. One negative 
aspect of purposive sampling is that bias is inherent and cannot be eliminated. The 
sample was specifically chosen for the reason that it is likely that it will provide the 
information the researcher is seeking (Lunsford & Lunsford, 1995). The bias was actually 
advantageous because it allowed for a more efficient survey administration to a topic-
related targeted population. Additionally, this method must take into consideration the 
context of the study. It is possible that a respondent may answer one way at one given 
point in time and a different way at another point in time simply because his or her frame 




variable (Marshall, 1996). However, literature has shown that this does not typically play 
a significant role on the results garnered from a questionnaire. 
There is no established sample size for a purposive study. Literature has 
discussed that the sample size should simply be large enough to answer the research 
question adequately (Marshall, 1996). The current study sought to acquire as many 
respondents within the designated subgroup as possible because it was known that 
inevitably a portion of the responses would be invalid. In order to evaluate the results of 
the study, statistical analysis had to be performed on the data. 
2.2.10 Purpose of using a Statistical Analysis Program 
The program selected to run these descriptive analyses was SPSS (originally, 
Statistical Package for the Social Sciences) which is a program commonly used in the 
social sciences. Although other programs exist, SPSS was the most logical choice 
considering the circumstances. Amongst the many statistical software packages on the 
market, SAS and SPSS are most frequently used. Each of these programs has its 
advantages and disadvantages. SPSS has proven to be the most reliable of the 
aforementioned packages even though it is considered to be more basic program. 
The reliability of these packages was determined by how well the programs 
performed certain tests and features. Specifically, univariate statistics, ANOVA, linear 
regression, nonlinear regression, and distributions were assessed. Microsoft Excel proved 
to have errors in each of these five categories. SAS made errors in four out of the five 
categories. SPSS incorrectly calculated in only three of the five (Altman & McDonald, 




The fact that undergraduate students with beginner-level experience in statistical 
analysis were going to be using the program was also a major factor in selecting SPSS 
over the other packages. On the other hand, SAS is designed for an experienced user who 
uses the program every day or on a frequent basis and has the skills essential for 
deciphering its rather confusing design. SAS is a better selection when complex data 
management is the prime function required. SPSS is a better selection when mainstream, 
simple data analysis is the prime function required (Acock, 2005). This study will only 
need basic data analysis functions to produce the desired results.  
2.2.11 Statistical Analyses Using SPSS 
SPSS can perform both simple and advanced statistical analyses. Some of the 
most commonly employed statistical applications involve computing frequencies, 
condescriptive frequencies, independent samples t-tests, Pearson‟s r, Spearman‟s Rho, 
and One-Way ANOVA (Andrews, Davidson, Klem, OMalley, & Rodgers, 1981). Several 
of the simpler computations fall under a general category called descriptive statistics. 
Descriptive statistics computed alongside creations of frequency tables, frequency 
distributions, graphs, and charts (especially pie charts because of their simplicity in data 
analysis and interpretation) can reveal a great deal of information about the generalities 
and the specificities in a particular data set (Feeney & Kirkpatrick, 2007). 
The purpose of descriptive statistics is to describe and present the data in order to 
show relationships, comparisons, and correlations amongst all of the variables being 
tested by the researchers. Typically, these researchers have at least beginner-level 
experience in statistical analysis (Hagan, 2006). A familiar group of descriptive statistics 




commonly used component of this group of descriptive statistics. All three components 
of this group present certain kinds of averages for the values in a data set. 
Another more specific group of descriptive statistics involves computing the 
range, average deviation, and standard deviation. Standard deviation is the most 
meaningful constituent in this group for performing more comprehensive statistical 
analyses for a data set. These values assess the spread of the values in a data set. 
In addition to descriptive statistics, there are several more in-depth statistical 
analyses that a researcher can perform in order to show greater and far more meaningful 
relationships, comparisons, and correlations amongst the variables in a data set. One of 
these statistical analyses is called a t-test, also known as a difference of means test. The 
purpose of a t-test is to compare the sample means of two separate groups. If these two 
means are different from each other, then the t-test will be statistically significant. The 
researcher will then be able to conclude that the samples are not from the same 
population. If these two means are not different from each other, then the t-test will not 
be statistically significant. The researcher would conclude that the samples either are not 
different or that the samples are coming from the same population. The latter two 
conclusions may sound as if they are the same, but in fact are making two separate 
conclusions which must always be stated together connected by an „or.‟ 
Another specific statistical analysis that a researcher can perform for clear 
portrayal of relationships, comparisons, and correlations amongst the variables in any 
data set is called One-Way ANOVA. This abbreviation stands for analysis of variance. 
The purpose of ANOVA is to compare three or more sample means in order to assess 




In addition to t-tests and ANOVA, another meaningful statistical analysis 
involves the usage of a correlation coefficient called Pearson‟s r. The range of values for 
Pearson‟s r is from 0 to + 1.00. 0 represents no statistical relationship. Values of + 1.00 
represent statistically perfect relationships. Values of + 0.20 represent negligible 
relationships. Values between + 0.20 and + 0.40 represent low relationships. Values 
between + 0.40 and + 0.60 represent moderate relationships. Values between + 0.60 and 
+ 0.80 represent highly moderate relationships. Values between + 0.80 and + 1.00 
represent high relationships. A minus sign in front of a value signifies a negative 
correlation, while a plus sign in front of a value signifies a positive correlation. Another 
correlation coefficient for statistical data analysis that reveals specific and meaningful 
relationships, comparisons, and correlations amongst variables in a data set is Spearman‟s 
Rho (rs), and its range of values is identical to the Pearson‟s r (Hagan, 2006). 
Literature regarding survey construction and analysis had discussed the 
importance of specifying exactly what a future study would aim to examine. The data 
collected and analyzed from the University of Maryland, College Park questionnaire was 
to relate the usage of protein supplements by members of campus. These results were to 
tie back into the results garnered from data collection from kidney cell modeling and 
biochemical analysis for a comprehensive analysis of protein supplements and in 




2.3 Kidney Cell Modeling Literature  
2.3.1 Executive Summary of Kidney Cell Modeling Literature 
Through this review, it has been established that the American diet already 
provides 150% the daily recommend allowance of protein. The effects of excessive 
protein are well documented for patients with kidney disease, and a decrease in protein 
intake has been proven to slow the progression of chronic kidney disease. On the other 
hand, little is known about the ill effects of excessive protein intake among healthy 
individuals. This community is likely to include athletes that take protein and amino acid 
supplements. The issue of hyperfiltration is nullified by its possibility of being a natural 
response and by the increase in kidney size associated with increased dietary protein. In 
order to study possible deleterious effects of excessive protein, it is important to focus on 
a particular amino acid, as different blends of amino acids produce very different 
physiological effects. For example, human studies have shown the induced change in 
serum LDL can be opposite for ingestion of different protein sources.  
Due to its benefits, glutamine has become a commonly used supplement among 
athletes. Its benefits are real when glutamine is in high demand by the body, but research 
data suggest that excess intake of glutamine may be deleterious for the kidney, especially 
for those who are at risk for chronic kidney disease such as individuals with diabetes, 
hypertension, obesity, or family histories of kidney disease. Researchers have used the 
mouse mesangial model in the past to study the effects of glutamine on gene expression 
for various in vitro markers for sclerosis, such as collagen. At the same time, few 




most studied amino acid was found to be arginine, which has been reported with 
conflicting data.  
The studies that have been done on glutamine in mesangial cells have indicated 
the significance of the dose of exposure or concentration of glutamine in experimental 
groups. The research questions of the current research were designed to address such 
issues. In addition, it was necessary to know the specific glutamine concentration in 
protein supplements taken by participants of the survey studies of the current research. A 
review of biochemical analyses was necessary, with specific attention to chromatography 
methods. 
2.3.2 High Protein Intake and Renal Health 
The typical American consumes more protein in their usual diet than the 
recommended dietary allowance (RDA) suggests. The current RDA intake is 0.8 grams 
of protein per kilogram of body weight per day. The average American consumes 1.2 
g/kg/day, or 15% of total caloric intake (Eisenstein, Roberts, Dallal, & Saltzman, 2002). 
There are no established definitions for “high protein” diets, but a review of data by 
Eisenstein et. al. suggests that an intake greater than 1.6 g/kg/day or 25% of caloric intake 
can be considered a high-protein diet. Intakes of greater than 2.4 g/kg/day or 35% energy 
intake can be considered extremely high.  
Current literature has shown that the use of high protein diets has become popular 
in the population in general and especially among the athletic community, aiming to 
increase physical performance and boost the immune system. In addition, the use of 
protein-rich diets gained the attention of individuals interested in losing weight. Among 




diabetes in the population is a low carbohydrate-high protein diet (Eisenstein, et al., 
2002). However, the benefits of a high protein intake decreasing the appetite and the 
levels of glycemia are counterbalanced by deleterious effects including an increased risk 
to accelerate the progression of chronic kidney disease.  
The increased consumption of high protein diets with no medical supervision 
raised concerns regarding the population at risk for chronic kidney disease. As the 
primary filtration system for the body, the kidneys are responsible for removing wastes, 
toxins, and excess nutrients. Nitrogenous waste and acid that accumulate from increasing 
dietary protein are filtered by the kidneys (Guyton & Hall, 2006). This continuous 
handling of protein and its byproducts makes renal health critically important. The focus 
on the effects of dietary protein on the kidneys has been heightened by studies showing 
that decreased protein intake slows the progression of chronic kidney disease. 
Thomas Addis suggested the restriction of protein intake by patients with kidney 
disease as early as 1948 (Brenner, Meyer, & Hostetter, 1982). The Modification of Diet 
in Renal Disease (MDRD) study conducted by Dr. Saulo Klahr in 1989 was the 
springboard for studies recommending that patients suffering from chronic renal 
insufficiency limit protein intake. The study showed the benefits of decreased protein 
intake for patients with kidney disease. It measured the decrease of glomerular filtration 
rate (GFR). Glomerular filtration rate is progressively reduced as kidney disease 
advances to renal failure. The measurement of GFR is used as an indicator of kidney 
function. Preservation of filtration is vital to slowing the progression of kidney disease. 
The experimental group with the lowest protein intake, less than 0.5 g/kg/day, still 




patients on a regular protein diet. It was determined that a decrease of 0.2 g/kg/day could 
slow the decline of GFR by as much as 1.15 mL/min/year. This may reduce the risk of 
renal failure or death by as much as 50% (Klahr, 1996). 
Several researchers have used the data gathered from the MDRD study in various 
analyses. A analysis by Levey et. al. (1999) supported the claim that lowering protein 
intake will slow the decline of GFR and the progression of renal disease. The analysis did 
not suggest dietary protein reductions would always slow GFR decline, but there was 
evidence to support that lower intake levels with additional intervention would slow the 
progression of kidney disease (Levey, et al., 1999). High protein diets for those with renal 
damage has since been discouraged. 
While research has supported the notion that high protein diets can be damaging 
to patients with kidney disease, it has not suggested any significant ill effects to the 
healthy population. Contrary to the findings relating consumption of high protein with 
deleterious effects in patients with chronic kidney disease, studies involving renal 
function in healthy individuals has left no reason to believe that high protein diets poses 
an unusual risk (Eisenstein, et al., 2002). One of the parameters examined in human renal 
studies is hyperfiltration. Hyperfiltration is seen early in many forms of kidney disease, 
and several studies have indicated that increasing protein in the diet, up to a saturation 
point of 125 g/day, significantly increases hyperfiltration (Eisenstein, et al., 2002). 
An increase in hyperfiltration may be a normal response to increased dietary 
protein. A study involving overweight to obese subjects (25 < body mass index (BMI) < 
34 kg/m
2
) showed changes in renal size and function over six months without any 




70.4 g/day in the low protein group and 107.8 g/day in the high protein group (Skov, et 
al., 1999). Increased protein led to a positive 5.2 ml/min change in GFR, while decreased 
protein led to a minus 7.1 ml/min change. Kidney volume increased by 9.1 cm
3
 in the 
high protein group, and decreased by 6.2 cm
3
 in the low protein group. While 
hyperfiltration was noted in the high protein group, net hyperfiltration, which considers 
the changes in renal size, did not significantly differ between the experimental and 
control population (Skov, et al., 1999). 
2.3.3 Amino Acids and Renal Health 
While studies involving high protein diets may not have shown any significant ill 
effects, studies involving amino acids show more exciting results. Amino acids are the 
natural building blocks of proteins. When protein is ingested, it is broken down into 
amino acids so that cells can absorb these vital nutrients from the blood and incorporate 
them into their cellular metabolism. 
In a 120-day feeding study of adult rats, serum lipid levels were examined to 
determine the influence of two different protein sources- casein and gelatin. Casein is 
high in glutamic acid, methionine, phenylalanine, and tyrosine, while gelatin is largely 
composed of arginine, glycine, and hydroxyproline. Both proteins would have been 
digested by the rats and their composite amino acids would be absorbed into the blood. 
Each protein source showed varying results. The casein-fed rats showed significant 
increases in serum levels of triacylglycerols and total cholesterol, while the reverse effect 
was observed in gelatin-fed rats. The stark contrast between the two protein sources 
shows how amino acids can produce very different physiological effects (Ratnayake, 




Giving specific attention to amino acids in regards to renal health, administration 
of high concentrations of amino acids has been shown to increase glomerular flow and 
filtration rate. These changes were previously attributed to a hemodynamic effect caused 
by the amino acid load. This idea changed when Meek et. al. (2003) demonstrated that a 
high concentration of amino acids induced increased expression among proteins 
considered in vitro markers of glomerular sclerosis. A similar response was observed 
with L-arginine, and the authors suggested that the glomeruli fibrotic response elicited by 
amino acids was independent of hemodynamic effects (Meek, et al., 2003).  
Arginine, a substrate of nitric oxide (NO) is one of the amino acids that have been 
most studied in the setting of chronic renal disease, mainly because of the NO-related 
hemodynamic effects. In vivo and in vitro studies with arginine resulted in controversial 
conclusions. While some investigators have shown that an increase in arginine may lead 
to more extensive renal damage (Cook, et al., 1994; Ketteler, Border, & Noble, 1994) 
others have found a protective role for this amino acid (Ingram, et al., 1995; Lubec, 
Aufricht, Amann, Kitzmüller, & Hoger, 1997; Narita, A., Ketteler, Ruoslahti, & Noble, 
1995). Only a few other amino acids have been individually studied as inducing changes 
in the course of renal diseases (Kaysen & Kropp, 1983). Extensive literature search has 
supported this notion. Few researchers are concerned with the effects of specific amino 
acids on renal health. 
The effect of different amino acids on human health has found its way from the 
scientific community into the realm of supplementation by athletes. The physiological 




the benefits of glutamine to athletes can be discussed, a basic background of glutamine 
and its physiological role must be established. 
2.3.4 Glutamine and its Physiological Role 
Glutamine is one of twenty naturally occurring amino acids in the human body 
and plays a major role in protein synthesis. It is strongly concentrated in cells of the 
central nervous system where it acts as a precursor for the synthesis of neurotransmitters, 
nucleotides, and glutathione, a small peptide important for some enzymatic activation 
(Newsholme, et al., 2003). In addition to its role in the central nervous system and high 
concentration in the intestinal walls, glutamine is in high demand in skeletal muscle 
(Connolly, 2004). Glutamine accounts for more than 60% of the total pool of free amino 
acid in muscle and is the most common amino acid in plasma (Antonio, 2002). In the 
blood, glutamine plays a strong role in maintaining immune function by acting as a fuel 
for lymphocytes and macrophages (Castell & Newsholme, 1997). Glutamine is also a 
substrate for hepatic and renal gluconeogenesis, the synthesis of glucose within the liver 
and kidneys, respectively, as well as a donor for nitrogen (Newsholme, et al., 2003).  
2.3.5 Glutamine in Sport and Exercise 
Glutamine has been shown to increase the production and release of plasma 
interleukin-6 (IL-6), an inflammatory cytokine innately tied with the immune response. 
In a study by Hiscock et al. (2003), it was shown that among a group of healthy males 
exercise alone induced an eleven-fold increase in plasma IL-6. Glutamine or glutamine-
rich protein potentiated the increase of plasma IL-6. An 18-fold increase was observed in 
males using a glutamine solution, while a 14-fold increase was observed among 




inflammatory cytokine secreted by T cells and macrophages in trauma. This interleukin 
regulates immune response and host defense mechanisms. In the kidney, renal tubular 
epithelial cells express IL-6 during inflammation (Kindt, Osborne, & Goldsby, 2007). 
A study by Wilmore and Shabert (1998) demonstrated the close relationship 
between glutamine availability and cell proliferation. Immunological response and 
proliferation of bowel mucosal cells increased with glutamine concentration. This effect 
was associated with repair of intestinal mucosa erosions and maintenance of the bowel 
barrier function (Wilmore & Shabert, 1998).  
Athletes have been shown to be more prone to infection after an exhaustive work 
out. Exercise reduces the body concentration of glutamine by 20-25% while surgery 
reduces the body concentration of glutamine by 37% (Lagranha, et al., 2005). A study 
was conducted in athletes comparing glutamine supplementation to phagocytosis, an 
important process in the immune system to rid the body of pathogens and cell debris. 
With glutamine supplementation, there was an increase in phagocytosis as well as 
oxidative capacity of neutrophils, in comparison to no change without supplementation 
(Lagranha, et al., 2005). Thus, exercise does not change phagocytosis or reactive oxygen 
species, but glutamine supplementation increases phagocytosis and has a major effect on 
the neutrophil function. 
Glutamine‟s role in metabolic acidosis may be important for athletes involved in 
intense anaerobic exercise. During metabolic acidosis glutamine produces ammonium 
ions after being converted to α-ketoglutarate. The presence of these ammonium ions 
counterbalances the increased plasma lactate and hydrogen ion concentration generated in 




effects of metabolic acidosis in the body (Antonio, Sanders, Kalman, Woodgate, & 
Street, 2002). 
Glutamine is particularly beneficial in high-intensity endurance training. An 
amino acid mixture containing glutamine, leucine, isoleucine, valine, and arginine was 
administered to 23 Japanese rugby players in a well known in vivo study. The amino acid 
mixture was given at 6.6 g/day for a period of 90 days. A number of positive results 
including quicker muscle recovery from fatigue, increased blood oxygen-carrying 
capacity, and decreased muscle damage indices were observed (Ohtani, Masaaki, & 
Maruyama, 2006). A significant increase in levels of LDL cholesterol was also noted 
among the experimental group. Normal lipid levels were restored after terminating 
administration of the amino acid mixture (Ohtani, Maruyama, Titchenal, & Kobayashi, 
2001).  
Interestingly, some human studies have shown that diets high in animal protein 
significantly reduce serum triglycerides and LDL cholesterol (Hu, 2005). Hu reviews 
these studies in which dietary fat intake, cholesterol, and fiber were kept constant while 
varying protein intake between 11 and 27% of total energy intake. All studies showed 
significant decreases in serum triglycerides and LDL (Hu, 2005). These opposing 
findings in serum levels of LDL reinforce the importance of protein source and amino 
acid compositions. Determining amino acid specific effects becomes important in such 
situations where protein and amino acid blends were used. 
2.3.6 Clinical Applications of Supplemental Glutamine 
In addition to its use in endurance training and high intensity exercise situations 




Decreased levels of glutamine may act as an indicator of catabolic states such as 
infection, surgery, trauma, and acidosis (Rowbottom, Keast, & Morton, 1996). Glutamine 
also improves nutrient absorption and therefore intestinal health as well as regulates 
muscle protein turnover (Connolly, 2004).  
One study has shown that postoperative patients benefited greatly from parenteral 
feedings enriched with glutamine. Subjects displayed a more optimal nitrogen balance as 
well as maintained intestinal permeability (Jiang, et al., 1999). Glutamine, has beneficial 
effects for burn patients. It has been linked to the proliferation of intra-cellular repletion 
of glutathione, an important forager of reactive oxygen species. Glutamine‟s abilities to 
limit skeletal muscle catabolism and control some inflammatory stimulation may indicate 
that it can improve a patient‟s chance of overcoming an acute illness. Improved T cell 
function in vitro and in stressed human patients is also seen in association with glutamine 
supplementation (Sheridan, et al., 2004). 
2.3.7 Adverse Effects of Glutamine on Kidney Cells 
Supplementation with amino acids and particularly glutamine has shown 
beneficial effects in humans when there is a high demand, like in athletics, or a 
deficiency, like in clinical applications. However, data from studies in vitro suggest that 
amino acids and glutamine in supraphysiological amount cause deleterious rather than 
beneficial effects on the kidney. Mesangial cells are one of the kidney cells affected by 
glutamine. They play an important role in glomerular filtration. In the normal kidney 
these cells maintain a low rate of proliferation, which can be substantially increased in 




with accumulation of extracellular matrix in kidney disease. Therefore, factors that 
stimulate mesangial cell proliferation may result in glomerular scarring. 
A study of cultured rat mesangial cells in the presence of varying concentrations 
of an amino acid mixture with and without glucose was performed to determine whether 
amino acids alone or in association with glucose would pose a risk for kidney disease. 
This study showed that elevated concentrations of both amino acids and glucose isolated 
or in combination induced an increase in mesangial cell proliferation and in the 
espression of markers of glomerular sclerosis (transforming growth factor β, type IV 
collagen, fibronectin, and thrombospondin-1). Thus, amino acids increase expression of 
both growth factors and matrix proteins in mesangial cells. The authors conclude that 
increased amino acids can cause renal damage similarly seen in elevated protein 
consumption (Meek, et al., 2003). 
While it has been shown that an increase in amino acids can cause renal damage, 
it is important to identify the role of specific amino acids. The demonstration that 
glutamine induced an increase in mesangial cell proliferation led to the hypothesis that 
this particular amino acid could induce further damage to these cells. To test that 
hypothesis, mouse mesangial cells were grown in the presence of varying concentrations 
of glutamine (0-2 mM) and markers of sclerosis (type IV collagen, tenascin, and 
fibronectin) and of mesangial cell injury (α-smooth muscle actin, SMA) were studied. 
Increase in glutamine caused a significant increase in the expression of α-SMA, type IV 
collagen, and fibronectin. Increased α-SMA expression is seen in many human 




injury. Thus, prolonged high intake of glutamine could cause mesangial cell injury 
(Lagranha, et al., 2005). 
A study with messangial cells grown for 72 hours in low glucose (5mM) or high 
glucose (25mM) with glutamine concentrations varying from 0-20 mM glutamine 
demonstrated that mesangial cell proliferation in low glucose significantly increased and 
reached a plateau with 1 mM glutamine. In the presence of high glucose, glutamine 
induced a dose dependent increase in proliferation. In diabetes, high glucose increases the 
renewal rate of the mesangial cells, mediated by a biosynthetic pathway involving 
glutamine:fructose-6-phosphate amido-transferase (GFAT). Similarly, glutamine effect 
on mesangial cell proliferation appears to be mediated by the GFAT pathway. Thus, 
chronic kidney disease may be induced by elevated levels of glutamine due to 
supplementation in high risk users, such as diabetes or those with higher blood glucose 





2.4 Biochemical Analysis Literature 
2.4.1 Executive Summary of Biochemical Analysis Literature Review 
It is important for scientists to study the true content of dietary supplements for 
consumers‟ safety, and the passing of DSHEA highlights the importance of this pursuit. 
This portion of the current study is concerned with quantifying the amount of glutamine 
in dietary supplements containing glutamine. There are various tools to determine 
glutamine content, which include HPLC, GC, and CE. While all of these devices are 
capable of quantifying the amount of glutamine, the literature suggests that HPLC will 
prove to be the most superior tool in this study. Advantages such as its high resolving 
power and ability not to alter any component of a substance with heat make HPLC an 
appropriate tool for this study. HPLC has already been shown to analyze amino acids in 
mediums, such as supplements and food products, further suggesting that it will serve 
well in analyzing dietary supplements. 
Protein-based dietary supplements cannot be simply dissolved and vaporized into 
the HPLC column to quantify the amount of glutamine. Instead, these supplements must 
be hydrolyzed and derivatized before entering the HPLC instrument to be analyzed. 
Research suggests that enzyme hydrolysis is the best way to quantify glutamine from 
protein rather than acid hydrolysis. Tsao and Otter (1999) used a three-enzyme system to 
degrade proteins into its amino acid constituents before HPLC analysis. Enzyme 
hydrolysis did not underestimate glutamine content like acid hydrolysis did, since acid 
hydrolysis converts a significant amount of glutamine into glutamic acid. In addition, 




glutamine to glutamic acid, further justifying enzyme hydrolysis as an appropriate means 
of breaking down protein-based supplements. 
As mentioned above, amino acids must be derivatized in order to be detected. 
PITC has been found to be a good derivatizing agent because it is stable and volatile, and 
has a fast reaction with amino acids. The combination of enzyme hydrolysis and PITC-
derivatization provides us with the best way to detect and quantify the amount of 
glutamine in protein-based dietary supplements. 
2.4.2 Biochemical Analysis Background 
Many dietary supplements are not under strict regulation from the United States 
Food and Drug Administration (FDA) as a result of the Dietary Supplement Health and 
Education Act of 1994 (DSHEA). As mentioned earlier, there are three basic guidelines 
that manufacturers of dietary supplements must adhere to in order to be regulated as a 
dietary supplement and not a drug. Simply put, the statements regarding the benefits must 
be related to a “classical nutrient deficiency disease” and must specifically say what the 
ingredient‟s main intended action is within the body (United States Food and Drug 
Administration, 1994). Additionally, the manufacturer must stand by their claim that the 
statement of benefits is truthful. Finally, the product must contain the warning “This 
statement has not been evaluated by the Food and Drug Administration. This product is 
not intended to diagnose, treat, cure, or prevent any disease” (United States Food and 
Drug Administration, 1994). 
Given the nature of this legislation, manufacturers potentially can add or take out 
certain amounts of chemicals into their products because the products are not being tested 




and may be ingesting a product without actually understanding what it may contain. 
Because there is no safety regulation, glutamine-containing dietary supplements were 
tested to compare their glutamine content against the content claims by manufacturers. 
2.4.3 Methods to Detect Amino Acids 
Amino acids are commonly detected and quantified using various analytical tools, 
including high-performance liquid chromatography (HPLC), gas chromatography (GC), 
and capillary electrophoresis (CE). The method of HPLC can separate amino acids 
through the partition of analytes between the mobile and stationary phase. In HPLC, a 
liquid mobile phase is eluted through a small column that contains a solid, tightly packed 
stationary phase. Reversed-phase liquid chromatography refers to the use of a nonpolar 
stationary phase with a relatively polar mobile phase to separate the molecules. The most 
polar molecules will elute the column first, and the most nonpolar molecules will elute 
last. Increasing the polarity of the mobile phase (polar solvent) increases the elution time 
(Skoog, Holler, & Nieman, 2007). One of the most frequent and important applications of 
HPLC is analyzing amino acids, and this is typically carried out in the reversed-phase 
(Concha-Herrera, Torres-Lapasio, Vivo-Truyols, & Garcia-Alvarez-Coque, 2006). 
The instrument employed for GC is significantly different from HPLC. The major 
components of a GC system are a column that can be temperature programmed, a sample 
inlet point, a carrier gas supply and control, a detector, an amplifier, and a data recorder 
system. Gas chromatography exploits the difference in the partition coefficient between a 
stationary liquid phase and a mobile gas phase of volatized analytes as they move through 
the column. The partition coefficients allow the most volatile analytes to elute first. The 




stationary phase is typically a high boiling point liquid material that is either coated onto 
the column or packed into the column. This tool is particularly useful when coupled to 
mass spectrometry (Wilson & Walker, 2005). 
A third tool that can be used to separate amino acids is CE, and the basis of this 
device is electrophoresis of samples through narrow tubes. The typical internal diameter 
of a tube is 50 μm, and this produces a large surface-to-volume ratio. The large surface-
to-volume ratio produces enhanced heat dissipation, which is advantageous because CE 
eliminates both convection currents and zone broadening caused by heat. CE also has the 
capability to detect concentrations as low as femtomole (10
-15
 moles) (Wilson & Walker, 
2005). 
All three of the instruments discussed above can be used to separate and detect 
amino acids. Separation techniques using GC and HPLC have been shown to be well 
established for analysis (Landers, 1994). While GC is probably the most commonly used 
form of chromatography, it is used for volatile compounds that do not need derivatization 
(Wilson & Walker, 2005). The procedure for analyzing amino acids in dietary 
supplements involves derivatization, which means that the amino acids are generally 
transformed chemically into another similar substance to be separated in a column. GC 
analysis includes volatilization; however, the process is time-consuming and the samples 
must be derivatized before their GC elution and quantification, and the derivatization 
must take place in water-free conditions (Molnar-Perl, 1994). Furthermore, a 
considerable number of substances that are tested using chromatography are heat-
sensitive. As mentioned above, amino acids that are to be analyzed must evaporate into a 




their boiling point to achieve this (Hanai, 2005). Therefore, the drawbacks of GC in 
analyzing amino acids show that this device is not the most appropriate way to detect 
amino acid concentrations. 
HPLC is a better tool for detecting amino acids than GC for many reasons. First, 
compounds are not subjected to an elevated temperature in HPLC preventing the 
alteration of any of the components (Hanai, 2005). Also, the process of derivatization is 
easier to manage in HPLC than GC. HPLC can be paired with an ultraviolet absorption or 
fluorescence detector in order to detect compounds that have derivatized (Molnar-Perl, 
1994). Also, gradient HPLC offers high peak capacity and efficiencies around 50,000 
theoretical plates. The resolving power of the chromatographic column increases with the 
number of theoretical plates per unit length (and the column length). Theoretical plates 
are directly related to the surface area of the stationary phase. Although small stationary 
phase particles create more resistance and back-pressure, small particle size stationary 
phases have been developed to withstand this pressure. This development alone is 
responsible for the faster and better resolution in HPLC, and explains why HPLC has 
emerged as the most powerful and versatile form of chromatography (Wilson & Walker, 
2005). 
Capillary electrophoresis is a newer technique that can also detect amino acids 
through derivatization. One of the major advantages of using CE is the ability to separate 
a large number of closely related materials in a very short period of time. Also, a single 
run in CE uses essentially zero solvent consumption and sample injection volumes are on 
the level of 5 to 10 nL. CE is a useful tool in protein digestion experiments because of its 




not include a precise high-pressure pump and consumes less reagants than liquid 
chromatography (Manaenkov, Sidorov, & Sulman, 2003). 
Conversely, the main drawback of CE is its poor concentration sensitivity and the 
fact that the separation buffer and sample diluent must be similar (Landers, 1994). 
Another drawback of CE is the ultraviolet (UV) laser that is used in the typical capillary 
electrophoresis-laser induced fluorescence (CE-LIF). The bright and coherent UV laser 
used is an expensive part. Light-emitting diodes (LED) have been proposed over UV 
lasers because their small size, low cost, ease of operation, and wider range of excitation 
wavelengths. However, the light from a LED are divergent and not pure, leading to a 
relatively high fluorescent background (Chang, Chiu, & Chang, 2006). Also, another 
disadvantage of CE is that adding substances to the carrier electrolyte through 
derivatization modifies the surface of the fused-silica capillary and often degrades the 
precision of analytical results (Manaenkov, et al., 2003). For these reasons, HPLC has 
been demonstrated to be an appropriate tool to be used in separating and detecting the 
amino acid glutamine. 
HPLC has been used to analyze amino acids in a wide range of mediums, 
including biological fluids, food, and supplements (Battaglia, et al., 1999; Baxter, 
Phillips, Dowlati, & Johns, 2004; Korös, Varga, & Molnár-Perl, 2008; Silva, et al., 2007; 
Tcherkas & Denisenko, 2001). For example, studies have examined the amino acids in 
human serum or plasma (Tcherkas & Denisenko, 2001; Tcherkas, Kartsova, & Krasnova, 
2001). The determination of amino acids in biological fluids, like serum, is important in 
clinical biochemistry. For example, the change in amino acid concentration in serum and 




Alzheimer‟s disease. The studies employed isocratic reversed-phase HPLC with either 
electrochemical detection or fluorescence detection in order to quantify the amount of 
amino acids in serum, such as leucine and phenylalanine (Tcherkas & Denisenko, 2001; 
Tcherkas, et al., 2001). These amino acids were pre-column derivatized by o-
phthalaldehyde (OPA), a derivatizing agent that will be discussed later in this section. 
HPLC can also be used in the analysis of food products, such as red wine. Pre-
column derivatization with dabsyl chloride was the method used to determine the amount 
of all twenty free amino acids in a particular red wine. The researchers then chose to 
evaluate the effect of the spoilage wine yeast D. bruzellensis on the free amino acid 
composition of the red wine (Silva, et al., 2007). While amino acid analysis has been 
thoroughly studied in the mediums mentioned above, it is important to note that there is 
less research completed on the detection of amino acids in supplements. A study that did 
identify and quantify amino acids in supplements used enzyme digestion, 9-
fluorenylmethyl chloroformate (FMOC) derivatization, and HPLC-UV to quantify 
glutamine in twelve nutritional supplements (Baxter, et al., 2004). Findings from this 
article will serve as a useful guide in the current study‟s research, and will be further 
discussed later in this section. 
2.4.4 Use of HPLC and Enzyme Hydrolysis to Detect Glutamine 
Glutamine must be released from protein in order for the glutamine content of 
protein-based supplements to be determined using HPLC. Acid hydrolysis is typically 
used for amino acid analysis. However, the chemical structure of glutamine is easily 
modifiable. Glutamine, in its free form alone, is very unstable. In acidic conditions, 




amount of glutamine present. However, there are also chemical modifications under 
alkaline conditions, and glutamine converts into pyroglutamic acid (PGA). These 
chemical conversions make it difficult to accurately quantify the amount of glutamine 
(Tsao & Otter, 1999). 
Enzyme hydrolysis provides a more efficient means to quantify the amount of 
glutamine than acid hydrolysis. Tsao and Otter (1999) developed a procedure to quantify 
unmodified glutamine using enzyme hydrolysis and a reversed-phase HPLC system. 
Three milk proteins were used in this study to quantify glutamine in protein, and the milk 
proteins were α-lactalbumin, β-lactoglobulin, and β-casein. Protein samples containing 
glutamine were subject to enzyme hydrolysis, and the three enzymes used were pronase 
E, aminopeptidase M, and prolidase. These enzymes were chosen based on the enzyme 
hydrolysis described by Tsao and Otter, and originally from the work of Henle et al. 
(1991). Pronase E is a protease that preferentially cleaves bonds between the hydrophobic 
amino acids: alanine, valine, leucine, isoleucine, phenylalanine, tryptophan, and tyrosine. 
Leucine aminopeptidase hydrolyzes bonds between leucine and other amino acids at the 
amino end of leucine. Prolidase cleaves glycine-proline bonds. The protein samples were 
also subjected to acid hydrolysis for comparison (Tsao & Otter, 1999). 
The average percent recoveries of glutamine following enzyme-hydrolysis for α-
lactalbumin, β-lactoglobulin, and β-casein were 77.5 ± 3.9, 97.5 ± 3.0, and 100.9 ± 2.7, 
respectively. The recovery rates for β-lactoglobulin and β-casein were very high, 
suggesting the near complete release of glutamine from these proteins. The percent 
recovery for α-lactalbumin was likely lower than expected because many of the 




Hydrolysis would be more difficult to achieve in these areas, which accounts for the low 
percent recovery of glutamine in α-lactalbumin (Tsao & Otter, 1999). 
Acidic amino acids are not the only residues that can prevent or slow down 
hydrolysis of proteins. Proline may be resistant to enzyme hydrolysis as well. Thirty-
eight percent of the glutamine residues of β-casein are adjacent to proline residues; 
however, this did not appear to affect the release of glutamine (average percent recovery 
= 100.9 ± 2.7). Tsao and Otter (1999) attributed this finding to aminopeptidase M, which 
specifically releases glutamine and asparagine from peptides. In this study, the rate of 
hydrolysis of the peptide glutamine-proline (10 minutes) was faster than that of proline-
glutamine (2 hours). Although aminopeptidase M releases glutamine from peptides, it 
does so at a much slower rate when those glutamine residues are adjacent to a proline 
residue. These results demonstrate how acidic amino acids and proline can prevent 
complete hydrolysis of protein samples (Tsao & Otter, 1999). 
Unlike enzyme hydrolysis, the mean percent recovery for the three proteins using 
acid hydrolysis could not be determined because glutamine residues were fully converted 
into glutamic acid residues. The discrepancy in the percent recovery of glutamic acid 
between enzyme and acid hydrolysis provided evidence for this conversion. The glutamic 
acid percent recoveries for α-lactalbumin, β-lactoglobulin, and β-casein were 35 ± 2.5, 
46.1 ± 2.9, and 32.3 ± 2.3 using enzyme hydrolysis, respectively, while the values were 
112.7 ± 5.2, 113, and 103.3 using acid hydrolysis (Tsao & Otter, 1999). 
Overall, it appeared that enzyme hydrolysis is a better method for the 
quantification of glutamine in proteins and peptides than acid hydrolysis. The proteins are 




chemical modifications. However there are slight drawbacks to this method. In particular, 
it is difficult to hydrolyze glutamine residues that are adjacent to acidic amino acids and 
proline. However, the advantages from this procedure outweigh this drawback and 
provide a more solid technique to quantify glutamine in protein-containing supplements 
(Tsao & Otter, 1999). 
This three-enzyme system has been used in other studies to determine the amount 
of glutamine (Baxter, et al., 2004). Baxter et al. (2004) has used the enzyme digestion as 
described by Tsao and Otter (1999) to quantify the amount of glutamine in twelve liquid 
nutritional products. The study reported that a significant fraction of glutamine 
deaminated to glutamic acid in the process of enzyme hydrolysis. The glutamine content 
(mole percentage) for purified proteins was 4.11 ± 0.11, while the mole percentage for 
nutritional products was 4.23 ± 0.13. These values were added to the actual glutamine 
concentrations measured in this study (Baxter, et al., 2004). This study suggests that 
enzyme hydrolysis also converts glutamine to glutamic acid, but not to the degree that 
acid hydrolysis does. 
The total glutamine concentrations in 11 of the 12 products were in the range of 
4.00 to 6.53 g per 1500 kcal. The extent of glutamine release was also examined in three 
caseinate-based nutritional products and in three purified proteins (β-casein, β-
lactoglobulin, and bovine serum albumin) by calculating the glutamine to GLX ratio. The 
molar amount of glutamine was determined from enzyme hydrolysis, while the molar 
amount of GLX was from acid hydrolysis. As mentioned above, each glutamine 
component includes a 4.1-4.4% component to account for glutamine deamination during 




was 91%, while the glutamine release from the three purified proteins averaged to be 
98%. These data indicated that enzyme hydrolysis was capable of releasing greater than 
90% of the total amount of glutamine in casein-dominated proteins (Baxter et al., 2004). 
Therefore, this study supported the need for enzyme hydrolysis in determining the 
amount of glutamine in proteins and protein-related products. 
2.4.5 Pre-column Derivatization of Glutamine with PITC 
Pre-column derivatization has been shown to be necessary in amino acid analysis 
using HPLC in order to make the amino acids detectable under UV light (Rowley, 
Martin, & Marsden, 1995). The best derivatizing agents react quickly and quantitatively 
without significant rapid degradation of the derivatization products. Also, these agents 
should have low detection limits and react with both primary and secondary amines. 
Derivatization should yield only one product per amino acid to allow each amino acid to 
be detected by HPLC. Good derivatizing agents do not interfere with the 
chromatographic separation (Bank, Jansen, Beekman, & te Koppele, 1996). Finally, 
derivatizing agents need to be volatile to make these agents more easily removed by 
evaporation (Heinrikson & Meredith, 1984). 
Pre-column derivatization has been proven superior to post-column derivatization 
due to better resolution and sensitivity (Allison, Mayer, & Shoup, 1984). Pre-column 
derivatization is also more user-friendly than the classical ion-exchange post-column 
techniques using ninhydrin (Strydom & Cohen, 1994). Several different agents have been 
used for the purposes of derivatization including fluorenylmethyl chloroformate (FMOC-




2.4.6 Fluorenylmethyl Chloroformate 
A study has shown some of the advantages of fluorenylmethyl chloroformate 
(FMOC-Cl), which include that it reacts quickly and quantitatively with both primary and 
secondary amines, and that it is relatively stable to other sample matrix components, such 
as salts. It also has detection limits as low as the picomolar level and is stable at room 
temperature for several days (Bank, et al., 1996). The major disadvantage of FMOC-Cl as 
a derivatizing agent is its reactivity with water. FMOC-Cl reacts with water to form 
FMOC-OH, which elutes in the middle of the chromatogram and often interferes with 
elution of amino acids. Therefore, the amount of FMOC-OH that elutes must be factored 
in and subtracted when quantifying some amino acids (Bank, et al., 1996). It is critical to 
remove any excess FMOC-Cl to ensure as little interference with amino acid 
quantification as possible (Carratù, Boniglia, & Bellomonte, 1995).  
2.4.7 Dabsyl Chloride 
Dabsyl chloride derivatives are also stable at room temperature and have 
detection limits in the low picomolar range. Dabsyl chloride derivatives can also be 
detected in the visible range at wavelengths from 436-460 nm (Krause, Bockhardt, 
Neckermann, Henle, & Klostermeyer, 1995). However, similar to FMOC-Cl, the major 
disadvantage of dabsyl chloride in derivatization is that this agent interferes with its 
derivatives and forms of multiple derivatives, which complicates quantification 
(Battaglia, et al., 1999). 
2.4.8 O-phthalaldehyde 
O-phthalaldehyde (OPA) is the most commonly used derivatizing agent due to its 




with a thiol, often mercaptoethanol, to form an isoindole (Concha-Herrera, et al., 2006). 
One major problem with OPA deriviatives is they are unstable, so they require an 
automated online monitor that gives exact reaction times and analysis must be done 
immediately (Siebert, Palmer Jr, & Hirsch, 1991). A second problem is that OPA does 
not derivatize glycine, threonine, or secondary amines, such as proline (Battaglia, et al., 
1999).  
2.4.9 Phenyl Isothiocyanate 
One advantage of Phenyl isothiocyanate (PITC) is that this agent derivatizes both 
primary and secondary amines (Battaglia, et al., 1999). A second advantage is that PITC-
derivatives have detection limits in the low picomolar level and can be quantified over a 
wide range of concentrations (Molnar-Perl, 1994). PITC is volatile, which means that its 
removal is possible using high-pressured vacuum (Heinrikson & Meredith, 1984). The 
removal of excess PITC is the most important step in the derivatization procedure 
because excess PITC can damage the HPLC column. PITC derivatives are much more 
stable than OPA derivatives and can be stored in a freezer for a long period of time 
(Molnar-Perl, 1994). Finally, the PITC reaction is quantitative and fast. Derivatization is 
more than 99% complete in only five minutes (Heinrikson & Meredith, 1984). However, 
the reaction is generally allowed 20 minutes for completion to be on the safe side 
(Molnar-Perl, 1994).  
Strydom and Cohen (1994) found the derivatizing agent 6-aminoquinolyl-N-
hydroxylsuccinimidyl carbamate (AQC) to be superior to PITC based on greater stability 
of the AQC derivatives. However, they did not analyze glutamine in their study. Phenyl 




1999). Tsao and Otter (1999) were able to quantify glutamine and obtained 97% recovery 
of free glutamine with PITC as the derivatizing agent, suggesting that PITC effectively 
derivatizes glutamine. These authors found that PITC had three peaks on their 
chromatograms, but none of these peaks interfered with peaks for any of the amino acids. 
Overall, the literature suggests that PITC can be used as a derivatizing agent in the 
accurate quantification of glutamine, and PITC has some significant advantages over 




2.5 Urinalysis Literature 
2.5.1 Executive Summary of Urinalysis Literature Review  
The detection of proteinuria is important in diagnosing and predicting the 
outcome of most renal diseases. However, the most common method involves the 
measurement of protein concentration in timed urine collections over a 24-hour period. 
Though this method helps to overcome the fluctuations in protein concentration observed 
throughout the day, it is time consuming and often imprecise. An alternative method that 
avoids the timed urine collections is the measurement of the ratio of protein to creatinine 
in single random urine samples. The time at which the spot urine sample is obtained does 
not impact the proteinuria test when the protein to creatinine ratio is measured. In 
addition, demographic factors such as the patient‟s sex, degree of proteinuria, and current 
renal state also do not impact the accuracy of the results. Since the determination of the 
urinary protein content is dependent on the creatinine content, a concern is that 
individuals who are orally consuming creatine (a creatinine precursor) may affect their 
protein to creatinine ratio; however, creatine supplementation does not alter the urinary 
protein to creatinine ratio. The effect of glutamine supplementation has also been studied 
using urinary protein measurements but only in animal models. Little research currently 
exists in correlating the effect of glutamine supplementation to increases in proteinuria as 
a precursor to renal disease in humans. 
2.5.2 Urinary Protein Excretion  
The glomerular filtration rate (GFR) provides the most accurate estimation of 
renal function (Kang, Han, Kim, & Cha, 2005). Therefore, it is important to have a 




renal disease and correctly prescribe drug dosages. Since it is difficult to measure the 
GFR in clinical practice, most physicians measure the serum creatinine concentration as 
an estimation of the GFR. Creatinine is a useful filtration marker since it is produced 
endogenously, filtered by the glomerulus, not protein bound, and metabolized in the 
kidney. It is secreted by renal tubule and affected by factors such as renal disease, muscle 
mass, meat intake, nutritional status and drugs (Kang, et al., 2005). The method 
traditionally used to measure creatinine clearance is based on the collection of urine 
samples over a 24-hour period. However, this method is inconvenient and sometimes 
inaccurate due to inconsistencies in collection times. Therefore, measurement of protein 
excretion is often used as a screening test to evaluate glomerular filtration. To eliminate 
the interference of changes in concentration of urine, the value of protein excretion is 
usually expressed as a ratio relative to the value of creatinine in the same sample of urine. 
Protein excreted by the kidney is a product of the serum proteins that have been 
filtered through the glomerulus. The kidney may excrete protein normally during 
congestive heart failure, upon exposure to cold, post-exercise, or during various 
conditions that cause alterations in renal circulation (King, 1957). Protein excreted by the 
kidney during chronic renal disease can indicate changes in the pathology of the disease. 
Increases in protein excretion often indicate progressing renal disease. Proteinuria is 
defined as an excessive rate of protein excretion relative to creatinine excretion in the 
urine. Chronic (persistent) proteinuria may be the only clinical evidence of progressive 





2.5.3 Urinary Protein Levels used to Detect Proteinuria  
Chronic renal disease affects over 5% of the general population and therefore, 
there is a need to detect early signs indicative of renal dysfunction when treatments are 
most effective (Gai, et al., 2006). Normally, small amounts of protein are excreted in the 
urine (approximately 80 mg/day) and contain both filtered plasma proteins, such as 
albumin and low molecular weight immunoglobulin, and secreted tubular proteins 
(CARI, 2004c).  
The normal range for creatinine excretion in young and middle-aged males is 
1100 to 2000 mg/day (16 to 26 mg/kg body weight per day) and in females is 750 to 1400 
mg/day (12 to 24 mg/kg body weight day). Levels of urinary creatinine excretion steadily 
decrease with age in both sexes from 8 to 15 mg/kg body weight per day once a person 
reaches the approximate age of 80 (Kampmann, Siersbaek-Neilsen, Kristensen, & 
Hansen, 1974). Generally, proteinuria is diagnosed in adults when there is greater than 
150 mg of protein excreted in a 24-hour period. In newborns (30 days), infants (12 





/day, and 85 mg/m
2
/day, respectively (Miltenyi, 1979). If 
proteinuria is detected in an asymptomatic patient, it is usually an indication of either an 
initial manifestation of a severe renal disease or a temporary nonprogressive renal 
abnormality of little importance (Miltenyi, 1979).  
2.5.4 Proteinuria Classifications  
Proteinuria is classified based on different qualities: quantity (non-nephrotic or 
nephrotic), character (intermittent or constant), posture (orthostatic or nonorthostatic), or 




proteinuria with hematuria) (Wingo & Clapp, 2000). In isolated proteinuria, there is no 
real evidence of renal disease and the proteinuria is likely a result of an urine sediment 
abnormality. Severe and/or constant proteinuria is often the result of a primary renal 
disease or it may be a result of a secondary involvement of the kidney from a systemic 
disease. Nevertheless, patients diagnosed with severe or constant proteinuria often have a 
decreased life expectancy in relation to the general population (Wingo & Clapp, 2000). 
As a result, it is vital that the methods used to identify and classify proteinuria are 
accurate, and that the result is confirmed by multiple measurements. 
A positive test for proteinuria has been shown to be a sign of potential renal 
damage and proteinuria diagnosis is often the first sign of a serious renal disease. If 
proteinuria is detected in a patient with a nonrenal illness, it is often concluded that the 
illness may also involve the kidneys. The most common cause of proteinuria is 
glomerular disease with serious manifestations such as the nephrotic syndrome, 
hypertension, or progressive renal failure (Abuelo, 1983). Regardless of the cause, 
diagnosis of proteinuria has several implications for the patient. Due to the severity of 
renal disease, if the proteinuria is classified as persistent, this may lead to rejection from 
the armed forces, denial of life insurance, or exclusion from new employment 
opportunities (Abuelo, 1983). Therefore, accurate diagnosis of proteinuria is important to 
appropriately evaluate the clinical actions to either treat the condition or, if treatment is 
unavailable, inform the patient of the prognosis.  
2.5.5 Methods for Assessing Proteinuria  
There are three main methods that have been used to detect and diagnose 




collection, and dipstick urinalysis. The standard method for measuring proteinuria is the 
24-hour urine collection. In the 24-hour urine collection method, accuracy is decreased 
due to uncertainties in the time of collection and volume determinations (Steinhauslin & 
Wauters, 1995). In addition, this method takes an entire day to collect and is, therefore, 
impractical for routine screening and inconvenient for patients and clinicians who need to 
make quick, informed decisions. A simple alternative to 24-hour urine collection for 
assessing urinary protein is to perform qualitative tests for protein concentration on 
random spot urine samples, either using dipstick urinalysis or measuring the protein to 
creatinine ratio. As compared to the traditional 24-hour urine collection, spot urine 
samples are more convenient for patients since only a single morning urine collection is 
required. The results are available within hours and there is higher sensitivity in the 
detection techniques (Wheeler, Blackhurst, Dellinger, & Ramsey, 2007). In combination 
with other signs and symptoms, a rapid screening test can accurately be used to predict 
24-hour proteinuria and help guide clinicians in making quick and informed decisions. 
 The dipstick urinalysis method is often used as an initial rapid screen to measure 
the concentration of protein in the urine. Unfortunately, this method results in low 
sensitivity and specificity, potentially due to inter-observer variation (Steinhauslin & 
Wauters, 1995). The dipstick method is susceptible to fluctuations in the water content of 
the urine so dilute urine may underestimate the protein concentration that would be 
measured in a 24-hour urine collection whereas a concentrated urine sample may 
overestimate it. Previous studies have shown that dipstick urinalysis products vary in 
degrees of accuracy with sensitivities ranging from 22 to 82% (Dwyer, Gorman, Carroll, 




disease in the patients or the time of day that the spot urine sample was obtained. 
Therefore, the dipstick method is highly limited in its ability to estimate the level of 
proteinuria and detect small but potentially clinically important changes in the levels of 
urinary protein excretion. Dipstick protein analysis has also been shown to result in high 
rates of false positives and false negatives. In studies that involve suitable at-risk 
populations, the incidence of proteinuria as detected by the dipstick method is less than 
10%, which is not consistent with the results of other methods (CARI, 2004b). An 
alternative method is to use a test strip on a single urine sample to detect proteinuria 
related to creatinine but this test is not widely available yet (Gai, et al., 2006). 
The use of the protein to creatinine ratio in a single urine sample also has 
advantages over both the 24-urine collection and the dipstick urinalysis. As opposed to 
the traditional 24-hour urine collection, measuring the protein to creatinine ratio in a 
single urine sample is time independent because the excretion of protein and creatinine 
are both expressed per unit time. This provides an estimation of 24-hour protein excretion 
if stable renal function is assumed. In addition, the ratio is normalized between urinary 
protein excretion and creatinine clearance (Wheeler, et al., 2007). As opposed to dipstick 
urinalysis, this technique is not subject to variation due to hydration status because it 
compares the spot urine protein excretion to the spot urine creatinine excretion, which 
normalizes the protein excretion to the same rate as glomerular filtration (Dwyer, et al., 
2008). It has been shown that the urine protein to creatinine ratio is more sensitive than 
automated dipstick urinalysis with sensitivities of 96% to 41% (P < 0.0001). The protein 
to creatinine ratio is also a better screening test for early diagnosis in more patients (64% 




method (Gai, et al., 2006). In addition, using random urine testing based on the ratio of 
creatinine to protein to assess proteinuria has been shown to have good correlation to 
results from 24-hour urine total protein measurements in a wide range of patient groups 
(i.e. normal, known renal disease, diabetes, etc. (CARI, 2004b). 
Therefore, the use of the protein to creatinine ratio accurately estimates the level 
of proteinuria and avoids the potential errors seen in the dipstick and 24-hour sampling 
methods. In a study of almost 300 outpatients with varying degrees of renal disease, a 
high correlation was observed between all the tests (P < 0.0001) but the highest 
regression coefficient was observed between the 24-hour urine collection and the protein 
to creatinine ratio (R = 0.82) and the lowest regression coefficient was observed between 
the protein to creatinine ratio and the dipstick urinalysis (R = 0.72). In addition, the 
dipstick urinalysis method was unable to detect proteinuria in approximately 31% of the 
patients examined (Gai, et al., 2006).  
2.5.6 Correlation Between Protein to Creatinine Ratio and 24-hour Urine Excretion  
The protein to creatinine ratio can be used to estimate urinary protein excretion 
because urinary creatinine clearance at a stable glomerular filtration rate (GFR) is fairly 
constant. In a study of approximately 40 patients with varying degrees of renal disease, 
24-hour urine samples and single-voided urine specimen from four different time points 
were collected. A strong correlation was observed between the 24-hour urine protein 
excretion measurements and the protein to creatinine ratio in single voided urine samples 
at varying degrees of creatinine clearance and ranges of proteinuria (Chu, et al., 1990). A 
simple ratio of the concentration of protein to the concentration of creatinine in a spot 




period because the ratio cancels out time as a variable (Ginsberg, Chang, Matarese, & 
Garella, 1983). In addition, there is a highly significant (P = 0.0001) correlation between 
the protein to creatinine ratio values in spot morning urine samples and 24-hour protein 
excretion but the correlation decreases with increases in the ratio value (Ruggenenti, 
Gaspari, Perna, & Rumuzzi, 1998).  
2.5.7 Effect of Time and Demographics on Spot Urine Samples for Protein to Creatinine 
Ratio  
The protein to creatinine ratio on both first morning and early morning urine 
samples and random urine samples correlates well with measurements from 24-hour 
urine collections. This indicates that the time at which the urine specimen is obtained 
does not impact the final results (CARI, 2004a). In a study by Ginsberg et al. (1983), the 
highest correlation between the protein to creatinine ratio and the 24-hour urinary protein 
excretion was seen when the spot urine samples were obtained after the first voided 
morning sample and before bedtime. Hence, even though the time at which the spot urine 
sample is obtained should not significantly impact the protein to creatinine ratio, if 
abnormally high levels of urinary protein are observed in a random untimed urine 
specimen, the results should be confirmed with a first morning urine sample to confirm 
the proteinuria diagnosis (CARI, 2004a).  
In a study to investigate the effect of several variables, such as time of samples, 
patient‟s sex, degrees of proteinuria, and renal function, the urinary protein to creatinine 
ratio was measuring in samples obtained at three time points throughout the day and 
compared to the 24-hour urine excretions. This study by Kristal et al. (1988) involved 




correlation was observed in urine samples collected at 08.00 and 12.00 hours and the 
lowest correlation was observed in urine samples obtained at 16.00 hours. This degree of 
correlation was unaffected by the patient‟s level of proteinuria or sex, but it was slightly 
affected by the rate of glomerular filtration (Kristal, Shasha, Labin, & Cohen, 1988). In a 
study by Chu et al. (1990), no significant differences were found between patients of 
different age groups or sexes when using the protein to creatinine ratio at different time 
intervals to estimate urine protein excretion. Therefore, the protein to creatinine ratio is 
not significantly affected by sex or age (Chu, et al., 1990).  
2.5.8 Effect of Oral Creatine Supplementation on Protein to Creatinine Ratio  
Creatine is synthesized endogenously by the body and stored in skeletal muscle 
tissue in a high-energy phosphorylated form. When it is phosphorylated, it plays an 
important role in the metabolism of energy by supplying phosphate groups to ADP to 
regenerate ATP (Poortmans, et al., 1997). When muscle contraction occurs, creatine and 
creatine phosphate are spontaneously converted directly into creatinine. Creatinine is then 
eliminated from the body in the urine through renal excretion at a relatively consistent 
rate. Therefore, creatinine is an ideal clinical marker to assess renal function (Ropero-
Miller, Paget-Wilkes, Doering, & Goldberger, 2000). 
Oral creatine supplementation of 20-30 grams of creatine per day for several days 
has been shown to increase human skeletal total creatine and phosporylcreatine (Balsom, 
Soderlund, & Ekblom, 1994). As a result, oral creatine supplementation has increased 
among athletes who hope to enhance their performance. However, it has been suggested 
that ingestion of such nitrogen-rich products might induce chronic renal hyperfiltration 




deterioration of the kidney (Brenner, et al., 1982). If taken in large excess, the two amino 
and one carboxyl groups of creatine and its high nitrogen content could theoretically add 
additional strain on the kidney (Poortmans, et al., 1997).  
One concern is if creatine supplementation affects blood samples and urine 
collections analyzed for creatine and creatinine. In a study of five healthy men who 
ingested either a placebo or 20 grams of creatine monohydrate per day for five 
consecutive days, the levels of creatine significantly increased in blood and urine 
excretion levels but the creatinine levels were unaffected (Poortmans, et al., 1997). The 
non-enzymatic reaction of muscle creatine to creatinine is not affected by a large influx 
of creatine from supplementation. This indicates that normalization of urinary analyses 
can still be measured using creatinine values even if patients are using creatine 
supplements (Poortmans, et al., 1997). Another short-term study did not reveal any 
apparent effect of oral creatine supplementation administered at recommended daily 
doses on the integrity of routine urine tests (Ropero-Miller, et al., 2000). Therefore, oral 
creatine supplementation does not affect creatinine clearance and protein excretion so the 
protein to creatinine ratio will not be altered if an individual is using creatine 
supplements.  
2.5.9 Testing for Albuminuria as Compared to Proteinuria  
Urinary protein excretion can be quantified in terms of total protein or albumin. 
Albumin, a small protein that is found in large quantities in the blood, is one of the first 
proteins to pass through the kidneys into the urine upon the development of kidney 
disease. Detection of albuminuria occurs by the same method as for proteinuria except 




ratio. The relationship between urinary albumin excretion and total protein excretion and 
the benefits of one test over the other remains undefined due to a lack of large-scale 
studies examining albuminuria and proteinuria (Atkins, Briganti, Zimmet, & Chadban, 
2003). A study by Shihabi et al. (1991) demonstrated that urinary albumin excretion 
levels increase seven-fold in patients with kidney disease while urinary total protein 
levels remain within the normal reference interval. The researchers found that urinary 
total protein measurements are often subject to analytical difficulties whereas urinary 
albumin excretion measurements are easier to standardize. Therefore, it was concluded 
that urinary albumin measurements are a more sensitive indicator of a wide variety of 
renal disorders than urinary total protein levels (Shihabi, Konen, & OConnor, 1991). A 
recent study by Collier et al. (2009) examined the relationship between proteinuria and 
albuminuria as a means to determine which is more sensitive and specific in detecting 
chronic kidney disease. Urine samples were analyzed using both the albumin to 
creatinine ratio (ACR) and the protein to creatinine ratio (PCR) and it was determined 
that either ratio can successfully be used to identify clinical proteinuria (Collier, Greenan, 
Brady, Murrary, & Cunningham, 2009). 
In the first large-scale, population-based study of the relationship between urinary 
albumin and total protein, a representative cross-section analysis of the Australian adult 
population showed that albuminuria rather than proteinuria is preferred for the testing of 
potential renal risk in the general population. Measurements of urine albumin excretion 
were strongly correlated with measurements for total protein excretion, particularly 
among the elderly, and those currently diagnosed with diabetes, hypertension, obesity and 




to protein ratio was 91.7% sensitive and 95.3% specific, but as a test among patients 
previously diagnosed with proteinuria, 8% were found to have urinary albumin excretion 
levels within the normal range. Therefore, it was concluded that while a measurements of 
the albumin to creatinine ratio may be a suitable test for general population screening for 
renal disease, overall it should not replace the standard protein to creatinine ratio testing 
for proteinuria in patients those with known or suspected renal disease (Atkins, et al., 
2003).  
2.5.10 Urinalysis Study on the Toxicology of Glutamine  
L-glutamine (Gln) is a semi-essential amino acid and mammals are unable to 
synthesize Gln sufficiently during catabolic stress. Therefore, administration of Gln is a 
potential therapeutic agent in critically ill patients and is contained in several dietary 
supplements available to the public. Due to the precedence of Gln supplements, a study 
was performed to examine the toxicological effects of Gln in male and female Sprague-
Dawley rats (Tsubuku, Hatayama, Mawatari, Smirga, & Kimura, 2004). Gln was 
administered as part of a standard diet at doses equal to 1.25%, 2.5%, and 5.0% (w/w). 
All diets were administered for 13 consecutive weeks following by a 5-week recovery 
period during which only the standard diet was administered to all animals. Among other 
tests, a urinalysis study was conducted in all rats during weeks 5 and 13 of Gln 
administration and also during week 5 of the recovery period post Gln administration. At 
the end of the administration period, several changes in urine parameters (particularly, 
total protein) were observed in the 2.5% and 5.0% groups (Tsubuku, et al., 2004). One 
trend indicated an increase in the number of positive incidences for total urinary protein 




increase and no pathological effects in the kidney tissues were observed. Since the 
changes in the 2.5% and 5.0% groups were infrequent and toxicologically insignificant, 
the definitive toxic level for Gln was determined to be greater than 5.0% (w/w) (Tsubuku, 






Chapter 3: Methodology 
3.1 Survey Research Methodology 
3.1.1 Survey Design and Administration 
Team Juiced designed a survey in both paper-and-pencil and computerized 
formats in order to collect data from individuals on the University of Maryland, College 
Park campus regarding their protein supplement usage (refer to Appendix A.1). The 
survey was intended to obtain information on the habits and behaviors of protein 
supplement users that was then used to complement the lab data found in the USU lab 
and the CFSAN lab at the FDA.  
A short, two-page questionnaire was administered to students who frequented the 
campus gyms, club athletic team members, intramural sports players, varsity athletes, and 
members of the Reserve Officers‟ Training Corps (ROTC). The survey was designed to 
be administered in person. Purposive sampling was used in order to target the student 
population that would provide the most relevant data efficiently and effectively. Since 
Team Juiced targeted students who engaged in physical activity, the survey was 
distributed to students who shared the characteristics of either a) participating in a varsity, 
intramural, or club sport at the university, b) exercising at one of the university‟s two 
recreational facilities on campus: the Eppley Recreation Center or Ritchie Coliseum, or c) 
being a member of the ROTC program.  
The survey immediately separated protein users and protein non-users by asking 
them to indicate in which category they belonged. Supplement users were asked which 
product(s) they currently use or have used in the past, how much of the product they 




supplements or medications that they took concurrently, and their present health status 
and family medical history regarding diabetes, kidney disease, clinical obesity, and 
hypertension. Non-users were similarly asked about their personal and family medical 
history as well as any medications that they were taking. All participants were asked to 
identify themselves as either gym-goers, club, intramural, or varsity athletes, or ROTC 
members. All participants were asked to state their sex, their age, and how many hours 
per week they exercised. In order to maintain participant anonymity, each survey was 
coded with a four-digit number on each page including the informed consent page. After 
completion of the survey, the informed consent page with the participant‟s name on it 
was separated from the rest of the survey thereby detaching any name association with 
particular survey responses. 
Survey distribution varied depending on which part of the targeted population 
was being tested. In order to survey students who exercised at one of the gyms on 
campus, Team Juiced had to schedule twelve different collection dates of five to ten 
hours per date at the Eppley Recreation Center or Ritchie Coliseum. On each date, Team 
Juiced set up a table and handed out surveys to students who were interested, also known 
as purposive sampling. To encourage attendance at the gym during the time of survey 
collection, members of Team Juiced sent out advertisements to various departmental, 
academic, and club e-mail listservs. Free water bottles were offered as an incentive for 
those who took the survey at one of the campus gyms. 
Club and intramural team members as well as ROTC cadets were surveyed 
differently. The presidents of the club and intramural teams were contacted via e-mail by 




during one of the teams‟ practices. Upon permission of the president, teams of two or 
three Team Juiced members went to a practice for each club or intramural team and 
distributed surveys. Twenty-one of the university‟s club teams were surveyed. These 
included the following: tennis, black belt club, women's volleyball, kendo, women's 
basketball, squash, sailing, women's soccer, weightlifting, water polo, Terp runners, 
men's crew (novice and regular), men's soccer, cycling, swimming, table tennis, softball, 
men's rugby, women's rugby, boxing, and men‟s volleyball. Intramural sports teams 
proved difficult to reach, but intramural flag football was surveyed and provided many 
useful data. In addition, members of ROTC were surveyed in the same manner as the 
club and intramural teams. The Director of the Army ROTC, LTC Ranelle A. Manaois 
was emailed for permission to distribute surveys. Surveys were given to LTC Manaois, 
and she distributed them to the cadets. Because of the cooperation from the presidents of 
each of these teams as well as LTC Manaois, there was no water bottle incentive for any 
of the club, intramural, or ROTC participants. 
To survey varsity athletes anonymously, Team Juiced had to use a new data 
collection technology method referred to as a computerized self-administered 
questionnaire (Biemer & Lyberg, 2003). Team Juiced used an online survey website, 
Survey Monkey to create an identical version of the paper-and-pencil survey available 
over the internet. Varsity athletes were surveyed over the internet because Team Juiced 
was not permitted to survey varsity athletes during their team practices. An 
announcement was sent to the varsity athlete e-mail listserv encouraging them to take the 
online survey and providing them with a direct web link to the survey. No incentive was 




ensure anonymity just as the paper surveys were. In total, online surveys accounted for 
approximately 10% of the overall responses with 96 varsity athletes completing the 
survey online. 
After collecting the responses from 947 total survey respondents, they were 
entered into an SPSS file for statistical analysis. Several conversions were required for 
this process in order to organize all of the data into standard measurements. For example, 
the actual survey listed several options for participants to describe the amount of each 
protein supplement that they took. They could provide the amount in number of the 
scoops, pills, or capsules. Due to the wide range of supplements used, each of these forms 
connoted a varying level of protein per serving size. Reference sheets were therefore 
generated by Team Juiced detailing the actual amount of protein in grams that the labels 
of each form (pills or powder) of the products claimed to contain in a serving size. These 
conversions were then used to generate the amount of protein in grams taken by each 
respondent. Similar conversions were made for length of usage. The survey allowed the 
participant to indicate either how many times per day they used a product or how many 
times per week they used it. For standardization purposes, all responses were entered into 
the SPSS file in terms of times per week. Therefore, if a participant provided information 
in times per day, that information was multiplied by seven. Responses in the duration of 
usage category needed to be standardized as well. Participants could indicate that they 
had taken a product for a duration of weeks, months, or years. In the SPSS file, Team 
Juiced converted all of these responses into weeks. If a participant therefore indicated that 
he or she was taking a product for three months, the response was entered into the SPSS 




Following entry, the data was “cleaned” by team members. Data cleaning 
involved double-checking each entered response on the SPSS file for accuracy by 
comparing it to the original paper-and-pencil or computerized answer sheet. The data 
cleaning process verified the information originally entered and validated it with the 
original answer sheet and checked all of the entries for accuracy. Accuracy was 
especially important in the conversions that were made. The purpose of data cleaning was 
to eliminate the probability of processing or measurement error to the best of the team‟s 
capability so that those errors would not skew the results.  
3.1.2 Data Entry Assumptions and Limitations  
There are several significant assumptions and limitations related to the data entry 
process that are critical to understanding the results of this research. First, when entering 
data into the “times of use” category, all numbers were converted into weeks with the 
understanding that there are four weeks in a month and fifty-two weeks in a year. For 
example, if a survey participant responded that he or she used a supplement two times per 
day, this was entered into the SPSS computer program as fourteen times per week. 
Another category was also added for individuals who responded that they used a 
supplement either rarely or inconsistently. The number “0” in the SPSS file coded for 
these types of users. A second assumption involved products with long and complicated 
names. For some surveys with incomplete product information, a specific product was 
assumed. This was the case for “Muscle Tech Nitro-Tech Hardcore,” “Muscle Tech Cell-
Tech Fruit Punch,” and “CytoSport Muscle Milk.” The most commonly incomplete 
product listed was “100% Whey.” For surveys claiming to be using “100% Whey”, the 




because GNC Pro-Performance Whey Protein was the most commonly used whey protein 
supplement. For surveys that listed “Smoothie Booster” for the type of protein 
supplement that the respondents were taking, it was assumed that the product was 
Smoothie Booster C from “The Smoothie Shop.” For the purposes of this study, all pure 
creatine products were classified as “other supplements” and not as protein.  
After most of the data had been entered, a second round of “data cleaning” 
ensued in which each survey in the SPSS system was checked for accuracy and 
consistency. This process consisted of going through all of the surveys again and making 
sure that the data had been accurately entered. During this second round of entry, the 
“amount taken” category was especially revised. This category coded information 
regarding how much protein an individual consumed at one time. For some surveys, the 
data recorded for this question was unclear or missing. In these cases, the product used 
was stated, and an assumption was made that the participant used the standard serving 
size. For example, if a participant responded that he or she used GNC Pro-Performance 
Whey Protein product but failed to say how much of the product he or she used at a given 
time, the serving size provided on this product label, 31 grams was assumed and entered 
into the SPSS file. In order to keep all of the numbers in this category consistent, each 
serving size was converted and entered in grams. This required some conversions of pills, 
scoops, and fluid ounces into grams. If the data showed that a person measured his or her 
protein intake in cups, it was assumed that one cup equaled one scoop and then the gram 
conversion was performed.  
In addition, for the respondents who were over the age of 25, the team grouped all 




the respondents over the age of 25 into one category. This is a limitation to the 
comparison of means for Age of the respondent vs. Amount of protein used for products 
1, 2, and 3 since the team is assuming one age for any of the respondents over the age of 
25 who in fact comprise a portion of the college-aged population that the team was 
testing. 
Statistical analyses were then performed using SPSS. The data was analyzed 
using descriptive statistics. Descriptive statistics included sample size numbers for 
various segments of the tested population, means, standard deviations, and frequency 
distributions. Tests for associations between variables for comparisons of means included 
multiple Spearman‟s Rho bivariate correlational tests. Additionally, depending on the 
nature of the comparison of means, independent samples t-tests and One-Way ANOVA 
variances were used to generate results. After completing these varying types of 




3.2 Kidney Cell Modeling Methodology  
3.2.1 Overview  
Several studies with humans and animal models have shown the increased 
development of chronic kidney disease in response to high-protein diets (Brenner, et al., 
1982; Klahr, 1996; Levey, et al., 1999). Of the constituent amino acid residues, glutamine 
is the most prevalent in common proteins such as casein and whey. Extending our efforts 
to serve the college athletic community, a group that commonly uses protein 
supplements, the team has collaborated with Dr. Sonia Doi, M.D., Ph.D., Director of 
Nephrology Research Laboratory, Department of Medicine, Uniformed Services 
University.                  
Under the guidance of Dr. Doi, the team aimed to discover the expression 
patterns of LDL-r in the mouse mesangial cell model in response to varying glutamine 
conditions. Such knowledge would ultimately contribute to finding a biochemical 
pathway by which glutamine affects kidney cells. Several researchers have previously 
used the mouse mesangial cell model (Doi, et al., 2000; Lagranha, et al., 2008; Meek, et 
al., 2003; Pithon-Curi, et al., 2006).  
Gene expression studies were used to detect the increase in the synthesis of 
several proteins in response to extracellular stimuli, i.e. glutamine concentration. In 
animal cells, the nucleus shields DNA but allows RNA to pass to the cytoplasm where it 
is translated into specific proteins. The presence of this messenger RNA is a good 
representation of the expression of particular protein molecules and their representative 




and simultaneous polymerase chain reaction to amplify the gene of interest can evaluate 
the gene expression and related protein synthesis.  
Sclerosis of the glomerulus is a major cause of kidney disease. LDL cholesterol 
plays a role in the development of plaques on the walls of blood vessels, and it is 
hypothesized that LDL also plays a role in the excretion of matrix proteins by the 
mesangial cells of the kidneys, causing glomerulosclerosis. This pathway of sclerosis in 
the kidney must be tested by examining the expression of LDL-receptor. The time- and 
dose-dependency of LDL-r in response to glutamine. The primary goal of these 
experiments was to determine the time exposure and dosage related behavior of LDL-r 
with respect to glutamine. This information would progress research in the field of renal 
molecular biology with implications to protein supplementation.  
3.2.2 Cell Culture  
A primary culture of mouse mesangial (passage 16) cells were grown in a T75 
flask coated with fibronectin in a 3:1 mixture of DMEM/Ham‟s F12 media containing 6 
mM glucose, 1 mM glutamine, 0.075% NaHCO3, penicillin (100 U/ml)/streptomycin 
(100 μg/ml), and 20% fetal bovine serum (FBS, Life Technologies, Rockville, MD, 
USA). The cells were incubated at 37°C and 5% CO2 for 96 hours in order to reach 
confluence. The cells were then removed from the flask with trypsin and counted using a 
hemocytometer. Using aseptic dilution methods, the cell suspension was reduced to 1.5 x 
10
5
 cells per ml. One ml of cells and 2 ml of 20% FBS media were transferred to each 
well of a 6-well plate coated with fibronectin. The plates were incubated at 37°C and 5% 




no additional glutamine and incubated for 24 hours at 37°C, 5% CO2. Glutamine was 
added as needed according to each experiment.  
3.2.3 Time Course Study  
 A time curve for the expression of LDL-r was found by varying exposure time to 
supraphysiological (2.0 mM) glutamine in 5% FBS. The starvation media was aspirated 
from the 6-well plate and media containing either 0 or 2.0 mM glutamine in 5% FBS was 
added for duplicate wells incubated for 2, 4, 6, 8, 12, and 24 hours at 37°C, 5% CO2.  
3.2.4 RNA Extraction 
After the cells were exposed to experimental glutamine conditions, the cells were 
lysed to extract RNA. After aspirating the treatment media, 400 μl of a freshly prepared 
RLT buffer with beta-mercaptoethanol was added to each well. The buffer was prepared 
with a Qiagen RNEASY PLUS kit with DNAse. The plate was swirled until the solution 
reached maximum viscosity. A 20 gauge needle was used to shear the cells in each well 
by moving the plunger up and down 8 times. Extracted RNA samples were transferred to 
a 1.5 ml microcentrifuge tube and stored at -80 °C.  
3.2.5 OD and Dilutions  
To measure the concentration of the extracted RNA, 2.8 μl of extracted RNA was 
diluted with 67.2 μl of depc water. The optical density (OD) of each sample was 
measured at 260 nm using a spectrophotometer. Thanks to the ratio of RNA:water used, 
the OD readings were given in μg/μl. Ten μl of all samples were diluted to 20 ng/μl for 




3.2.6 Real Time RT-PCR  
TAQMAN one-step RT-PCR kit was used with 50 ng of RNA, 300 ng of forward 
and reverse primers and 200 ng of fluorescent probe per gene (See Appendix for Primers 
Chart). Beta-actin was used as the housekeeping gene for all experiments. A 
housekeeping gene allows normalization of genes of interest, such as LDL-r, so that the 
number of cells per well does not the level of expression. Samples were run in the 
Applied Biosystems 5700 system.  
3.2.7 Data Analysis 
The software loaded with the Applied Biosystems 5700 gave graphs of 
fluorescence versus cycle number. Each sample represented one well cultured as 
specified by the experimental protocol. All samples from an RT-PCR assay were given 
superimposed on the same graph. The cycle threshold (ct) is an value used to compare the 
relative expression of each sample. The ct values were found by adjusting a horizontal 
curser to intersect the most linear region of the graph. Ct values from genes of interest 
were normalized using the ct values from beta-actin expression. These normalized values 
were then compared, as a ratio, to control cells from each experiment that were not 
exposed to any glutamine. The ratio, or fold change compared to control cells, was used 
for discussion and included in all figures. All values reported represented mean ± 
standard error of the mean (SEM) of replicates. Statistical comparisons were done using 
one-way ANOVA tests.  
3.2.8 Dose Response Study 
After discovering the time curve of LDL-r expression from a 2.0 mM 




glutamine concentrations at 6 hours of exposure. Cells were cultured as in the time course 
study. Following the starvation step, 5% FBS media with glutamine concentrations of 0, 
0.5, 1.0, 2.0, 5.0, 7.0, 10.0, and 20.0 mM were added and incubated in duplicate wells for 
6 hours at 37°C, 5% CO2. RNA extraction, ODs and dilutions, and one-step RT-PCR was 
performed as in the time course study.  
3.2.9 Chronic Study 
After discovering the dose-dependent behavior of LDL-r in response to increasing 
glutamine concentrations at 6 hours, the chronic effects of glutamine were tested by 
exposing cells to varying glutamine concentrations for 48 hours. Cells were cultured as in 
the time course study. Following the starvation step, 5% FBS media with glutamine 
concentrations of 0, 0.5, 2.0, and 10.0 mM were added and incubated in triplicate wells 
for 48 hours at 37°C, 5% CO2. RNA extraction, ODs and dilutions, and one-step RT-PCR 
was performed as in the time course study. In addition to RT-PCR for LDL-r and beta-
actin, assays were run for 3-hydroxy-3-methyl-glutaryl Coenzyme A (HMG Co-A) 





3.3 Biochemical Analysis Methodology 
3.3.1 Materials 
L-glutamine and L-glutamic acid standards were obtained from the Sigma-
Aldrich Chemical Company. The enzymes used for the enzymatic hydrolysis were 
pronase E (5.9 units/mg solid), leucine aminopeptidase (12 units/mg solid), and prolidase 
(127 units/mg solid), all of which were obtained from the Sigma-Aldrich Chemical 
Company. The derivatizing solution consisted of a 7:1:1:1 ratio of ethanol, water, PITC, 
and triethylamine. The redry solution consisted of a 2:2:1 ratio of ethanol, Milli-Q water, 
and triethylamine. Solid sodium phosphate, acetonitrile, and N-2-
Hydroxyethylpiperazine-N'-2-Ethanesulfonic Acid (HEPES) buffer were obtained from 
Sigma-Aldrich as well. The protein and glutamine supplements used are listed below: 
 Body Tech L-Glutamine Powder, Recovery Agent 
 BSN Cell Mass 
 Companion Nutrition Pro-Score 100 
 Cytosport Complete Whey Protein 
 Cytosport Cytogainer  
 Cytosport Evo Pro 
 Cytosport Muscle Milk 
 EAS L-Glutamine 
 EAS Myoplex Original 
 GNC L-Glutamine Dietary Supplement 
 GNC Pro Performance 100% Whey Protein 
 GNC Pro Performance L-Glutamine 
 Met-RX Instantized 100% Ultramyosin Whey 
 Muscle Tech Mass Tech 
 Muscle Tech Nitro-Tech Hardcore 
 Optimum Nutrition Pro Complex 
 Optimum Nutrition Gold Standard Natural 100% Whey 
 Optimum Nutrition Gold Standard 100% Whey 
 Optimum Nutrition Glutamine Powder 
 Prolab Pure whey 




Any claims or conclusions made regarding the glutamine content of these 
products do not reflect the views or findings of the Food and Drug Administration. For 
the purposes of developing this method, each supplement will be designated a numerical 
name from Supplement 1 to Supplement 21. All of the supplements were obtained online 
from bodybuilding.com, with the exception of GNC Pro Performance 100% Whey 
Protein, which was purchased at a General Nutritional Center store. 
3.3.2 HPLC Conditions 
The HPLC analysis of the supplements was performed on a Waters2695 
Separations Module using a Vydac Denali C18 (250 mm x 4.6 mm, 120 Ǻ, 5 μm, Grace 
Davison Discovery Science, Deerfield, IL) reversed-phase column. Detection was 
performed with a Waters2996 Photodiode Array UV detector. The flow rate was 1.0 
mL/min with an injection volume of 5 µL. The mobile phase consisted of 25 mM sodium 
phosphate in water at a pH of 3.30 (solvent A), and acetonitrile (solvent B). The pH of 
the sodium phosphate solution was adjusted to 3.30 using phosphoric acid. At 0 minutes, 
the composition of the mobile phase was 95 % A and 5 % B. A gradient was started such 
that the composition of the mobile phase was 60 % A and 40 % B at 40 minutes. By 42 
minutes, the mobile phase was 20 % A and 80 % B. The composition of the mobile phase 
was maintained at 20 % A and 80 % B from 42 minutes to 50 minutes. The starting 
condition of 95 % A and 5 % B was reestablished by 51 minutes.  
3.3.3 Enzymatic Degradation 
The enzymatic degradation method was taken from Baxter et al. (2004). A 0.10 
M HEPES buffer solution in water with 0.1 % (w/v) sodium azide was made, and the pH 




50 mL of the 0.1 M HEPES buffer to give a concentration of 1.0 mg/mL. A 12 unit/mL 
solution of pronase E was made by adding 2 mL of 0.1 M HEPES to 4 mg of pronase E. 
A 24 unit/mL solution of leucine aminopeptidase was made by adding 1 mL of water to 2 
mg of leucine aminopeptidase. The prolidase solution was made by adding 1 mL of water 
to 1.5 mg of prolidase to give a concentration of 190 units/mL. A volume of 1 mL of each 
dissolved protein solution was added to a different vial. To each vial was added 50 µL of 
pronase E, 20 µL of leucine aminopeptidase, and 10 µL of prolidase for a total volume of 
1080 µL. Then, the samples were incubated for 20 hours at a temperature of 37 ºC.  
3.3.4 PITC Derivatization  
The derivatization method was adapted from the method used by Tsao and Otter 
(1999). After 20 hours of incubation, 50 µL was taken from each sample. The 50 µL 
samples were dried with argon gas in a 2 mL vial. Once the samples were dry, 50 µL of 
the redry solution was added, and the samples were mixed in a sonicator for 10 minutes. 
Then, the samples were dried a second time with argon gas. Next, 50 µL of the PITC 
derivatizing solution were added, and the samples were mixed in the sonicator for 20 
minutes. It is important to always allow at least 20 minutes for the PITC reaction. Finally, 
the samples were dried again with the argon gas and were vacuum dried overnight. The 
next day, 2 mL of ethanol were added to each derivatized sample. The samples were 
mixed in a sonicator for 10 minutes and then analyzed with reversed-phase HPLC. 
3.3.5 Data Analysis 
All supplements were tested in duplicates at least once, and some supplements 
were tested in duplicates a second time. Samples were analyzed with Empower Pro 




manually integrated to determine retention time and peak area. Calibration curves were 
constructed with area on the y-axis and concentration on the x-axis. The slope with a y-
intercept was determined using Microsoft Excel and the formula: LINEST(Y1:Y5, 
X1:X5, FALSE, FALSE). The y-intercept was determined using the formula: 
INDEX(LINEST(Y1:Y5, X1:X5), 2). The slope with the y-intercept equal to 0 was also 
determined because the line should have passed through the origin. This slope was used 
in the final calculations of all samples. The slope was determined with the formula: 
LINEST(Y1:Y5, X1:X5, FALSE, FALSE). Concentrations of samples were determined 
using the area determined by integration and the slope of the calibration curve. Finally, 




3.4 Urinalysis Methodology 
Included at the end of Team Juiced‟s survey was a page asking participants if 
they would be willing to take part in a follow-up study that concerned protein excretion 
in their urine. Survey respondents were asked to indicate if they were willing to 
participate and to include their contact information if so. To encourage participation in 
this part of the study, students who agreed to donate urine samples were entered into a 
raffle for an iPod shuffle with the incentive that the first thirty participants would have 
their names entered into the raffle five times. The cheapest iPod was used as an incentive 
to minimize the selective pressure for economically disadvantaged students. Because the 
participants in this section of the project were voluntary, they represented a convenience 
sample (Biemer & Lyberg, 2003). Samples were collected twice, once in the spring and 
fall semesters of 2008. Participants who volunteered were informed to arrive at the 
University of Maryland, University Health Center at a specified time over the course of 
three different days. Once there, the members of the surveying team noted the 
participant‟s height and weight measurements and provided them with a sterile urine 
collection cup for the urine sample. Participants were once again identified by the four-
digit number from their initial survey response and the urine samples were separated 
from any identifiable personal information. 
After the sample was given, it was stored in a refrigerated container until it was 
analyzed. The urine samples were taken from the University Health Center to the 
National Institutes of Technology (NIH) in Bethesda, Maryland. A urinalysis test was 
performed on the spot urine samples using the protein to creatinine ratio discussed in the 




680 0120) machine was used to detect the amount of protein excreted in the urine based 
on the protein to creatinine ratio. High levels of urinary protein excretion (proteinuria) are 
a precursor to renal diseases. The team wanted to draw a link between protein, 




Chapter 4: Results 
4.1 Survey Research Results 
4.1.1 Calculations Made from Raw Survey Data 
Survey data was first separated into frequencies and percentages that were 
pertinent to the statistical test results. Survey collection generated 947 total respondents, 
382 of which were using protein supplements. By examining the data, it was discovered 
that the most popular protein products taken by participants were GNC Pro-Performance 
Whey Protein with 96 users (25.13% of protein users), a generic form of whey protein 
with 65 users (17.02% of protein users), and CytoSport Muscle Milk with 38 users 
(9.95% of users). Only 13 respondents were taking the pure form of glutamine, called L-
glutamine.  
The average amount of protein taken by participants per week was also calculated 
in order to compare it to the Recommended Dietary Allowance‟s (RDA) suggested 
protein consumption for humans. The RDA recommends that humans ingest 0.8 grams 
(g) of protein per kilogram (kg) of body weight per day which translates into 5.6 g of 
protein per kg of body weight per week. The average American diet consists of 8.4 g of 
protein per kg of body weight per week (Eisenstein, et al., 2002). Survey data revealed 
that the average protein supplement intake amongst participants was 183.4 g per week. 
This 183.4 g demonstrated that survey participants were taking 30% more protein per 
week than the average American population based on the average American diet. Team 
Juiced then used 72.1 kg of body weight as a standard measure of body weight for both 
males and females because a study conducted in 1972 by Van Cott and Kinkade found 




72.1 kg (Johnson, 1999). Based on 72 kg of body weight and the RDA suggestion for 
protein intake it was found that survey participants were consuming 50% of the 
recommended daily allowance from supplements alone. 
4.1.2 Statistical Tests Performed on Raw Survey Data 
A variety of statistical tests were used to evaluate the survey data. Each test 
compared an independent variable to the amount of protein taken per week for each 
product listed by the participant. Each test used 95% confidence. Since the participant 
could list up to three products, the test evaluated the selected variable in terms of the 
amount of protein taken per week for the first product, then in terms of the amount of 
protein taken per week for the second product, and again for the amount of protein taken 
per week for the third product. The first, second, and third product is not a named product 
itself, but a grouping of all of the individual products that a participant listed under each 
category.  
4.1.3 Hours of exercise per week vs. amount of protein used for products 1, 2, and 3 
The first comparison of means assessed was entitled hours of exercise per week 
vs. amount of protein used for products 1, 2, and 3. In this comparison of means, hours of 
exercise per week served as the independent variable, and the level of measurement for 
this variable was ordinal. It was an ordinal variable since it involved categories that were 
ordered by rank. The categories include 1-5 hours of exercise per week, 6-10 hours of 
exercise per week, and greater than ten hours of exercise per week. The amount of 
protein taken for products 1, 2, and 3 served as the dependent variable, and the level of 




Since the independent variable in this comparison is ordinal and the dependent 
variable is interval-ratio, the appropriate test to use was the Spearman‟s Rho test. As seen 
in Figure 1, for the individuals exercising anywhere between one hour to greater than ten 
hours per week and using product 1, the two-tailed significance p-value was 0.136 which 
was greater than 0.05 and therefore statistically insignificant showing insufficient 
evidence to support a relationship between the independent and dependent variables and 
therefore number of hours an individual was exercising and how much protein he or she 
was consuming. For the individuals exercising anywhere between one hour to greater 
than ten hours per week and using product 2, the two-tailed significance p-value was 
0.330 which was greater than 0.05 and therefore statistically insignificant also depicting 
insufficient evidence to support a relationship between the independent and dependent 
variables. For the individuals exercising anywhere between one hour to greater than ten 
hours per week and using product 3, the two-tailed significance p-value was 0.228 which 
was greater than 0.05 and therefore statistically insignificant showing insufficient 
evidence to support a relationship between the independent and dependent variables. 
Figure 1: Spearman’s Rho Test for Hours of exercise per week vs. Amount of protein used 
for products 1, 2, and 3 
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Correlation is signif icant at the 0.05 level (2-tailed).*. 
 
A Spearman‟s Rho test was used to determine whether a statistically significant relationship exists 
between the comparison of means entitled hours of exercise vs. amount of protein used for 




4.1.4 Gender of the respondent vs. Amount of protein used for products 1, 2, and 3 
The second comparison of means assessed in this study was entitled gender of the 
respondent vs. amount of protein used for products 1, 2, and 3. In this comparison of 
means, the gender of the respondent served as the independent variable, and the level of 
measurement for this variable was nominal. It was a nominal variable since it involved 
categories that were not ordered by rank. The amount of protein taken for products 1, 2, 
and 3 served as the dependent variable, and the level of measurement for this variable 
was interval-ratio. 
Figure 2: Independent Samples T-Test for Gender of the respondent vs. Amount of protein 
used for products 1, 2, and 3 
Independent Samples Test
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Independent Samples T-Test was used to determine a statistically significant relationship in the 
comparison of means entitled Gender of the respondent vs. Amount of protein used for products 1, 
2, and 3.  
 
A statistically significant relationship exists between the gender of the respondent 
compared to the amount of protein used for product 1 since more males are using product 
1 than females, and more males are using more of product 1 than females. Since the 
independent variable in this comparison is nominal with only two categories and the 
dependent variable is interval-ratio, the appropriate test to use was the Independent 




tailed significance p-value was 0.046 which was less than 0.05 and therefore statistically 
significant indicating that there is a statistically significant relationship between the 
independent and dependent variables. Therefore, the amount of protein that the 
respondent consumed was dependent on his or her gender. The descriptive statistics 
above depicted that more males were using more of the protein supplements than 
females. This test further revealed this statistically-significant finding that deeper 
reinforced the aforementioned descriptive statistics. In addition, fewer males were using a 
second or third product. Moreover, no females were using a third product. Therefore, 
more males were supplementing more of product 1 than females. For the males and 
females using product 2, the two-tailed significance p-value was 0.457 which was greater 
than 0.05 and therefore statistically insignificant demonstrating that there is no 
relationship between the independent and dependent variables. 
4.1.5 Assessing Personal and Family Risk Factors as Variables 
Additionally, it is important to note that in the comparison of means for each of 
the risk factors of kidney disease, clinical obesity, hypertension, and diabetes that an 
individual carries personally or through family history, there can be two pathways for 
determining any statistically significant relationships. For each risk factor tested 
individually or through family history, the risk factor served as the independent nominal 
variable while the amount of protein used served as the dependent interval-ratio variable. 
The other option for comparison could be switching the two variables so that the 
independent variable would be the amount of protein used while each risk factor tested 
individually or through family history would be the dependent variable. No matter which 




always be interval-ratio, the test will always be the same: Independent Samples t-test. 
The two explanations or interpretations that the reversed comparisons could offer are 1) if 
the individual has a particular risk factor personally present, will that impact the amount 
of protein that the individual consumes, and 2) does the amount of protein that the 
individual consumes impact the risk of whether the individual would have the risk factor 
in a later stage of his or her life.  
4.1 6 Respondent with a family history of diabetes vs. amount of protein used for 
products 1, 2, and 3 
The third comparison of means assessed was entitled respondent with a family 
history of diabetes vs. amount of protein used. In this comparison of means, respondents 
with a family history of diabetes served as the independent variable, and the level of 
measurement for this variable was nominal. It was a nominal variable since it involved 
categories of “yes” and “no” that were not ordered by rank. The amount of protein used 
for products 1, 2, and 3 served as the dependent variable, and the level of measurement 
for this variable was interval-ratio.  
Since the independent variable in this comparison is nominal with only two 
categories and the dependent variable is interval-ratio, the appropriate test to use was the 
Independent Samples t-test. The amount of protein used was compared between 
participants with and without the stated risk factor. Because it was difficult to combine 
the amounts reported in Products 1, 2, and 3, the relationships between amount of protein 
and risk factor was analyzed independently for each “cell.” Products 1, 2, and 3 are not 
distint products, rather the first, second, and third cells available for participants to report 




Shown in Figure 3, the individuals with a family history of diabetes using 
product 1, the two-tailed significance p-value was 0.123 and therefore statistically 
insignificant and demonstrating insufficient evidence to support a relationship between 
the independent and dependent variables. For the individuals with a family history of 
diabetes using product 2, the two-tailed significance p-value was 0.519, thereby 
statistically insignificant and indicating insufficient evidence to support a relationship 
between the independent and dependent variables. Lastly, for the individuals with a 
family history of diabetes using product 3, the two-tailed significance p-value was 0.461 
and therefore also statistically insignificant portraying insufficient evidence to support a 
relationship between the independent and dependent variables.  
Figure 3: Independent Samples T-Test for respondent with a family history of diabetes vs. 
amount of protein used for products 1, 2, and 3 
Independent Samples Test
3.175 .076 1.546 284 .123 9.4292 6.1008 -2.5794 21.4377
1.274 118.934 .205 9.4292 7.4010 -5.2257 24.0841
1.220 .276 -.650 39 .519 -14.59747 22.44680 -60.00042 30.80548
-.658 32.889 .515 -14.59747 22.18138 -59.73158 30.53665
4.569 .065 .774 8 .461 44.80000 57.88713 -88.68796 178.28796
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Independent Samples t-test was used to determine whether or not a statistically significant 
relationship exists between an individual with a family history of diabetes vs. amount of protein 
used for products 1, 2, and 3. 
4.1.7 Respondent with a family history of kidney disease vs. amount of protein used for 
products 1, 2, and 3 
The fourth comparison of means assessed was entitled respondent with a family 




comparison of means, respondent with a family history of kidney disease served as the 
independent variable, and the level of measurement for this variable was nominal. It was 
a nominal variable since it involved categories of “yes” and “no” that were not ordered 
by rank. The amount of protein used for products 1, 2, and 3 served as the dependent 
variable, and the level of measurement for this variable was interval-ratio.  
Since the independent variable in this comparison is nominal with only two 
categories and the dependent variable is interval-ratio, the appropriate test to use was the 
Independent Samples t-test. As seen in Figure 4, for the individuals with a family history 
of kidney disease using product 1, the two-tailed significance p-value was 0.639 and 
therefore statistically insignificant and demonstrating insufficient evidence to support a 
relationship between the independent and dependent variables. For the individuals with a 
family history of kidney disease using a second product, the two-tailed significance p-
value was 0.561, thereby statistically insignificant and indicating insufficient evidence to 
support a relationship between the independent and dependent variables. 
Figure 4: Independent Samples T-Test for respondent with a family history of kidney disease 
vs. amount of protein used for products 1, 2, and 3 
Independent Samples Test
.125 .724 -.469 284 .639 -13.2124 28.1581 -68.6375 42.2127
-.954 2.186 .433 -13.2124 13.8494 -68.1873 41.7625
. . -.586 39 .561 -42.67246 72.80933 -189.943 104.59831
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An Independent Samples t-test was used to determine whether a statistically significant 
relationship exists between the comparison of means for the respondents with a family history of 




Since there were no individuals with a family history of kidney disease using a 
third product, the independent variable in this comparison of means regarding a third 
product could not be tested against the dependent variable and therefore, a statistical test 
could not be executed to determine a two-tailed significance p-value.  
4.1.8 Respondent with a family history of clinical obesity vs. amount of protein used for 
products 1, 2, and 3 
The fifth comparison of means assessed was entitled respondent with a family 
history of clinical obesity vs. amount of protein used for products 1, 2, and 3. In this 
comparison of means, respondent with a family history of clinical obesity served as the 
independent variable, and the level of measurement for this variable was nominal. It was 
a nominal variable since it involved categories of “yes” and “no” that were not ordered 
by rank. The amount of protein used for products 1, 2, and 3 served as the dependent 
variable, and the level of measurement for this variable was interval-ratio. 
 Since the independent variable in this comparison is nominal with only two 
categories and the dependent variable is interval-ratio, the appropriate test to use was the 
Independent Samples t-test. For the individuals with a family history of clinical obesity 
using product 1, the two-tailed significance p was 0.433 and therefore statistically 
insignificant and indicating insufficient evidence to support a relationship between the 




As seen in Figure 5, for the individuals with a family history of clinical obesity 
using product 2, the two-tailed significance p-value was 0.537 and thereby statistically 
insignificant and representing insufficient evidence to support a relationship between the 
independent and dependent variables. Lastly, for the individuals with a family history of 
clinical obesity using product 3, the two-tailed significance p-value was 0.549 and 
statistically insignificant portraying insufficient evidence to support a relationship 
between the independent and dependent variables.  
Figure 5: Independent Samples T-Test for respondent with a family history of clinical 
obesity vs. amount of protein used for products 1, 2, and 3 
Independent Samples Test
.656 .419 .785 284 .433 11.2307 14.2984 -16.9136 39.3751
.595 11.532 .563 11.2307 18.8693 -30.0678 52.5293
.176 .677 .623 39 .537 32.45133 52.11051 -72.95212 137.85478
.515 1.069 .693 32.45133 63.04571 -655.972 720.87469
. . -.626 8 .549 -61.11111 97.66360 -286.324 164.10156
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An Independent Samples t-test was used to determine whether there was a statistically significant 
relationship between an individual with a family history of clinical obesity using greater quantities 
of products 1, 2, and 3.  
4.1.9 Respondent with a family history of hypertension vs. amount of protein used for 
products 1, 2, and 3 
The sixth and final comparison of means assessed by the team was entitled 
respondent with a family history of hypertension vs. amount of protein used for products 
1, 2, and 3. In this comparison of means, respondent with a family history of 
hypertension served as the independent variable, and the level of measurement for this 




“no” that were not ordered by rank. The amount of protein used for products 1, 2, and 3 
served as the dependent variable, and the level of measurement for this variable was 
interval-ratio. 
 Since the independent variable in this comparison is nominal with only two 
categories and the dependent variable is interval-ratio, the appropriate test to use was the 
Independent Samples t-test. For the individuals with a family history of hypertension 
using product 1, the two-tailed significance p-value was 0.458 and therefore statistically 
insignificant indicating insufficient evidence to support a relationship between the 
independent and dependent variables. As seen in Figure 6, for the individuals with a 
family history of hypertension using product 2, the two-tailed significance p-value was 
0.707 and thereby also statistically insignificant demonstrating insufficient evidence to 
support a relationship between the independent and dependent variables. 
Figure 6: Independent Samples T-Test for respondent with a family history of hypertension 
vs. amount of protein used for products 1 and 2 
Independent Samples Test
.818 .367 -.744 283 .458 -5.8172 7.8198 -21.2095 9.5751
-.916 81.191 .362 -5.8172 6.3481 -18.4474 6.8130
.010 .923 -.378 38 .707 -16.57833 43.83795 -105.324 72.16696
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An Independent Samples t-test was used to assess the relationship between whether an individual 





4.2 Kidney Cell Modeling Results 
4.2.1 Time Course Study 
In the time course study a supraphysiological level of 2.0 mM of glutamine was 
used to determine the time dependent behavior of LDL-r expression. Figure 7 shows that 
as early as two hours, an increase of greater than 50% or 1.5-fold was observed when 
comparing the beta-actin normalized LDL-r expression in cells grown in 2.0 mM 
glutamine versus control cells grown in the absence of glutamine. Experimental cells in 
2.0 mM of glutamine showed increasingly elevated expression for LDL-r up to greater 
than twofold the baseline of control cells between 6 and 8 hours. The fold change versus 
control cells dropped at 12 and 24 hours; expression remained elevated in experimental 
cells, still showing an increase of 1.5-fold after 24 hours.  
Figure 7: LDL-r time course in 2.0 mM glutamine 
 
Fold change/control = ratio of normalized LDL-r expression in experimental versus control cells 




4.2.2 Dose Response Study 
It was apparent from the time course study that LDL-r expression was responding 
optimally between 6-8 hours, when it showed the highest increase in expression as 
compared to control cells. Six hours was chosen for the dose response study so that 
culture and extraction could be done comfortably within one work day. The findings of 
the dose response study are summarized in Figure 8. As little as 0.5 mM of glutamine 
showed an increase in LDL-r expression of approximately 3.5-fold as compared to 
control cells not exposed to any glutamine after 6 hours of exposure. This elevated level 
of expression was maintained through 20.0 mM of glutamine. LDL-r expression was no 
higher than 3.5-fold at any concentration of glutamine higher than 0.5 mM. 
Figure 8: LDL-r dose curve at 6 hours 
 
Fold change/control = ratio of normalized LDL-r expression in experimental versus control cells 
exposed to no glutamine. Gln = glutamine. Data points are given for 0.0, 0.5, 1.0, 2.0, 5.0, 7.0, 
10.0, and 20.0 mM. Note the horizontal axis of concentration is not drawn to scale. Error bars are 




4.2.3 Chronic Study 
The dose dependent studies conducted at 48 hours of exposure to glutamine were 
conducted to gain insight on conditions of chronic glutamine over-use. LDL-r, as well as 
HMG CoA reductase, which is the key enzyme in the cholesterol synthesis pathway, 
matrix proteins (collagen I, fibronectin, and collagen IV), and growth factor TGF-β were 
tested for expression at 0.5, 2.0, and 10.0 mM of glutamine at 48 hours of exposure. 
LDL-r expression was found to be dose dependent, unlike at 6 hours of exposure. As 
shown in Figure 9, a statistically significant increase was observed for LDL-r expression 
compared to control cells for 0.5 and 2.0 mM, both showed a 1.5-fold increase in 
expression. Dose dependency was apparent when analyzing cells exposed to 10.0 mM of 
glutamine where the fold increase was nearly threefold, approximately double the 
expression seen at 0.5 and 2.0 mM glutamine. 
Figure 9: LDL-r dose response at 48 hour 
 
Fold change/control = ratio of normalized LDL-r expression in experimental versus control cells 
exposed to no glutamine. Gln = glutamine. Error bars are given based on the variance between 





While LDL-r shows an extrinsic path for LDL to enter the cells, HMG CoA 
reductase represents an internal mechanism by which the cellular metabolism generates 
lipids. Unlike LDL-r expression, cells did not show a statistically significant increase in 
the expression of HMG CoA reductase in response to increasing concentrations of 
glutamine for 48 hours of exposure. Figure 10 shows a variation between triplicate wells 
in error bars that cover nearly a 0.5-fold range. Cells exposed to 10.0 mM of glutamine 
showed a higher level of HMG CoA reductase expression, up to nearly twofold higher 
than baseline, but the variation between wells was still too large to prove statistical 
significance. 
Figure 10: HMG CoA reductase dose response at 48 hours 
 
Fold change/control = ratio of normalized HMG CoA reductase expression in experimental versus 
control cells exposed to no glutamine. Gln = glutamine. Error bars are given based on the variance 





All three matrix proteins were found to have a trend towards increased expression 
as compared to control cells over the increasing doses of glutamine for 48 hours of 
exposure. Collagen I and fibronectin both showed statistically significant increases as 
compared to control cells. As seen in Figure 11, cells exposed to 10.0 mM of glutamine 
were significantly higher in collagen I expression, showing a level approximately twofold 
greater than control cells. For fibronectin expression, Figure 12 illustrates a significant 
increase of approximately 1.5-fold as compared to control cells for cells exposed to both 
2.0 and 10.0 mM of glutamine. This increase in expression for fibronectin was slightly 
less than the increase noted for collagen I. As shown by Figure 13, expression of 
collagen IV largely mirrored that of collagen I expression, but with larger variation 
between wells. Without this variation, the approximately 1.5- to twofold increase in 
collagen IV expression for cells exposed to 10.0 mM of glutamine may also have been 
significant.  
Figure 11: Collagen I dose response at 48 hours 
 
Fold change/control = ratio of normalized collagen I expression in experimental versus control 
cells exposed to no glutamine. Gln = glutamine. Error bars are given based on the variance 
between triplicate wells. Asterisks = statistical significance of P<0.05 compared to control cells at 




Figure 12: Fibronectin dose response at 48 hours 
 
Fold change/control = ratio of normalized fibronectin expression in experimental versus control 
cells exposed to no glutamine. Gln = glutamine. Error bars are given based on the variance 
between triplicate wells. Asterisks = statistical significance of P<0.05 compared to control cells at 
0.0 mM glutamine. 
Figure 13: Collagen IV dose response at 48 hours 
 
Fold change/control = ratio of normalized collagen IV expression in experimental versus control 
cells exposed to no glutamine. Gln = glutamine. Error bars are given based on the variance 




The growth factor, TGF-β was found to be constant throughout increasing 
concentrations of glutamine exposure for 48 hours. Unusually large amounts of variation 
were observed between triplicate wells, but the averages of TGF-beta expression were 
held constant at the baseline established by control cells not exposed to any glutamine. 
Figure 14 shows the variation as error bars. 
Figure 14: TGF-beta dose response at 48 hours 
 
Fold change/control = ratio of normalized TGF-beta expression in experimental versus control 
cells exposed to no glutamine. Gln = glutamine. Error bars are given based on the variance 




4.3 Biochemical Analysis of Glutamine Results 
4.3.1 Determination of Retention Time and Calibration Curve for Glutamine 
The retention time (RT) of glutamine was determined in order to quantify the 
concentration of glutamine in each supplement. Also, it was observed whether the 
enzyme hydrolysis and PITC derivatization processes caused any glutamine to convert 
into glutamic acid. Glutamine and glutamic acid standards were first tested separately 
using HPLC to determine the RT for both of these amino acids. The glutamine standard 
produced a peak with a RT of approximately 14 minutes, while the glutamic acid 
standard peak had a RT of approximately 17 minutes. The chromatogram shown in 
Figure 15 displays these retention times for glutamine and glutamic acid in the same 
HPLC separation. 
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An equal mixture of glutamine (gln) and glutamic acid (glu) was tested. High performance liquid 
chromatography was used to detect glutamine and glutamic acid after phenyl isothiocyanate 
derivatization. The retention time for glutamine was approximately 14 minutes, while the retention 





Different concentrations of a glutamine standard were then tested for calibration. 
A calibration curve was completed to establish the relationship between the HPLC 
machine measuring glutamine concentration and the actual glutamine concentration. The 
calibration curve, which is shown in Figure 16, had a slope of 551253.1 with an R
2
 value 
of 0.9999. This slope was used to measure the concentrations in the supplements. The 
average RT for glutamine was 14.05 ± 0.0055 s. Figure 17 shows there were no peaks 
around 17 minutes (RT for glutamic acid) in any of the glutamine standard runs for the 
calibration curve. 






















High performance liquid chromatography was used to measure the concentrations of five different 
glutamine (gln) solutions: 0.01, 0.05, 0.10, 0.50, 1.00 mg/mL after phenyl isothiocyanate 
derivatization. Glutamine was eluted from the high performance liquid chromatography column 
using a sodium phosphate/acetonitrile mobile phase after 14.0514 ± 0.0055 s. The areas of the 
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High performance liquid chromatography was used to measure five concentrations from a 
glutamine standard after phenyl isothiocyanate derivatization. This chromatogram is taken from 
the high performance liquid chromatography run with a 0.1 mg/mL concentration of glutamine. 






4.3.2 Pure Glutamine Supplements 
The supplements tested were split into two groups: glutamine and protein. The 
five glutamine supplements tested were Supplement 1, 8, 12, 19, and 21. All pure 
glutamine supplements were expected to have 100% recovery of glutamine. The five 
glutamine supplements listed in Table 1 yielded similar concentrations of glutamine as 
compared to the sample concentration. The average percent recovery for these three 
supplements was between 98% and approximately 102%. The chromatograms for these 
five supplements are included in Figure 18 on the following page. There was a clear peak 
with a RT of approximately 14 minutes for each pure glutamine supplement. There were 
no peaks at approximately 17 minutes, which would indicate the presence of glutamic 
acid. 
Table 1: Measured Glutamine Concentrations from Pure Glutamine Supplements  
Supplement # [Supplement] (mg/mL) Measured [Gln] (mg/mL) Percent Recovery 
1 1.040 1.035 ± 0.0053 101.41 
8 1.003 1.024 ± 0.0370 102.01 
12 1.022 1.011 ± 0.0255 98.89 
19 1.022 1.017 ± 0.0053 99.46 
21 1.035 1.006 ± 0.0241 98.29 
Five pure glutamine (gln) supplements with a concentration of approximately 1 mg/mL were 
derivatized, and the glutamine content was measured using high performance liquid 
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Figure 18: Pure Glutamine Chromatograms 

















High performance liquid chromatography was used to test the glutamine concentration in five pure 
glutamine supplements after phenyl isothiocyanate derivatization. Each chromatogram has a peak 






4.3.3 Protein Supplements with Glutamine Content on Label 
The concentrations of glutamine were then measured in protein supplements with 
and without glutamine content on the supplement bottle‟s label by manufacturers. The 
nine protein supplements with glutamine content on the label will be discussed first, and 
these supplements were Supplement 2, 4, 5, 6, 11, 13, 16, 17, and 18. These supplements 
were hydrolyzed and derivatized with PITC according to the procedure. An example of a 
chromatogram from one of these protein supplements is shown in Figure 19.  
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Supplement 11 was hydrolyzed with enzymes and derivatized with phenyl isothiocyanate to 




The concentration of glutamine was measured, and the amount of glutamine 
detected per serving size for these nine supplements are listed in Table 2. 
 
Table 2: Measured Amount of Glutamine from Protein Supplements, with Glutamine 
Content on Label 




Amount of Gln 
Detected, per 
serving size (g) 
2 0.99 0.0377 ± 0.0002 0.61 
4 1.11 0.0510 ± 0.0003 1.01 
5 1.05 0.0371 ± 0.0010 5.33 
6 1.33 0.1866 ± 0.0014 4.51 
11 1.02 0.0419 ± 0.0001 1.15 
13 1.00 0.0400 ± 0.0004 1.24 
16 1.02 0.0550 ± 0.0002 3.99 
17 1.01 0.0472 ± 0.0000 1.47 
18 1.03 0.0304 ± 0.0001 0.95 
 
Protein supplements with a concentration of about 1 mg/mL were derivatized with phenyl 
isothiocyanate, and then run through high performance liquid chromatography. The 
chromatograms were used to determine the glutamine concentration in each protein supplement. 






The comparison of the amount of glutamine detected versus the amount of 
glutamine expected to be in the supplements, as determined by the manufacturer‟s labels, 
is displayed in Table 3. Supplement 2, 4, 11, 13, 16, 17, and 18 measured less glutamine 
than listed on their labels. Supplement 5 and 6 measured more glutamine than is stated on 
the labels by manufacturers. 
 
Table 3: Comparison of Measured Glutamine Recovery and Percent Glutamine on Label of 
Protein Supplements  
Supplement # Amount of Gln 
Detected, per serving 
size (g) 
Amount of Gln, from Label 
(g) 
2 0.61 2.00 
4 1.01 12.50 
5 5.33 2.00 
6 4.51 3.00 
11 1.15 3.56 
13 1.24 4.00 
16 3.99 10.50 
17 1.47 4.08 





4.3.4 Protein Supplements without Glutamine Content on Label 
Glutamine concentrations in protein supplements without the glutamine content 
listed on the label by manufacturers were also measured. These six supplements were 
Supplement 3, 7, 9, 14, 15, and 20. The glutamine concentrations measured in these six 
protein supplements are listed in Table 4. The amount of glutamine detected in each 
sample was approximately 3 grams or less. Since the manufacturers do not list any 
information about the glutamine content on their labels, it was not possible to compare 
the amount of glutamine detected with what was expected. 
Table 4: Measured Amount of Glutamine in Protein Supplements Without an Amount of 
Glutamine on Label 




Amount of Gln 
Detected, per serving 
size (g) 
3 1.02 0.0437 ± 0.0115 1.73 
7 1.03 0.0450 ± 0.0014 3.06 
9  0.99 0.0169 ± 0.0029 1.33 
14 2.05 0.0191 ± 0.0003 2.12 
15 1.06 0.0179 ± 0.0032 0.48 
20 1.05 0.0472 ± 0.0006 1.44 
 
Protein supplements (without a glutamine amount on the label) with a concentration of about 1 
mg/mL, except Supplement 14, were derivatized with phenyl isothiocyanate. High performance 





4.4 Urinalysis Results 
In addition to the data collected from the survey, urine samples of survey 
respondents were gathered and tested for the presence of abnormal amounts of protein. 
The samples were then sent to the National Institute of Health (NIH) for processing and 
analysis. At the time this thesis was written, the results from the urinalysis have yet to be 
completed. The researchers are optimistic that the samples will be received from the NIH 





Chapter 5: Discussion 
5.1 Survey Research Discussion 
5.1.1 Assumptions 
Given the nature of this survey study, a few basic assumptions were made in 
order to account for links between any data found and patterns noticed to ensure 
reliability and validity. First, it was assumed that some of the protein supplements used 
by the surveyed population of college students at the University of Maryland, College 
Park contained the amino acid glutamine. A significant component of this study involved 
lab research at USU that was concerned with the effects of varying dosages and 
concentrations of glutamine on rat mesangial cells. Because the purpose of the survey 
data was to connect results pertaining to human supplement consumption to the lab 
research focusing on effects of consumption, it was important that the same amino acid 
be studied. This assumption was verified by an extensive search of the content labels of 
protein supplements taken by the survey participants. Nearly every label either listed 
glutamine or whey protein as a key ingredient. Whey protein was assumed to contain 
glutamine for the purposes of this study. This assumption could be made because all of 
the protein supplements tested for glutamine content at the FDA that listed whey protein 
as an ingredient were found to contain glutamine. Second, it was assumed that in 
answering the survey questionnaire, respondents were honest about their answers 
regarding supplement usage as well as family and personal medical history. The current 
study was designed to discern possible links between protein supplement usage and long-
term health risks so it was imperative that the data be as accurate as possible. Dishonesty 




personal nature or in regard to socially stigmatized behavior (Biemer & Lyberg, 2003). 
Because the questions asked did not involve discussing a sensitive topic, respondents had 
no incentive or motivation to lie which reduced the possibility of intentional 
misstatement. Given the lack of means to verify subjects‟ responses, respondent honesty 
was a required assumption. In addition, because the survey was anonymous and the 
respondents therefore had little to fear about others knowing what information they 
revealed, the assumption that they were being honest was strengthened. 
Third, in designing and administering the survey, it was assumed that any bias on 
the part of the respondent, the experimenters, or the survey design itself would not 
significantly affect the results in a manner that would skew the data in favor of a 
particular trend. Due to the limited interaction between the subjects and the 
experimenters, as this was either a paper-and-pencil questionnaire or computerized 
questionnaire as opposed to an interview, experimenter influence on subject response was 
minimal. In terms of respondent selection bias, it was assumed that people who were 
interested in the topic of protein supplements were more likely to fill out the survey than 
those who were not. However, because the project does not address a question of the 
prevalence of protein supplementation on campus, it was actually beneficial to target 
subjects likely to be more knowledgeable in order to obtain the most focused data. 
Respondent questionnaire bias could have played a role if the subjects did not understand 
the intent of the questions asked (Leedy & Ormrod, 2005). Another potential type of error 
was specification error which often occurs when questions appear confusing to the 
respondent. Specification error means that the concept measured is different from the 




sampling bias on the part of the experimental design is usually present when attempting 
to generalize from a small population sample to a larger more comprehensive population. 
Sampling bias often occurs because the experimenters do not verify absolute randomness 
of the sample or do not take into consideration characteristics about those who did not 
respond (Leedy & Ormrod, 2005). Sampling bias is assumed not to have a large effect on 
this study because the study intentionally targeted members of what was considered an 
active population at a university including varsity, intramural, and club athletes as well as 
non-athlete students that exercise at either of the university‟s recreational facilities 
(Geary F. Eppley Recreation Center or Ritchie Coliseum). The study did not aim to 
collect information about a sample in order to generalize about a larger and more 
comprehensive population.  
Lastly, it was assumed that any non-sampling error was unlikely to have a 
significant effect on the results of the survey analysis. Due to the team‟s extensive data 
cleaning procedures, the assumption was made that any error in measurement or 
processing was double-checked and eliminated through this process as to not 
significantly affect the results or discussion of the data (Biemer & Lyberg, 2003).  
5.1.2 Discussion of Results 
It was the goal of the survey portion of this research project to better understand 
the supplementation habits of protein users at the University of Maryland, College Park. 
This included gathering information regarding the types of products commonly used, the 
average protein intake, how much exercise was completed each week, and the 





Before administering the survey, the team had assumed that college students were 
in fact using protein supplements. Past studies have shown that college students are more 
likely to be using supplements than the general population (Newberry, et al., 2001). The 
team did discover that approximately 40% of the targeted population was using protein 
supplements therefore providing a sample that would produce pertinent information to 
the study. In addition, Team Juiced believed that protein supplements would be the most 
commonly taken form of NVNM supplements based on an earlier study that stated the 
high popularity of protein supplements amongst college students (Ayranci, et al., 2005; 
Perkin, et al., 2002). The large percentage of participants using protein supplements also 
verified the team‟s belief. 
Arguably the most important finding of the survey research was that individuals 
with more risk factors for kidney disease took no less protein than individuals with fewer 
or no risk factors at all. There was no statistically significant relationship between risk 
factors and supplemental protein intake. Participants suffering from diabetes, obesity, or 
hypertension or those with a higher likelihood of developing these illnesses due to their 
family health history were at higher risk of developing kidney disease. The survey data 
showed that these individuals were taking no less supplemental protein than low risk 
participants. There was also no significant difference in the percentage of people with and 
without risk factors who used protein supplements. These findings were extremely 
important because of the known link between protein and kidney disease and because of 
the possible link between glutamine and glomerular scarring. The comparisons performed 




been done in any other studies in the past decade, making these findings an integral part 
of emerging research. 
The findings concerning protein intake and risk factors for kidney disease 
suggested that participants either did not understand the risks associated with protein and 
renal health or that they did not know how to properly regulate their protein intake. The 
indifference of this at risk population was concerning. Since protein supplements are 
regulated as foods and not drugs, it is not a far reach to assume that most users did not 
consult their doctors before engaging in a supplementation regime. Protein users need to 
be better educated and informed on the potential health risks of high protein intake. An 
advocacy, awareness, or educational program may be necessary for individuals 
interesting in supplementation regimens. It cannot be expected that the regulatory 
industry will jump to act upon the findings of this study because of the market 
ramifications of any changes.  
Another surprising and very important finding of the present study was the 
overwhelming amount of protein taken by the survey participants that used these 
supplements. Among those using protein supplements, the average participant was taking 
50% of the recommended daily allowance (RDA) of protein from supplements alone. 
Literature states that the average dietary intake of protein among Americans is already 
150% of the RDA (Eisenstein, et al., 2002). It was assumed that the survey participants 
consumed similar diets to those stated in literature. If anything, the survey participants 
may be increasing their dietary protein intake for the same reasons that they take 
supplemental protein. When combining the 150% dietary intake of protein with the 50% 




much as double the RDA of protein. A value this high was not previously found in the 
literature. Participants that used protein supplements may not understand the significance 
of how much dietary protein they were consuming. They also may not be aware of the 
possible detrimental effects of excess protein, especially for those with family risk factors 
for kidney disease. The fact that participants were who taking protein supplements could 
have been consuming double the RDA of protein from a combination of dietary and 
supplementary sources reiterates the importance of consumer education. Consumers need 
to know how much protein they are consuming, what the recommended amount of 
protein is, and what the possible consequences of high protein intake are.  
After careful analysis of the data, one statistically significant comparison was 
established. The important trend revealed through the survey data in this study is that the 
average number of grams of protein taken per week is overwhelmingly higher for men 
than for women. While it may seem obvious that men take more protein than their female 
counterparts, it is important to understand the rationale that motivates this conventional 
wisdom conclusion as well as the reasons why the data supports it. The first logical 
conclusion is that the serving size for men is larger based on height, weight, and body 
composition. However, on product labels only one serving size is given, and it is the 
personal responsibility of the individual to determine if this recommendation is 
appropriate. Product labels almost never encourage users to tailor the serving size to their 
personal dimensions. Therefore, another explanation for why men take more protein than 
women is that the perceived benefits of protein supplementation as well as the 
bodybuilding culture appeal predominantly to men. The media and the male fitness 




physical features that equate to career success, social dominance, and sexual power. 
Consequently, protein supplements are marketed as a fast and effective way to achieve 
these types of physical goals. For women, the ideals of physical perfection as dictated by 
the media and norms of societal behavior are very different. The benefits of protein 
supplementation are less attractive to women who generally aim for lean, fit bodies rather 
than ones overwrought with muscles and bulk. This finding that men use protein 
supplements more than women highlights important social issues such as body image and 
the gender gap and should signal to the Food and Drug Administration that perhaps more 
attention should be paid to such an influential societal force.  
It is noteworthy to mention that the current research team uncovered a surprising 
finding that there was not a statistically significant p-value for the comparison between 
the number of hours that an individual was exercising per week and the amount of protein 
that he or she consumed. Based on previous research that stated that there was a strong 
correlation between supplement usage and exercise, Team Juiced believed that data 
would display a relationship between hours of exercise and protein supplement 
consumption (Ayranci, et al., 2005). Therefore the team had made an earlier assumption 
prior to distributing and administering the surveys to the various segments of its targeted 
population that the large sample size being tested would reveal a statistically significant 
p-value especially since varsity athletes comprised a segment of the team‟s sampled 
population. Varsity athletes were a major part of the study based on the previously 
established fact that supplement usage correlates with exercising more than three times 
per month (Perkin, et al., 2002). Another study also had shown that 88% of varsity 




did not produce such a high number; in fact only 33% of varsity athletes surveyed were 
found to be using supplements. This low percentage may have played a role in the lack of 
statistical significance. When comparing hours of exercise and amount of protein used, 
the p-value was greater than 0.05. Although the p-value is not statistically significant, it is 
important to take note that it still indicates the existence of a relationship between the two 
variables. Despite the fact that the team‟s earlier assumptions were unconfirmed in this 
particular study, it is important to recognize the potential relationship between protein use 
and hours spent exercising. If more research is aimed at discovering the link between 
these variables, the scientific community will have an easier time at isolating and 
studying individuals participating in these behaviors. The isolation of these groups 
becomes especially important when relating behavioral trends to physiological effects. 
By understanding this potential statistical relationship, scientists will be better able to 
target protein users should laboratory evidence reveal harmful or useful biological effects 
of supplementation. This data may also be important to advertisers because they will now 
have more information to adjust and improve their marketing strategies to their desired 
consumer population. 
5.1.3 Possible Limitations-Survey  
Given the scope and breadth of this survey as well as the sheer size of the 
potential target population and the rules and regulations for soliciting survey responses at 
the university, the experiment was limited by several factors. First, the survey was limited 
by the amount of available times for the group to distribute surveys both in regard to 
obtaining club sport and intramural team responses and obtaining responses at the 




several weeks to target as many people as possible. However, the Campus Recreation 
Services at the university and the schedules of team members limited the survey 
distribution to twelve scheduled dates for a certain allotted period of time per date. This 
may have played a role in affecting the types of individuals who responded to the survey. 
For example, because surveying at the facilities was usually conducted in the afternoon, 
there was a chance that early morning users of the gym facilities were not able to take the 
survey. However, because the survey was designed to gain an understanding of frequency 
and amounts of protein supplementation by protein supplement users as opposed to 
prevalence of supplementation on campus, this is unlikely to have significantly affected 
the results.  
Second, this study was also limited by the fact that the team could not actively 
solicit individuals to take the survey. In accordance with the policy of Campus Recreation 
Services in regard to maintaining a level of comfort for their facility users, only 
respondents who approached the team out of their own curiosity or interest were allowed 
to take the survey. In order to reduce the possibility that people would not take the 
survey, an incentive of a free water bottle for participants at the gym was offered. Third, 
the most active and athletic group of students, the varsity athletes, were not able to be 
surveyed to the extent that was desirable. Due to hesitation and general inapproachability 
by sports coaches and managers, survey responses from varsity athletes only consisted of 
approximately 10% of the total responses collected. Fourth, the length of the survey may 
have deterred certain individuals from taking the survey due to time constraints. The 
actual survey itself was two pages, but it appeared longer to the viewer due to the 




the follow-up study information sheet. Respondent preference for a shorter survey may 
have limited the number of responses. Fifth, the reference list of commonly used protein 
supplements included with the survey may not have been comprehensive. Some 
participants may have been unable to recall the name of the supplement that they used 
and could not find it on the list making it impossible for their responses to be entirely 
complete or accurate. Finally, as alluded to above, this study was limited by the time 
constraints of the participants. The people surveyed at the gym tended to be in a rush or 
had other obligations which again may have limited the number of responses collected. 
In addition to the above limitations, there are certain characteristics about the 
interviewer or experimenter that may have affected the nature of the responses collected. 
The age range for the surveyors on this team was between 19-21 years old which may 
have deterred respondents from participating due to their perception of the experimenters 
as peers as opposed to an authoritative figure. Additionally, this was the first time 
conducting a large-scale survey for many of the surveyors. This may have affected the 
results in that research has shown that interviewers with a greater amount of experience 
tend to correlate with higher response rates in a survey questionnaire (Biemer & Lyberg, 
2003). Lastly, a lack of interviewer success in obtaining approval to conduct the study 
especially with regard to gaining varsity athlete responses may have affected the response 
rate (Biemer & Lyberg, 2003). These characteristics of the surveyors are likely to have 





5.1.4 Possible Limitations-Data Analysis 
The values for standard deviations in many of the comparisons of means 
performed could have limited the team‟s statistical findings. Standard deviation 
represents variation around the mean. The reason why the team may not have been able 
to uncover more statistical findings in the comparisons of means tested could be a direct 
consequence of the massive amount of variation in the responses provided by the 
respondents for these particular questions asked on the team‟s survey. Moreover, there 
may have been a lot of random error as a result of the large standard deviation values 
present for each comparison of means tested as well as the observations that the 
relationships were too small to detect with the available data. It is possible that had there 
been less variation around the mean, the team would have uncovered more statistically 




5.2 Kidney Cell Modeling Discussion  
5.2.1 Assumptions 
There were two critical assumptions in the studies conducted using the mouse 
mesangial cell model. The first assumption was made when deciding what concentration 
of glutamine the control cells should be exposed to. Two possibilities were considered: 
either control cells would be exposed to physiological levels of glutamine to simulate 
normal in vivo conditions, or control cells would be exposed to no glutamine at all. The 
decision was made to not introduce any glutamine after the starvation step of cell culture 
for the control cells. This decision was largely made due to the knowledge of glutamine‟s 
importance to the normal growth of cells. Any amount of glutamine immediately after a 
period of 24 starvation in 5% FBS and no glutamine would stimulate some response. It 
was important that control cells did not exhibit any growth response or division. To draw 
comparisons to physiological levels of glutamine, the concentrations of 0.5 and 1.0 mM 
glutamine were added to the dose response study. This allowed a comparison to control 
cells with no glutamine as well as comparisons to physiological levels. 
The second assumption was made in designing the chronic study. The aim of the 
study was to simulate conditions of chronic glutamine over-use. It would have been very 
impractical based on our time and laboratory constraints to expose the cells to high 
concentrations of glutamine over an extended period in the magnitude of years or even 
months. Drawing an analogy to many other fields of testing, such as tire wear, it was 
assumed that exposing the cells to the glutamine concentrations of interest for an 
unusually long time would provide reasonably accurate data for extrapolating to chronic 




approach would equate to Bridgestone continuously running its tires for days until 
failure. It is practically unreasonable to think that drivers would drive continuously for 
such an extended period, but this method gives the manufacturer an idea of the life of 
their tire. Similarly it would be wrong to assume that serum levels of glutamine would 
stay elevated at 2.0 or 10.0 mM of glutamine for 48 hours consecutively, but this still 
gives an idea as to what the long-term effects of such transient changes over years may 
be. 
5.2.2 Discussion of Results 
The three experiments conducted, the time course study, the dose response study, 
and the chronic study, were designed to answer the following research questions, 
respectively: 
1)  What is the time dependent behavior of LDL-r expression in mesangial 
cells exposed to a supraphysiological level glutamine up to 24 hours of 
exposure? 
2)  What is the dose dependent behavior of LDL-r expression in mesangial 
cells exposed to increasing concentrations of glutamine up to 20.0 mM at 
the peak time of expression from the time course study? 
3)  What effect does glutamine have on a chronic scale with respect to the 
expression of various proteins that may contribute to glomerular sclerosis, 
hardening of the kidney tissue that ultimately results in renal failure? 
Unpublished results from Dr. Sonia Doi‟s lab showed the intracellular 
accumulation of neutral lipids in response to glutamine conditions. Knowing of this 
accumulation, it was important to elucidate both the time- and dose-dependency of LDL-r 
expression in response to glutamine.  
The time course was first of the three experiments conducted. Mesangial cells 




4, 6, 8, 12, and 24 hours. Because each control and experimental set of cells required at 
least duplicate wells per time of exposure, it was necessary to divide the experiment into 
two sets containing three-time points each . The experimental groups that were exposed 
to 2.0 mM glutamine, more than double the physiological serum level, showed increased 
expression of LDL-r at all time points. At as early as 2 hours of exposure to 2.0 mM 
glutamine, the mesangial cells showed a significant increase in the expression of LDL-r 
indicating a quick rate of genetic up-regulation. The phenomenon may be accounted for 
by the fact that cells are normally exposed to a baseline amount of glutamine, between 
0.5 and 0.9 mM of glutamine in physiological conditions. The control cells in this 
experiment were grown in the absence of glutamine. The fact that LDL-r expression was 
increased in 2 hours shows the importance of glutamine to the functioning of the cell.  
The up-regulation of the receptor continued to increase through 8 hours of 
glutamine exposure. This suggested that intracellular demand for LDL remained high 
within this period of time. Considering that the cells were starved for 24 hours in 
conditions of low glucose (6 mM) and 5% FBS serum, it was not unreasonable too see 
that the cells required more lipids than they held at the end of starvation. While LDL-r 
expression remained elevated compared to the control cells throughout the entire time 
course of the experiment, its fold increase as compared to the control cells was less after 
8 hours. The 12 and 24 hour time points each showed decreasing levels of expression. 
This suggested that after 8 hours of LDL-r mRNA being translated to receptor proteins, 
the cell might be signaled to decrease its manufacturing of LDL-r. Most likely, LDL itself 
would be responsible for this negative feedback. Because of the variance between 




After determining that the highest response of LDL-r expression as compared to 
the control cells occurred between 6 and 8 hours, the dose experiment was conducted to 
determine the dose-dependent behavior for up-regulation of LDL-r expression in 
mesangial cells. Testing increasing concentrations of glutamine at 6 hours of exposure 
showed that glutamine levels as low as 0.5 mM produced a significant increase in LDL-r 
expression- over threefold greater than the baseline of no glutamine (P<0.05). This 
threefold increase was maintained through 20.0 mM glutamine conditions. Normal serum 
levels of glutamine range between 0.5 and 0.9 mM. It was important to note that there 
was no significant increase in expression relative to this baseline at higher concentrations. 
Mesangial cells showed relatively the same level of LDL-r expression at 1.0, 2.0, 5.0, 7.0, 
10.0, and 20.0 mM glutamine. This suggested that supraphysiological levels of glutamine 
did not affect the expression of LDL-r for up to 6 hours of exposure. The results of the 
dose response study did not provide insight to if this constant level of LDL-r expression 
would remain true for longer periods of exposure. At 6 hours of exposure, the limiting 
factor in LDL-r expression may be the saturation of cellular machinery rather than the 
lack of stimulus by environmental glutamine. The observed plateau effect may change at 
later time periods of exposure. For this reason, the chronic study followed to determine 
the prolonged effect of glutamine. 
The chronic study tested the expression of LDL-r, HMG CoA reductase, three 
matrix proteins (collagen I and IV and fibronectin), and TGF-beta in increasing 
glutamine conditions for 48 hours of exposure. The purpose of this extensive exposure 
time was not to suggest that serum levels of glutamine could remain elevated for as long 




after years of excessive glutamine use. An evaluation of the LDL-r expression at this time 
was intended to bring insight to the significance of the constant LDL-r expression with 
respect to physiological level after 6 hours of exposure. 
Consistent with the 6-hour findings of the dose experiment, a glutamine level of 
0.5 mM significantly increased the level of LDL-r expression (P<0.05). Instead of seeing 
an increase of greater than threefold more than the control cells, an increase of 1.5-fold 
was observed for 0.5 mM of glutamine. The same 1.5-fold increase was seen for 2.0 mM 
of glutamine. At the highest concentration tested for 48 hours, 10.0 mM glutamine, the 
increase in LDL-r was nearly threefold. It is unclear whether this increase was 
significantly higher than what is observed at 0.5 and 2.0 mM glutamine without the use 
of statistical analysis. The nearly two-fold difference in expression between the 10.0 mM 
glutamine samples and both the 0.5 and 2.0 mM glutamine samples would indicate that 
this increase at 10.0 mM glutamine was significantly higher. The fact that 10.0 mM 
glutamine induced a higher up-regulation of LDL-r expression as compared to the 0.5 
mM physiological level and 2.0 mM supraphysiological level was critically important. 
This finding suggested that if serum spikes in glutamine after dietary overload exceed a 
certain level, possibly 2.0 mM, more receptor proteins may be present after periods of 
chronic glutamine over-use. If more receptor is present for extended periods of time, 
LDL may begin to accumulate within the cell and cause changes in matrix production. 
Finding that glutamine significantly increased the expression of collagen I after 
48 hours of exposure to mouse mesangial cells supported the findings in literature 
concerning glutamine and collagen expression. Glutamine had previously been shown to 




cells (Bellon, Chaqour, Wegrowski, Monboisse, & Borel, 1995; Pithon-Curi, et al., 
2006). The current research specifically identified the significant increase in expression 
of collagen I, while Pithon-Curi et. al. (2006) discussed the glutamine dependence of 
collagen IV expression. 
Finding a significant increase in the expression of matrix proteins collagen I and 
fibronectin was more important because it could contribute to the sclerosis of renal tissue. 
Sclerosis of the glomerulus occurs when extracellular matrix proteins accumulate and 
occupy the space of the capillary beds, affecting filtration.  
It would be valuable to investigate the height to which serum levels of glutamine 
can reach after dietary overloads. If the serum increases are above a threshold level, 10.0 
mM glutamine for example, the chronic changes seen in the 48 hour experiment would be 
very important. Assuming the 48 hours of exposure time reasonably model a period of 
chronic glutamine over-use, serum spikes of greater than 10.0 mM glutamine would 
contribute to greater expression of collagen I and fibronectin. This could mean hardening 
of kidney tissue and decreased renal function. Fibronectin showed a significant increase 
in expression even at concentrations of glutamine as low as 2.0 mM (P<0.05).  
While statistical significance was not attained for the increase in expression of 
collagen IV, higher concentrations of glutamine show a trend towards increased collagen 
IV expression. Literature has shown that glutamine is required for the expression of 
collagen IV in mesangial cells (Pithon-Curi, et al., 2006). Naturally, it was thought that 
there may be a dose-dependent behavior for this matrix protein. Compared to the control 
cells containing no glutamine, cells exposed to 0.5 mM glutamine did not show any 




1.5 fold increase in collagen IV expression as compared to the control cells, the variance 
in the duplicates did not provide statistical significance. The highest concentration of 10.0 
mM glutamine also had issues of variability between duplicate wells, but showed an 
increase of approximately twofold compared to the control cells. A repeat of this 
experiment using triplicate wells would be beneficial to indicate the significance of 
collagen IV up-regulation in the 10 mM glutamine range.  
The increased expression of matrix proteins, collagen IV and fibronectin, was 
particularly important because TGF-beta expression remained constant over the 
increasing glutamine range. The TGF-beta pathway is known to increase matrix protein 
excretion; thus, it could be argued that the effects of glutamine were non-specific to these 
matrix proteins if TGF-beta were also up-regulated. Because the expression of TGF-beta 
remained constant over increasing glutamine concentrations, it may mean that glutamine 
increased the expression of collagen I and fibronectin by some other, unknown pathway. 
It is premature to jump to this conclusion without further study because, like the dose 
response study, the chronic study showed only a snap-shot in time. The expression of 
TGF-beta may have been up-regulated at an earlier point, causing the non-specific 
increase in matrix proteins. Determining the exact pathway by which collagen I and 
fibronectin were up-regulated would be the focus of further research. Small interfering 
RNA (siRNA) used to knockout gene expression or protein inhibitors that specifically 
block signaling molecules could be used effectively to test various related biochemical 
pathways. 
The expression of HMG CoA reductase was investigated to determine if 




HMG CoA reductase is an enzyme that is critical in the synthesis of lipids and 
cholesterols, including LDL. While there was some trend towards increased expression of 
HMG CoA reductase with increasing glutamine concentrations, variance between 
duplicate wells did not allow statistical significance. If the increase in HMG CoA 
reductase expression was found to be significant, it would only contribute to the 
conclusion that overloads of glutamine could be deleterious via chronic changes. 
5.2.3 Implications of Research 
The culmination of the three experiments to determine the time- and dose-
dependent expression of LDL-r in response to glutamine and the effect of prolonged 
glutamine exposure to matrix protein expression showed that LDL-r expression increased 
in a both a time- and dose-dependent manner. This was an important and novel finding- 
gaining recognition by the American Society of Nephrology for abstract publication and 
poster presentation at their 2008 annual meeting (Sharma, et al., 2008). Showing that 
glutamine significantly increases the expression of LDL-r in mouse mesangial cells 
elucidates a pathway by which LDL may accumulate within the cell. This is supported by 
unpublished findings of neutral lipid accumulation within mesangial cells in response to 
glutamine exposure from Dr. Doi‟s laboratory. Using oil-red-O staining methods and 
microscopy imaging, it would be important to clearly show an increase in intracellular 
LDL in the presence of high levels of glutamine. Using fluorescent tags to illuminate the 
actual LDL-r molecules would also be a valuable addition to the research. 
Doi et al. (2000) had previously shown that glutamine increases the glucose-
induced proliferation of mesangial cells. This proliferation, via glutamine:fructose 6-




suggested that glutamine could pose a risk for kidney disease in individuals with diabetes 
(Doi, et al., 2000). The increased expression of LDL-r in response to glutamine found by 
the current research was significant in the absence of additional glucose, extending its 
importance to non-diabetics. In addition, the results of the chronic study gave insight to 
the possible long-term implications of higher levels of LDL-r. 
With the increasing incidence of chronic kidney disease in the United States, the 
rates of atherosclerotic cardiovascular disease among these individuals is notably higher 
than in the general population. This can be largely attributed to the abnormalities in lipid 
metabolism. The oxidation of LDL is especially important, a process that is usually 
prevented to a certain extent by high density lipoprotein, or HDL cholesterol. The 
oxidized LDL loses its affinity for LDL-receptor and instead of being taking in by cells it 
is “ingested” by macrophages, stimulating them to become foam cells. Foam cells play a 
role in cardiovascular disease, and similar phenomenon with foam cells is seen in the 
glomeruli. The activity of foam cells play a role in the progression of chronic kidney 
disease and glomerular sclerosis (Vaziri, 2008). The complexity of LDL metabolism and 
its possible avenues to contribute to kidney disease show that in order to fully understand 
the up-regulation of matrix proteins, more than LDL-receptor may need to be studied. 
Specifically, an in vivo model may be necessary. 
The expression of matrix proteins collagen I and fibronectin was significantly 
increased in a dose-dependent manner. These findings add to the already known 
glutamine dependency of matrix protein collagen IV (Pithon-Curi, et al., 2006). The 
current research could not show statistical significance for the observed increase in 




between triplicate samples. A repeat of the chronic study experiment could show 
significance for collagen IV, as well. The observation that TGF-beta did not increase over 
increasing glutamine concentrations adds to the value of the matrix protein findings. 
Because the TGF-beta pathway can contribute to non-specific increases in the expression 
of matrix proteins, it was valuable to negate the increased expression of TGF-beta for the 
48 hour time point. It would be unreasonable to jump to the conclusion that because 
TGF-beta was unchanged for this snap-shot in time that it was unrelated to the increase in 
expression of matrix proteins. Still it is suggested from the data that a glutamine-
dependent pathway involving the accumulation of LDL within the cell may be involved 
in the increased expression of collagen I and fibronectin. Knowing the exact pathway 
would be critically important to preventing cells from excreting these pro-fibrotic 
proteins, contributing to glomerular sclerosis and renal pathology, especially with the 
contributions of mesangial cell proliferation. Glutamine was shown to increase the 
proliferation of mesangial cells in culture, thereby increasing the number of cells that can 
excrete extra-cellular matrix protein in response to glutamine (Lagranha, Doi, Pithon-
Curi, Curi, & Sellitti, 2008). Further studies with siRNA or inhibiting proteins could 
elucidate a more specific pathway for the observed up-regulation of collagen I and 
fibronectin.  
The risk from excessive glutamine of induced mesangial cell proliferation and 
lipid accumulation, possibly leading to excretion of pro-fibrotic matrix proteins, becomes 
especially important for the college-aged community taking protein supplements. The 
risk is only amplified by considering results form the survey branch of research showing 




and that participants with predisposing risk factors for kidney disease were just as likely 
to report protein supplementation as those without risk factors. The novelty of this social 
finding among college-aged athletes combined with the previously unknown increase in 
LDL-r expression in response to glutamine levels prove to be of great relevance to both 
the athletic community and the scientific community. There is both a need for awareness 
for indiscriminate supplementation glutamine, as well as a need for researchers to renew 
investigation in the possible deleterious effects of glutamine in regards to renal health. 
5.2.4 Possible Limitations 
It is important to note that significant findings from cell culture methods are 
usually followed up by in vivo animal studies. To make the conclusion that glutamine 
poses a definite risk for glomerulosclerosis or at least deleterious effects to lipid balance 
in mesangial cells would not be appropriate without validating studies in which animals, 
such as mice or rats, are given glutamine and their mesangial cells are found to react in 
the same way as seen by the current research. The distinction lies in the path by which 
glutamine would present itself to the mesangial cells in the kidney. In practical 
applications, ingested glutamine must be absorbed by the gut and maintained in the blood 
stream. Among the complexities of the physiological responses, the uptake of glutamine 
by muscle cells may be the most significant. Future research testing for LDL-r expression 
in mesangial cells as well as the expression of matrix proteins in response to various 
conditions of glutamine ingestion would be critically important to further substantiating 
the current findings. Human subject testing, depending on the magnitude of the findings 




5.3 Biochemical Analysis Discussion 
5.3.1 Assumptions 
Given the small scale of the reactions used in the method developed in this study, 
a couple of assumptions were made. One assumption was that all protein supplements 
were water-soluble and would dissolve in aqueous buffer, even though the solutions often 
appeared cloudy when protein supplements were mixed with HEPES, because the labels 
for all protein supplements directed the user to mix the supplements in water. In addition, 
the supplements were mixed very well in the sonicator in the lab, so it is reasonable to 
assume these supplements were sufficiently dissolved. The second assumption was that 
vacuum drying the derivatized samples overnight sufficiently dried the samples before 
analysis. This assumption was necessary because the quantity of sample in each vial was 
so small that it was difficult to see whether or not a sample was completely dry. Finally, 
lipids can interfere with solubility in ethanol, but it was assumed in this study that the 
high lipid content of some of the samples would not interfere with solubility.  
5.3.2 Conversion of Glutamine to Glutamic Acid 
Research by Tsao and Otter (1999) suggested that glutamine converts to glutamic 
acid during the enzymatic degradation and PITC derivatization procedure, so both 
glutamine and glutamic acid must be quantified in order to correctly quantify the 
glutamine content. However, there was no peak correlating to glutamic acid (retention 
time of approximately 17 minutes) on any chromatograms for pure glutamine samples. 
This demonstrates that glutamine was never converted to glutamic acid in these samples. 
Therefore, a correction for the conversion of glutamine to glutamic acid was not 




5.3.3 Glutamine Quantification in Pure Glutamine Samples 
The method designed in this study was proven to be reproducible and effective 
for quantifying glutamine in pure glutamine samples. The method was refined using an 
L-glutamine standard until 100% recovery was consistently determined. Then, some of 
the pure glutamine products were preliminarily tested and found to have recoveries near 
100%. The glutamine recovery was 98% or higher for all glutamine supplements tested: 
Supplement 1, Supplement 8, Supplement 12, Supplement 19, and Supplement 21. This 
shows that these supplements, which claim to be pure glutamine, have glutamine contents 
consistent with those claimed on their labels. This means a person taking these glutamine 
products is actually ingesting the amount of glutamine they believe to be ingesting. The 
supplements were not tested for specific additives, so it is possible that they also contain 
trace amounts of other chemicals.  
5.3.4 Glutamine Quantification in Protein Samples 
The results gathered from the present study cannot be used to confidently 
determine whether the amount of glutamine in commonly used protein supplements is in 
accordance with that claimed on the label because the method was not consistently 
reproducible when quantifying glutamine in protein samples. Previous studies using 
methods similar to the method designed accurately quantified glutamine in milk proteins 
(Tsao & Otter, 1999) and commercial liquid nutritional products (Baxter, et al., 2004). 
This suggests that these methodologies may need further revision to accurately quantify 
glutamine in protein supplements. Very few other studies have been conducted that 
specifically quantify glutamine, so it is difficult to compare the results obtained in this 




In the current study, chromatograms for six protein supplements had standard 
deviations of the glutamine peak area greater than 6% of the total glutamine peak area: 
Supplement 3, Supplement 9, Supplement 11, Supplement 13, Supplement 14, and 
Supplement 15. This high standard deviation is most likely due to differences in 
enzymatic degradation since a high standard deviation was only seen with the protein 
supplements and not with the pure glutamine supplements, which do not require 
enzymatic degradation. 
Using the HPLC method developed in this study, seven of the nine protein 
supplements that reported glutamine contents were found to contain less glutamine than 
the amount reported. These supplements included Supplement 2, Supplement 4, 
Supplement 11, Supplement 13, Supplement 16, Supplement 17, and Supplement 18.  
One possibility to account for the decreased amount of glutamine detected using 
the HPLC analysis method compared to the amount reported on the labeling is that the 
protein supplement labels were inaccurate or unclear. The protein supplements may have 
ingredients not listed on the label or ingredients that are claimed but have unspecified 
amounts, such that the amount of glutamine in one serving is less than the amount of 
glutamine claimed to be in a serving. It is important to note that the method used in this 
study was not fully validated, so inaccuracy of labels is only one possibility for any 
discrepancies; this study did not prove in any way that the labels are inaccurate.  
One way in which the labels were unclear is some of the protein supplement 
labels had very specific amounts of glutamine listed whereas other labels were more 
vague. For example, Supplement 11 listed its glutamine content as 3358 mg, while 




peptides. It is unclear to what exactly the phrase “glutamine precursors or peptides” 
refers. These precursors and peptides may not solely refer to glutamine content and 
therefore the actual amount of glutamine may be less than 4 g. This discrepancy in the 
wording of the labels would result in a difference between the amount of glutamine 
determined and that claimed on the label. A related issue is that some of the labels gave 
glutamine contents but listed glutamine and whey protein as separate ingredients. This 
could be misleading for consumers who do not realize that glutamine is included in whey 
protein, so the amount of glutamine in these products is actually more than the amount 
claimed on the label.  
A second and perhaps more likely possibility for the low recoveries is that the 
protein samples were not completely degraded by the enzymes, and therefore, a different 
combination of enzymes may be needed for the degradation to be more effective. The 
literature is lacking with respect to enzymatic degradation of protein supplements. 
Although these enzymes, pronase E, leucine aminopeptidase, and prolidase, have been 
used previously for enzymatic degradation in quantifying glutamine by Baxter et al. 
(2004), these researchers were quantifying glutamine in commercial liquid nutritional 
products rather than protein supplements. Several of the protein supplements were tested 
in the current study both with and without the enzymatic degradation step in the method, 
and the use of enzymes resulted in an increase in glutamine recovery. However, 
glutamine recovery still was not increased to levels consistent with the labels.  
A final possibility for the low recoveries is that the samples with high lipid 




before quantification using HPLC (Yi, et al., 2009). Better data may have been obtained 
if any lipids were removed with hexane prior to quantification.  
Although the accuracy of the current method may be held in question, two of the 
protein supplements were found to contain higher amounts of glutamine by the HPLC 
analysis than the amounts reported on the labels. Two protein supplements, Supplement 5 
and Supplement 6, had glutamine recoveries higher than those claimed on their labels. 
The amounts of glutamine in the samples were about 1.5 times and 2.7 times those 
claimed on the labels, respectively.  
These two protein samples had low standard deviations of less than 2% of the 
total areas for glutamine peaks between duplicate trials. Supplement 5 and Supplement 6 
were tested along with Supplement 4 and Supplement 20 a second time in order to test 
the accuracy of the results since the amount of glutamine detected was higher than that 
claimed on the label. The new percentages of glutamine detected were all within 15% of 
the first set of trials. The detected glutamine contents for Supplement 5 and Supplement 6 
were once again higher than the amounts claimed on the label. This second test was 
conducted over one month after the first set of trials and used the original calibration 
curve due to time constraints. Considering a calibration that was over a month old was 
used, this is reasonable variability, and it suggests that these two supplements do in fact 
have higher glutamine contents than is claimed on their labels. The data from the first set 
of trials was discussed above because the calibration used for these trials was more 
current than the calibration used for the second set of trials. 
These results are especially surprising considering that the amounts of glutamine 




the manufacturers. When a higher amount of glutamine was determined than was 
claimed, it was most likely not due to a problem with the enzymatic degradation method. 
The enzymes alone were tested in ethanol to determine if there was glutamine in the 
enzymes that would add to the total glutamine content determined in the protein 
supplements. The enzymes did not add to the total glutamine content. Therefore, the only 
potential problem with the enzymatic degradation method is that the enzymes do not 
completely degrade the protein samples. However, this would lead to a decrease in the 
amount of glutamine detected by the HPLC method rather than an increase in the amount 
detected. The statistical significance of the results cannot be reported because there was 
not sufficient time to thoroughly validate the method. However, unlike the other 
supplements tested, the determined amount of glutamine in Supplement 5 and 
Supplement 6 were higher than the glutamine claims on the labels of these protein 
supplements. Therefore, it suggests that the glutamine contents reported by the 
manufacturers were in fact lower than the actual glutamine content for these two protein 
supplements.  
It was hoped that the exact glutamine content of the protein supplements with 
unlisted glutamine contents could be reported. However, the protein supplements in this 
category could not be analyzed for their exact glutamine content because the accuracy of 
the method was not fully validated.  
5.3.5 Implications of Research 
The use of HPLC with PITC precolumn derivatization described in this thesis was 
proven to be an effective and reproducible method for quantifying glutamine in pure 




claimed on their labels. The manufacturers were accurate in their claims of glutamine 
content for these products. The reproducibility and accuracy of the current method for 
quantifying glutamine in protein supplements is unclear based on the data. For the 
majority of the protein supplements tested, the amount of glutamine determined by the 
HPLC analysis is much less than the amount of glutamine claimed by the manufacturers. 
This could be due to an enzymatic degradation methodology problem, solubility problem, 
or false manufacturing claims. However, it was shown that glutamine recovery increases 
when enzymes are used compared to when enzymes are not used. More method 
development would be beneficial in determining if the specific enzymes used are the best 
possible for protein supplement degradation. It also might be more effective to use other 
enzymes in addition to the ones used in this methodology. 
The finding that two protein supplements had glutamine contents higher than 
those claimed on their labels is an important finding in this study. This is important 
information particularly for consumers of these supplements (Supplement 5 and 
Supplement 6) due to the possible risks associated with consuming more glutamine than 
anticipated. After validation of methods and further testing for confirmation, consumers 
may need to be informed of the dangers of excess glutamine use in combination with the 
knowledge that any specific products contain more glutamine than is reported on the 
labeling. 
The results of the present study suggest that the biochemical analysis research 
pursuit in this study was justified as a valuable area of research and more research should 
be conducted in this area to verify the efficacy of the protein degradation method. This is 




in protein supplements. While the data presented here do not prove that any of the 
products tested had false manufacturing claims, they suggest that research with a fully 
validated method may show that certain protein supplements have more glutamine than 
claimed. Further method validation is also important to determine exactly how much 
glutamine is in protein supplements with no glutamine content claims.  
The FDA is not able to regulate dietary supplements as stringently as products in 
the category of drugs, leaving consumers at risk until there is reason for the FDA to 
further investigate a particular supplement. Based on the results showing adverse effects 
of glutamine on mouse mesangial cells, product label glutamine claims that are lower 
than the actual glutamine content of the supplement are potentially dangerous to 
consumers. If consumers believe they are using safe amounts of glutamine based on false 
product claims, they could potentially be putting themselves at risk for detrimental effects 
to their kidneys.  
5.3.6 Possible Limitations  
There were a few important limiting factors in the glutamine quantification 
results obtained. Two related limitations are the use of enzymes for protein degradation 
and the instability of glutamine. Acid hydrolysis is the more commonly used method for 
protein degradation in HPLC analysis, but acid hydrolysis could not be used in this study 
because glutamine is unstable. A lack of literature on protein degradation in HPLC 
analysis exists, so the enzymes used by Baxter et al. (2004) were the enzymes used in this 
study even though they may not be the most effective enzyme combination. The 
instability of glutamine may have also led to the high standard deviations between 




Another major limitation was the time frame for this study. Extensive method 
development was required because there are few previous studies of glutamine 
quantification in the literature. This method development was a significant part of the 
results of the study. However, the amount of time spent on method development and the 
limited amount of time for research before the presentation of this thesis detracted from 
the quantification results obtained. 
A final limitation was the expense of the chemicals used, particularly the 
enzymes. The enzymes were very expensive and their purchase was graciously funded by 
the FDA. However, a limited quantity of enzymes could be purchased due to the expense, 
so the quantity of enzymes was often a limiting factor in analyzing protein samples. In 
addition, according to Baxter et al. (2004), the enzymes work best when the enzyme 
solutions are prepared fresh. It was not always possible to use fresh enzymes in this study 
because the enzymes are very expensive, and it would not have been economically 




5.4 Urinalysis Discussion 
5.4.1 Assumptions and Limitations 
Given the nature of the study, some assumptions for the urinalysis follow-up 
study were made in order to generalize the results to a larger population. First, it was 
assumed that each particular spot urine sample given by voluntary student members was 
an accurate portrayal of the normal level of protein excretion in that particular person. 
Any random fluctuation in the person‟s levels of protein excretion at that time due to 
outside factors was not taken into consideration as to not skew the data. Secondly, it was 
assumed that the thermal conditions for the urine samples collected at the University 
Health Center were maintained at proper temperature and pH, so that the levels of protein 
excretion in the results would retain their accuracy during transport to the analysis facility 
and storage.  
Similar to the survey component of the project, the follow-up urinalysis study 
was limited by a few uncontrollable factors. First, the study was limited by the last time 
of consumption of protein supplements by the participants relative to the time of day the 
sample was collected. If protein supplements were used that day or even a few days prior, 
or a meal was eaten with a significantly high amount of protein, the levels of protein 
represented in the urine may be significantly higher in that sample. These levels of 
protein excretion may not necessarily be reflective of normal protein supplement usage or 
of protein supplementation at all, which was why the first assumption was necessary. 
Second, the last time of exercise would inevitably affect the protein concentration in the 
urine as well. If the person had exercised recently, the protein excretion will be higher 




for protein excretion and analyzed, there would be limitations surrounding the sensitivity 
and specificity of the protein to creatinine test and kit assay. Each test varies in terms of 
the sensitivity and the specificity of the test and the kit assay and therefore, our results 























Chapter 6: Conclusion 
The three branches of study conducted by Team Juiced have important findings 
that, when integrated, highlight the potential for harm under the current state for 
consumers of protein supplements. The findings from kidney cell modeling conducted at 
USU show significant changes in cellular lipid uptake and pro-fibrotic behavior under 
chronic conditions of glutamine over-use. The survey results show that many college 
students are receiving far more than the recommended daily amount of protein and 
therefore are also likely to be receiving excess glutamine in their diets. Finally, the results 
from the biochemical analysis conducted at the CFSAN suggest that some supplements 
may have more glutamine than is claimed on their labels. Consumers could be 
unknowingly ingesting more glutamine than they realize. 
The first significant finding from kidney cell modeling is that the expression of 
LDL-r in mouse mesangial cells more than doubled in response to supraphysiological 
glutamine in a time-dependent manner, increasing up to eight hours of exposure. This 
was important because many other genes take much longer to react to environmental 
conditions. LDL-r can significantly change its expression in mesangial cells in as little as 
two hours. This makes future in vivo studies that address the duration of elevated serum 
glutamine levels after ingestion critically important.  
Second, kidney cell modeling showed that the expression of LDL-r in mouse 
mesangial cells did not respond to an increasing dose of glutamine at six hours of 
exposure. An increase in glutamine to physiological levels caused a threefold increase in 
LDL-r expression, but expression does not continue to increase with increasing glutamine 




threshold for the six hours time point. This threshold could either be a point of 
physiological saturation when the cells were producing as much LDL-r as possible or a 
state of homeostasis such that by negative feedback, the level of LDL-r up-regulation did 
not increase. The combination of elucidating the time- and dose-dependent behavior of 
LDL-r expression in response to glutamine was very important to the nephrology 
community. The American Society of Nephrology published an abstract of this data and 
the research was presented at the society‟s 2008 national conference in Philadelphia, PA. 
Third, at 48 hours of glutamine exposure at increasing concentrations, LDL-r did 
respond in a dose dependent manner. The expression of LDL-r for 10.0 mM glutamine 
was approximately double the observed expression at 0.5 and 2.0 mM glutamine. This 
suggested that one of the most significant variables in chronic glutamine over-use would 
be the level of glutamine exposure. It then becomes imperative to know how high the 
concentration of serum glutamine may reach in vivo after ingestion of glutamine. 
Finally, collagen I and fibronectin, two matrix proteins considered to be pro-
fibrotic and markers of glomerular sclerosis, were both significantly increased with 10.0 
mM glutamine after 48 hours of exposure. Important follow-up research would attempt to 
elucidate the exact pathway by which collagen I and fibronectin were up-regulated. By 
knowing the exact biochemical pathway, it would be possible to develop new therapeutic 
strategies to prevent the progression of chronic kidney disease. 
The survey results showed that the dangers of chronic glutamine use suggested by 
the in vitro studies on mouse mesangial cells are relevant to college students because 
many at the University of Maryland, College Park greatly exceed the recommended 




that over 40% of those surveyed were using protein supplements, and thirteen people 
were using L-glutamine. This proved that the targeted group was an effective sample for 
extracting information about the use of protein supplements. 
The average protein user was taking twice the total recommended weekly amount 
of protein. It was suspected that people might have been taking so much protein because 
they were unaware of the effect that excess protein can have on the body. Male protein 
supplement users took more protein per week than women, possibly aspiring to a 
muscular body image portrayed in media. This could suggest more men are at risk for the 
negative effects of chronic glutamine over-use. It was surprising that there was no 
significant relationship between the amount of protein taken and the number of hours of 
exercise per week, as supported by literature.  
The most significant finding of the survey research was that participants with risk 
factors for kidney disease were no less likely to take protein supplements than those with 
no risk factors. As discussed earlier, high levels of protein intake have been shown to be 
deleterious to kidney disease patients. Given the findings of the project that showed the 
ill effects of chronic glutamine over-use on kidney function, a large population of protein 
supplement users already at risk for kidney disease could have been putting their health at 
further risk by ingesting an excess of protein. 
The survey research could have been improved by surveying more varsity 
athletes. Varsity athletes likely use more protein supplements than less competitive 
athletes or gym users. It would be very useful to study the pattern of protein supplement 
use by more varsity athletes in the future because these athletes may be at even higher 




following up with results from the current kidney cell modeling could also warrant 
further analysis of individuals at risk for kidney disease through survey research. 
The final part of the team‟s research attempted to determine the accuracy of 
protein supplement label claims of glutamine content. All of the protein supplements 
tested and many of the pure glutamine products tested were listed as products taken by 
survey participants. A method for glutamine quantification was developed that was 
reproducible and effective for quantifying glutamine in pure glutamine supplements. All 
supplements listed as pure glutamine were found to contain at least 98% glutamine, 
leaving no reason to believe that the product label claims for glutamine content were 
inaccurate.  
The reproducibility and the accuracy of the method for quantifying glutamine in 
protein supplements are unclear. The statistical significance of the determined glutamine 
content of protein supplements could not be determined. However, seven of the nine 
protein supplements with glutamine content claims had less glutamine than claimed 
based on the developed method. Two protein supplements, Supplement 6 and 
Supplement 5, were found to have glutamine contents much higher than the amount 
claimed. Determined glutamine contents higher than those claimed were unlikely due to a 
fault in the method. Because the general trend of the method was to undershoot the 
claimed glutamine concentration, seven out of nine times, it was even more important 
when two supplements showed higher glutamine concentrations than reported. This was 
significant because educated consumers, those who are aware of the data showing the 
possible adverse effects of excess glutamine on the kidneys yet want to use protein 




amount of glutamine. It is important that these consumers choose a supplement that 
actually has the amount of glutamine claimed. While statistical significance cannot be 
reported for protein supplements with higher glutamine concentrations because the 
method was not fully validated, it was still very important that the preliminary data 
suggest manufacturer‟s claims may not be accurate. This was the case with the weight 
loss supplement StarCaps, as recently brought to attention by The New York Times. 
Consumers should be well aware of the inherent risk involved with using supplements 
readily available in the market. 
Overall, the research of Team Juiced showed that 1) glutamine changed the 
normal functioning of mesangial cells in a manner that could cause serious damage to the 
kidneys in conditions of chronic glutamine over-use, 2) the average protein supplement 
user consumed twice the recommended amount of protein per week, and the people at 
risk for kidney disease were no less likely to take excess protein than are those not at risk, 
and 3) all over-the-counter glutamine supplements tested had the amount of glutamine 
claimed on their labels while two protein supplements taken by survey participants may 
have contained more glutamine than was claimed by the labels. Together, these findings 
argue that college-aged student athletes who are predisposed to kidney disease by factors 
such as diabetes, hypertension, clinical obesity, or a family history of kidney disease are 
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A.1 Survey Research Appendix 
A.1.1 Distributed Survey 
University of Maryland Protein Supplementation Survey 
 
1) How did we find you?   
 
(Circle one) Varsity athletic team  Club/Intramural sport team  Gym 
 
2) Have you ever used protein supplements?  
 
(Circle One) Yes   No  If you answer “No” skip to Question 4. 
 
3) Provide the details of the product(s) and how you used them below. If you cannot 
remember the exact name of the product, refer to the LAST PAGE for a list of 





       (fill in name) 
 







How often?   Times per day  Times per week 
          
 
      (fill in number)           (Circle one) 
   
 
How much? Grams      Ounces    Scoops      Pills 
 
 
      (fill in number)         (Circle one) 
 
 
For how long?  Weeks Months Years 
      
  





       (fill in name) 
 










How often?   Times per day  Times per week 
          
 
      (fill in number)           (Circle one) 
   
 
How much? Grams      Ounces    Scoops      Pills 
 
 
      (fill in number)         (Circle one) 
 
 
For how long?  Weeks Months Years 
      
  





       (fill in name) 
 










How often?   Times per day  Times per week 
          
 
      (fill in number)           (Circle one) 
   
 
How much? Grams      Ounces    Scoops      Pills 
 
 
      (fill in number)         (Circle one) 
 
 
For how long?  Weeks Months Years 
      
  
     (fill in number)        (Circle one) 
 
4) What other supplements and/or prescription medication do you take or were 




5) Do you have any of these health conditions? (Circle all that apply) 
 








6) Do any of your blood relatives in your immediate family (siblings, parents, blood 
aunts/uncles, grandparents) have any of the following? (Circle all that apply) 
 
Diabetes Kidney Disease Clinical Obesity Hypertension  None 
of these 
 
7) Participant Info: 
 
Sex (Circle one)    Male  Female 
 
Age (Circle one)     18     19     20     21     22     23     24     25 
 
Hours of physical training per week (Circle one) 1-5 6-10  >10 
 
Please be sure all sections of the survey are complete. Thank you for your time and 
cooperation. Feel free to add any additional comments below: 
 
A.1.2 Comparison Test 
A.1.2.1 How did we find you? vs. Amount of protein used for product #s 1, 2, & 3  
The first comparison of means assessed was entitled How did we find you? vs. 
Amount of protein used for product #s 1, 2, & 3. How did we find you? was the first 
question that the respondents answered in the team‟s survey. In this comparison of 
means, How did we find you? served as the independent variable, and the level of 
measurement for this variable was nominal. It was a nominal variable since it involved 




& 3 served as the dependent variable, and the level of measurement for this variable was 
interval-ratio.  
Descriptive statistics revealed that for varsity athletic teams, the number of 
varsity athletes using product #1 was 27 versus eight varsity athletes using product #2 
versus three varsity athletes using product #3. The mean for varsity athletes using product 
#1 was 53.691 compared to a mean of 58.7888 for varsity athletes using product #2 
compared to a mean of 116.6667 for varsity athletes using product #3. The standard 
deviation for varsity athletes using product #1 was 32.7443 versus a standard deviation of 
68.19345 for varsity athletes using product #2 versus a standard deviation of 167.43158 
for varsity athletes using product #3.  
The number of club/intramural sport team athletes using product #1 was 113 
versus ten club/intramural sport team athletes using product #2 versus two 
club/intramural sport team athletes using product #3. The mean for club/intramural sport 
team athletes using product #1 was 43.805 compared to a mean of 51.5500 for 
club/intramural sport team athletes using product #2 compared to a mean of 28.0000 for 
club/intramural sport team athletes using product #3. The standard deviation for 
club/intramural sport team athletes using product #1 was 30.9330 versus a standard 
deviation of 43.49422 for club/intramural sport team athletes using product #2 versus a 
standard deviation of 5.65685 for club/intramural sport team athletes using product #3.  
The number of gym-goers using product #1 was 148 versus 23 gym-goers using 
product #2 versus five gym-goers using product #3. The mean for gym-goers using 
product #1 was 53.474 compared to a mean of 62.5691 for gym-goers using product #2 




for gym-goers using product #1 was 60.4108 versus a standard deviation of 81.16831 for 
gym-goers using product #2 versus a standard deviation of 22.40982 for gym-goers using 
product #3.  
The number of ROTC members using product #1 was 3. No ROTC participant 
used a second or third product. The mean for ROTC members using product #1 was 
30.000. The standard deviation for ROTC members using product #1 was 1.7321. 
Combining the four groups surveyed, the total number of individuals using 
product #1 was 291 versus 41 individuals using product #2 versus ten individuals using 
product #3. The mean for individuals using product #1 was 49.498 compared to a mean 
of 59.1439 for individuals using product #2 compared to a mean of 60.0000 for 
individuals using product #3. The standard deviation for individuals using product #1 was 
48.3928 versus a standard deviation of 69.88708 for individuals using product #2 versus 





Figure 20: Sample Size Numbers, Means, and Standard Deviations for How did we find you? 
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Sample numbers, means, and standard deviations for varsity athletes who used product #s 1, 2, & 
3; sample numbers, means, and standard deviations for club/intramural sport team athletes who 
used product #s 1, 2, & 3; sample numbers, means, and standard deviations for gym-goers who 
used product #s 1, 2, & 3; sample numbers, means, and standard deviations for ROTC members 
who used product #s 1, 2, & 3; and sample numbers, means, and standard deviations for total 
number of respondents who used product #s 1, 2, & 3. 
Since the independent variable in this comparison is nominal and has three or 
more categories (four categories to be exact) and the dependent variable is interval-ratio, 
the appropriate test to use was the One-Way ANOVA test. For individuals using product 
#1, the two-tailed significance p-value was 0.356 which was greater than 0.05 and 
therefore statistically insignificant indicating insufficient evidence to support a 
relationship between the independent and dependent variables. Similarly, for individuals 
using product #2, the two-tailed significance p-value was 0.921 which was greater than 




support a relationship between the independent and dependent variables. Lastly, for 
individuals using product #3, the two-tailed significance p-value was 0.471 which was 
greater than 0.05 and therefore statistically insignificant as well portraying insufficient 
evidence to support a relationship between the independent and dependent variables.  
Figure 21: One-Way ANOVA Test for How did we find you? vs. Amount of protein used for 
product #s 1, 2, & 3 
ANOVA
7617.098 3 2539.033 1.085 .356
671521.9 287 2339.797
679139.0 290
847.511 2 423.755 .083 .921
194520.6 38 5118.964
195368.2 40



















Squares df Mean Square F Sig.
 
A One-Way ANOVA test was used to determine whether a statistically significant relationship 
exists between the comparison of means entitled How did we find you? vs. Amount of protein used 
for product #s 1, 2, & 3. 
 
A.1.2.2 Hours of exercise per week vs. Amount of protein used for product #s 1, 2, & 3 
Descriptive statistics revealed that the number of individuals who were using 
product #1 and exercising 1-5 hours per week was 62 compared to five individuals who 
were using product #2 and exercising 1-5 hours per week compared to three individuals 
who were using product #3 and exercising 1-5 hours per week. The mean for individuals 
who were using product #1 and exercising 1-5 hours per week was 49.089 versus a mean 
of 30.8577 for individuals who were using product #2 and exercising 1-5 hours per week 




hours per week. The standard deviation for individuals who were using product #1 and 
exercising 1-5 hours per week was 54.7520 compared to a standard deviation value of 
31.89973 for individuals who were using product #2 and exercising 1-5 hours per week 
compared to a standard deviation value of 16.25833 for individuals who were using 
product #3 and exercising 1-5 hours per week.  
The number of individuals who were using product #1 and exercising 6-10 hours 
per week was 136 compared to sixteen individuals who were using product #2 and 
exercising 6-10 hours per week. There were no individuals who were using a third 
product and exercising 6-10 hours per week. The mean for individuals who were using 
product #1 and exercising 6-10 hours per week was 46.573 versus a mean of 67.2375 for 
individuals who were using product #2 and exercising 6-10 hours per week. The standard 
deviation for individuals who were using product #1 and exercising 6-10 hours per week 
was 37.1459 compared to a standard deviation value of 92.83747 for individuals who 
were using product #2 and exercising 6-10 hours per week.  
The number of individuals who were using product #1 and exercising greater than 
ten hours per week was 95 compared to 21 individuals who were using product #2 and 
exercising greater than ten hours per week compared to seven individuals who were using 
product #3 and exercising greater than ten hours per week. The mean for individuals who 
were using product #1 and exercising greater than ten hours per week was 53.930 versus 
a mean of 64.2767 for individuals who were using product #2 and exercising greater than 
ten hours per week versus a mean of 64.5714 for individuals who were using product #3 
and exercising greater than ten hours per week. The standard deviation for individuals 




compared to a standard deviation value of 57.27230 for individuals who were using 
product #2 and exercising greater than ten hours per week compared to a standard 
deviation value of 108.79623 for individuals who were using product #3 and exercising 
greater than ten hours per week.  
Combining all three categories of hours, the total number of individuals who were 
exercising anywhere from one hour to greater than ten hours and using product #1 was 
293 compared to a total number 42 individuals using product #2 compared to a total of 
ten individuals using product #3. The mean for the total number of individuals exercising 
and using product #1 was 49.491 versus a mean of 61.4261 for the individuals exercising 
and using product #2 versus a mean of 60.0000 for the individuals exercising and using 
product #3. The standard deviation for the total number of individuals exercising and 
using product #1 was 48.2451 compared to a standard deviation value of 70.59638 for the 
individuals exercising and using product #2 compared to a standard deviation value of 





Figure 22: Sample Size Numbers, Means, and Standard Deviations for Hours of exercise per 
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Sample numbers, means, and standard deviations for individuals exercising 1-5 hours per week 
and using product #s 1, 2, & 3; sample numbers, means, and standard deviations for individuals 
exercising 6-10 hours per week and using product #s 1 and 2; sample numbers, means, and 
standard deviations for individuals exercising greater than ten hours per week and using product 
#s 1, 2, & 3; and sample numbers, means, and standard deviations for the total number of 
individuals exercising anywhere between one hour to greater than ten hours per week and using 
product #s 1, 2, & 3. 
 
A.1.2.3 Age of the respondent vs. Amount of protein used for product #s 1, 2, & 3 
The third comparison of means examined was entitled Age of the respondent vs. 
Amount of protein for product #s 1, 2, & 3. This was also one of the questions asked in 
the team‟s survey. In this comparison of means, the age of the respondent served as the 
independent variable, and the level of measurement for this variable was ordinal. It was 
an ordinal variable since it involved categories that were ordered by rank. The amount of 
protein taken for product #s 1, 2, and 3 served as the dependent variable, and the level of 




Descriptive statistics revealed that the number of eighteen year-olds using product 
#1 was 58 compared to nine eighteen year-olds using product #2 compared to two 
eighteen year-olds using product #3. The mean for eighteen year-olds using product #1 
was 53.229 versus a mean of 68.5344 for eighteen year-olds using product #2 versus a 
mean of 157.5000 for eighteen year-olds using product #3. The standard deviation for 
eighteen year-olds using product #1 was 53.4510 compared to a standard deviation value 
of 69.22417 for eighteen year-olds using product #2 compared to a standard deviation 
value of 215.66757 for eighteen year-olds using product #3.  
The number of nineteen year-olds using product #1 was 63 compared to nine 
nineteen year-olds using product #2 compared to three nineteen year-olds using product 
#3. The mean for nineteen year-olds using product #1 was 45.463 versus a mean of 
36.6667 for nineteen year-olds using product #2 versus a mean of 42.3333 for nineteen 
year-olds using product #3. The standard deviation for nineteen year-olds using product 
#1 was 25.5238 compared to a standard deviation value of 22.70325 for nineteen year-
olds using product #2 compared to a standard deviation value of 12.05543 for nineteen 
year-olds using product #3.  
The number of twenty year-olds using product #1 was 74 compared to twelve 
twenty year-olds using product #2 compared to two twenty year-olds using product #3. 
The mean for twenty year-olds using product #1 was 53.131 versus a mean of 53.7917 
for twenty year-olds using product #2 versus a mean of 20.0000 for twenty year-olds 
using product #3. The standard deviation for twenty year-olds using product #1 was 




product #2 compared to a standard deviation value of 0.00000 for twenty year-olds using 
product #3.  
The number of twenty-one year-olds using product #1 was 38 compared to four 
twenty-one year-olds using product #2. There were no twenty-one year-old respondents 
using a third product. The mean for twenty-one year-olds using product #1 was 52.104 
versus a mean of 99.1196 for twenty-one year-olds using product #2. The standard 
deviation for twenty-one year-olds using product #1 was 59.2100 compared to a standard 
deviation value of 193.93081 for twenty-one year-olds using product #2.  
The number of twenty-two year-olds using product #1 was 26 compared to four 
twenty-two year-olds using product #2. There were no twenty-two year-old respondents 
using product #3. The mean for twenty-two year-olds using product #1 was 35.920 versus 
a mean of 63.7775 for twenty-two year-olds using product #2. The standard deviation for 
twenty-two year-olds using product #1 was 18.0605 compared to a standard deviation 
value of 45.70969 for twenty-two year-olds using product #2.  
The number of twenty-three year-olds using product #1 was twelve compared to 
three twenty-three year-olds using product #2 compared to two twenty-three year-olds 
using product #3. The mean for twenty-three year-olds using product #1 was 62.321 
versus a mean of 68.6667 for twenty-three year-olds using product #2 versus a mean of 
28.0000 for twenty-three year-olds using product #3. The standard deviation for twenty-
three year-olds using product #1 was 68.1558 compared to a standard deviation value of 
75.08218 for twenty-three year-olds using product #2 compared to a standard deviation 




The number of twenty-four year-olds using product #1 was four. There were no 
twenty-four year-old respondents using product #s 2 & 3. The mean for twenty-four year-
olds using product #1 was 39.375. The standard deviation for twenty-four year-olds using 
product #1 was 7.5650.  
The number of twenty-five year-olds using product #1 was eight. There were no 
twenty-five year-old respondents using product #s 2 & 3. The mean for twenty-five year-
olds using product #1 was 43.143. The standard deviation for twenty-five year-olds using 
product #1 was 22.7093.  
The number of individual respondents over the age of 25 using product #1 was 
ten compared to one individual respondent over the age of 25 using product #2 compared 
to also one individual respondent over the age of 25 using product #3. The mean for the 
number of individual respondents over the age of 25 using product #1 was 45.330 versus 
a mean of 130.0000 for the individuals using product #2 versus a mean of 62.0000 for the 
individuals using product #3. The standard deviation for the number of individual 
respondents over the age of 25 using product #1 was 22.5469. Since the means and 
numbers of the individuals in this group taking product #s 2 & 3 were both of the value of 
one, standard deviation could not be assessed as a result of a lack of variation around the 
mean.  
The total number of respondents from age eighteen onward using product #1 was 
293 compared to 42 individuals using product #2 compared to ten individuals using 
product #3. The mean for these individuals using product #1 was 49.491 versus a mean of 
61.4261 for the individuals using product #2 versus a mean of 60.0000 for the individuals 




48.2451 compared to a standard deviation value of 70.59638 for the individuals using 
product #2 compared to a standard deviation value of 89.46508 for the individuals using 
product #3. This comparison of means for the total number of respondents from age 
eighteen onward vs. amount of protein taken for product #s 1, 2, & 3 is equivalent to the 
comparison of means for the total number of respondents exercising anywhere from one 
hour per week to greater than ten hours per week vs. amount of protein taken for product 





Figure 23: Sample Size Numbers, Means, and Standard Deviations for Age of the respondent 
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Sample sizes, means, and standard deviations for individual respondents in various college-aged 
groups ranging from age eighteen to over 25 using product #s 1, 2, & 3. 
 
Since the independent variable in this comparison is ordinal and the dependent 
variable is interval-ratio, the appropriate test to use was the Spearman‟s Rho test. For the 




tailed significance p –value was 0.603 which is greater than 0.05 and therefore 
statistically insignificant depicting insufficient evidence to support a relationship between 
the independent and dependent variables. For the individuals in the same age range taking 
product #2, the two-tailed significance p-value was 0.832 which is greater than 0.05 and 
therefore also statistically insignificant indicating insufficient evidence to support a 
relationship between the independent and dependent variables. Lastly, for the individuals 
in this age range taking product #3, the two-tailed significance p-value was 0.959 which 
is greater than 0.05 and is statistically insignificant thereby showing insufficient evidence 
to support a relationship between the independent and dependent variables.  
Figure 24: Spearman’s Rho Test for Age of the respondent vs. Amount of protein used for 
product #s 1, 2, & 3 
Correlations
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Correlation is signif icant at  the 0.05 level (2-tailed).*. 
 
Spearman‟s Rho test was used to determine whether there was a relationship in the comparison 
between the age of the respondent and how much product he or she was using. 
 
A.1.2.4 Gender of the respondent vs. Amount of protein used for product #s 1, 2, & 3 
Descriptive statistics revealed that the number of males using product #1 was 261 




mean for the males using product #1 was 51.496 versus a mean of 63.2647 for the males 
using product #2 versus a mean of 60.0000 for the males using product #3. The standard 
deviation value for males using product #1 was 50.4726 compared to a standard deviation 
value of 71.84933 for males using product #2 compared to a standard deviation value of 
89.46508 for males using product #3.  
The number of females using product #1 was 27 compared to two females using 
product #2. There were no female respondents using a third product. The mean for the 
females using product #1 was 31.976 versus a mean of 24.6550 for the females using 
product #2. The standard deviation value for the females using product #1 was 13.2412 
compared to a standard deviation value of 12.94713 for the females using product #2.  
Combining both the male and female groups surveyed, the total number of males 
and females using product #1 was 288 compared to 42 males and females using product 
#2 compared to ten males and females using product #3. The mean for the males and 
females using product #1 was 49.666 versus a mean of 61.4261 for the males and females 
using product #2 versus a mean of 60.0000 for the males and females using product #3. 
The standard deviation value for the males and females using product #1 was 48.5406 
compared to a standard deviation value of 70.59638 for the males and females using 
product #2 compared to a standard deviation value of 89.46508 for the males and females 





Figure 25: Sample Size Numbers, Means, and Standard Deviations for Gender of the 
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Sample numbers, means, and standard deviations for the males using product #s 1, 2, & 3; sample 
numbers, means, and standard deviations for the females using product #s 1, 2, & 3; sample 
numbers, means, and standard deviations for the total number of males and females surveyed 
using product #s 1, 2, & 3. 
 
A.1.2.5 Respondent with diabetes vs. Amount of protein used for product #s 1, 2, & 3 
The fifth comparison of means attempted to be assessed was entitled Respondent 
with diabetes vs. Amount of protein used for product #s 1, 2, & 3. This was one of the 
questions asked in the team‟s survey. In this comparison of means, Respondent with 
diabetes served as the independent variable, and the level of measurement for this 
variable was nominal. It was a nominal variable since it involved categories of “yes” and 
“no” that were not ordered by rank. The amount of protein taken for product #s 1, 2, and 
3 served as the dependent variable, and the level of measurement for this variable was 
interval-ratio.  
Descriptive statistics revealed that there were no individual respondents who had 




determined since there were no diabetic individuals in the surveyed population and 
therefore no diabetic individuals using a first, second, or third product. In addition, since 
there were no diabetic individuals in the surveyed population, the independent variable in 
this comparison of means cannot be tested and therefore, a statistical test could not be 
executed. 
A.1.2.6 Respondent with a family history of diabetes v. Amount of protein used for 
product #s 1, 2, & 3 
Descriptive statistics revealed that the number of individuals with a family history 
of diabetes using product #1 was 93 compared to twenty individuals with a family history 
of diabetes using product #2 compared to five individuals with a family history of 
diabetes using product #3. The mean for the individuals with a family history of diabetes 
using product #1 was 55.770 versus a mean of 54.6549 for the individuals with a family 
history of diabetes using product #2 versus a mean of 82.4000 for the individuals with a 
family history of diabetes using product #3. The standard deviation for the individuals 
with a family history of diabetes using product #1 was 66.7734 compared to a standard 
deviation value of 51.71011 for the individuals with a family history of diabetes using 
product #2 compared to a standard deviation value of 127.92302 for the individuals with 





Figure 26: Sample Size Numbers, Means, and Standard Deviations for Respondent with a 
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Numbers of individuals with a family history of diabetes, their associated means, and their 
associated standard deviations compared to the amount of protein they were using for product #s 
1, 2, & 3. 
 
A.1.2.7 Respondent with kidney disease vs. Amount of protein used for product #s 1, 2, & 
3 
The seventh comparison of means attempted to be assessed was entitled 
Respondent with kidney disease vs. Amount of protein used for product #s 1, 2, & 3. This 
was one of the questions asked in the team‟s survey. In this comparison of means, 
Respondent with kidney disease served as the independent variable, and the level of 
measurement for this variable was nominal. It was a nominal variable since it involved 
categories of “yes” and “no” that were not ordered by rank. The amount of protein taken 
for product #s 1, 2, and 3 served as the dependent variable, and the level of measurement 
for this variable was interval-ratio.  
Descriptive statistics revealed that there were no individual respondents who had 




could be determined since there were no individuals with kidney disease in the surveyed 
population and therefore no individuals using product #s 1, 2, and 3. In addition, since 
there were no individuals with kidney disease in the surveyed population, the 
independent variable in this comparison of means cannot be tested and therefore, a 
statistical test could not be executed. 
A.1.2.8 Respondent with a family history of kidney disease vs. Amount of protein used for 
product #s 1, 2, & 3 
Descriptive statistics revealed that the number of individuals with a family history 
of kidney disease using product #1 was three compared to one individual with a family 
history of kidney disease using product #2. There were no individuals with a family 
history of kidney disease using a third product. The mean for the individuals with a 
family history of kidney disease using product #1 was 36.333 versus a mean of 20.5000 
for the individuals with a family history of kidney disease using product #2. The standard 
deviation for the individuals with a family history of kidney disease using product #1 was 
23.4592. There was no standard deviation value available for individuals with a family 
history of kidney disease using product #2 since there was a lack of variation around the 
mean since there was only one individual with a family history of kidney disease using 





Figure 27: Sample Size Numbers, Means, and Standard Deviations for Respondent with a 
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Numbers of individuals with a family history of kidney disease, their associated means, and their 
associated standard deviations compared to the amount of protein they were using for product #s 
1, 2, & 3. 
 
A.1.2.9 Respondent with clinical obesity vs. Amount of protein used for product #s 1, 2, & 
3 
The ninth comparison of means assessed was entitled Respondent with clinical 
obesity vs. Amount of protein used for product #s 1, 2, & 3. This was one of the 
questions asked in the team‟s survey. In this comparison of means, Respondent with 
clinical obesity served as the independent variable, and the level of measurement for this 
variable was nominal. It was a nominal variable since it involved categories of “yes” and 
“no” that were not ordered by rank. The amount of protein taken for product #s 1, 2, and 
3 served as the dependent variable, and the level of measurement for this variable was 
interval-ratio.  
Descriptive statistics revealed that the number of individuals with clinical obesity 




product or a third product. The mean for the individuals with clinical obesity using 
product #1 was 31.000. There was no standard deviation value available for individuals 
with clinical obesity using product #1 since there was a lack of variation around the mean 
related to only one individual with clinical obesity using product #1.  
Figure 28: Sample Size Numbers, Means, and Standard Deviations for Respondent with 
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Number of individuals with clinical obesity using product #1 with its associated mean. 
 
Since the independent variable in this comparison is nominal with only two 
categories and the dependent variable is interval-ratio, the appropriate test to use was the 
Independent Samples t-test. For the individuals with clinical obesity using product #1, the 
two-tailed significance p-value was 0.706 which was greater than 0.05 and therefore 
statistically insignificant and demonstrating insufficient evidence to support a 
relationship between the independent and dependent variables. Since there were no 
individuals with clinical obesity using a second or third product, the independent variable 




against the dependent variable and therefore, a statistical test could not be executed to 
determine a two-tailed significance p-value.  
Figure 29: Independent Samples T-Test for Respondent with clinical obesity vs. Amount of 
protein used for product #s 1, 2, & 3 
Independent Samples Test
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An Independent Samples t-test was used to determine whether a statistically significant 
relationship exists between whether an individual with clinical obesity would be consuming 
greater quantities of product #1. 
 
A.1.2.10 Respondent with a family history of clinical obesity vs. Amount of protein used 
for product #s 1, 2, & 3 
Descriptive statistics revealed that the number of individuals with a family history 
of clinical obesity using product #1 was twelve compared to two individuals with a 
family history of clinical obesity using product #2 compared to one individual with a 
family history of clinical obesity using product #3. The mean for the individuals with a 
family history of clinical obesity using product #1 was 60.167 versus a mean of 93.0000 
for individuals with a family history of clinical obesity using product #2 versus a mean of 
5.0000 for individuals with a family history of clinical obesity using product #3. The 
standard deviation for the individuals with a family history of clinical obesity using 
product #1 was 64.5978 compared to a standard deviation value of 87.68124 for 
individuals with a family history of clinical obesity using product #2. There was no 




using product #3 since there was a lack of variation around the mean related to only one 
individual with a family history of clinical obesity using product #3.  
 
Figure 30: Sample Size Numbers, Means, and Standard Deviations for Respondent with a 
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Number of individuals with a family history of clinical obesity using product #s 1, 2, & 3 with 
their associated means and standard deviations. 
 
A.1.2.11 Respondent with hypertension vs. Amount of protein used for products 1, 2, & 3 
The eleventh comparison of means assessed was entitled Respondent with 
hypertension vs. Amount of protein used for product #s 1, 2, & 3. This was one of the 
questions asked in the team‟s survey. In this comparison of means, Respondent with 
hypertension served as the independent variable, and the level of measurement for this 
variable was nominal. It was a nominal variable since it involved categories of “yes” and 
“no” that were not ordered by rank. The amount of protein taken for product #s 1, 2, and 





Descriptive statistics revealed that the number of individuals with hypertension 
using product #1 was five. There were no individuals with hypertension using a second or 
third product. The mean for the individuals with hypertension using product #1 was 
41.380. The standard deviation for the individuals with hypertension using product #1 
was 17.5306. 
Figure 31: Sample Size Numbers, Means, and Standard Deviations for Respondent with 
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Number of individuals with hypertension using product #1 with its associated mean and standard 
deviation. 
 
Since the independent variable in this comparison is nominal with only two 
categories and the dependent variable is interval-ratio, the appropriate test to use was the 
Independent Samples t-test. For the individuals with hypertension using product #1, the 
two-tailed significance p value was 0.713 which is greater than 0.05 and therefore 
statistically insignificant demonstrating insufficient evidence to support a relationship 




Figure 32: Independent Samples T-Test for Respondent with hypertension vs. Amount of 
protein used for product #s 1, 2, & 3 
Independent Samples Test
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Independent Samples t-test was used to determine whether a statistically significant relationship 
exists between whether an individual with hypertension uses greater quantities of product #1. 
 
A.1.2.12 Respondent with a family history of hypertension vs. Amount of protein used for 
product #s 1, 2, & 3 
Descriptive statistics revealed that the number of individuals with a family history 
of hypertension using product #1 was 46 compared to three individuals with a family 
history of hypertension using product #2. There were no individuals with a family history 
of hypertension using a third product. The mean for the individuals with a family history 
of hypertension using product #1 was 44.565 versus a mean of 47.0000 for the 
individuals with a family history of hypertension using product #2. The standard 
deviation for the individuals with a family history of hypertension using product #1 was 
36.9253 compared to a standard deviation value of 59.35487 for individuals with a family 





Figure 33: Sample Size Numbers, Means, and Standard Deviations for Respondent with a 
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Number of individuals with a family history of hypertension using product #s 1 and 2 with their 
associated means and standard deviations. 
 
A.1.3 Inferential Statistical Procedure (Courtesy of Dr. Lehman) 
Now it is time to consider which inferential statistical procedure you need to perform. All 
of these statistical procedures are found under the Analyze command. Below is a list of 
possible combinations of level of measurement and independent and dependent variables 
that you can use as a guide to finding the right statistical test. Note that Independent 




IV is Nominal and DV is Nominal: Analyze…Descriptive Statistics…Crosstabs  
* Put your IV in the box designated as “Column (s)” and your DV in the box designated 
as “Row (s).” For “Statistics,” choose “Chi-Square.” For “Cells,” in the box designated as 






IV is Nominal and DV is Ordinal: Analyze…Descriptive Statistics…Crosstabs 
* Put your IV in the box designated as “Column (s)” and your DV in the box designated 
as “Row (s).” For “Statistics,” choose “Chi-Square.” For “Cells,” in the box designated as 
“Counts,” check “Expected” and in the box designated as “Percentages,” check 
“Column.” 
 
IV is Nominal with only two categories (e.g. Gender) and DV is Interval, Ratio, or 
Interval-Ratio: Analyze…Compare Means…Independent Samples T-Test  
* Put your IV in the box designated as “Grouping Variable” and then specify the values 
of your groups in the box designated as “Define Groups” (Hint: check your frequency 
distribution if necessary to find the actual values of the variable that goes in the “Define 
Groups” box). Put your DV in the box designated as “Test Variable (s).” 
 
IV is Nominal and has three or more categories (e.g. Race) and DV is Interval, Ratio, or 
Interval-Ratio: Analyze...Compare Means…One-Way ANOVA  
* Put your IV in the box designated as “Factor” and your DV in the box designated as 
“Dependent List.” In the “Options” button under Statistics, check “Descriptives.” 
 
IV is Ordinal and DV is Nominal: Analyze…Descriptive Statistics…Crosstabs 
* Put your IV in the box designated as “Column (s)” and your DV in the box designated 
as “Row (s).” For Statistics, choose “Chi-Square.” 
 
IV is Ordinal and DV is Ordinal: Analyze…Correlate…Bivariate 
* Put both your IV and your DV in the box designated as “Variables.” Under 
“Correlation Coefficients,” uncheck the box designated as “Pearson,” and check the box 
designated as “Spearman.” 
 





* Put both your IV and your DV in the box designated as “Variables.” Under 
“Correlation Coefficients,” uncheck the box designated as “Pearson,” and check the box 
designated as “Spearman.” 
IV is Interval, Ratio, or Interval-Ratio and DV is Nominal: Please avoid this 
combination. 
* The correct procedure is called “Logistic Regression” but is beyond the scope of the 
team‟s project. 
 
IV is Interval, Ratio, or Interval-Ratio and DV is Ordinal: 
Analyze…Correlate…Bivariate 
* Put both your IV and your DV in the box designated as “Variables.” Under 
“Correlation Coefficients,” uncheck the box designated as “Pearson,” and check the box 
designated as “Spearman.” 
 
IV is Interval, Ratio, or Interval-Ratio and DV is Interval, Ratio, or Interval-Ratio: 
Analyze…Correlate…Bivariate 
Put both your IV and your DV in the box designated as “Variables.” Under “Correlation 





A.1.4 Product Codes 
Name of 
Product Code Serving Size  
 




Total amount of 
GLUTAMINE per 
serving 
(if info available) 
4Ever Fit L-
Glutamine 29 1 scoop = 5 g 
5 g of L-Glutamine in 
this product. This is a 
purely glutamine 
product. 
5 g of L- Glutamine in 
product. This is a 
purely glutamine 
product. 
All the Whey 
Opti-Blend 99 1 scoop = 30 g 
20 g  3.203 g 
American 
Whey 87 1 scoop = 27 g 
20g   
AST GL3 L-
Glutamine 25 2 teaspoon = 10 g 
10 g of L-Glutamine 
in this product. This is 
a purely glutamine 
product. 
10 g of L-Glutamine in 






Muscle Protein 82 1 scoop = 31 g 
 
20 g  
 
Big100 Protein 
Bar (Met-Rx) 60 1 bar = 100 g 
28 g   
Bioplex L-
Glutamine 31 1 tablespoon = 10 g 
10 g of L- Glutamine 
in product. This is a 
purely glutamine 
product. 
10 g of L-Glutamine in 




MyoZene 10 3 scoops =  118 g 
 




Energy Drink 66 8 fl. oz  
24 g   
Boost High 
Protein  68 8 fl. oz 









BSNCellMass 1 1 scoop = 16g 
2 g of glutamine 
AKG. 
2 g of glutamine AKG. 
BSN Syntha-6 79 1 scoop = 44g 22 g  
Champion 
Whey Protein 
and Soy Protein 46 ½ packet = 34.708 g 
 
23 g  
 
Cytogainer by 
Cytosport 71 4 scoops =  150 g 
54 g   
Cytosport 
100% Whey 64 1 scoop = 22 g 
18 g   
CytoSport 
EvoPro 9 1 scoop = 32 g 
26 g   
CytoSport 
Muscle Milk 
Light 3 8.5 fl. oz 
20 g   
CytoSport 
Muscle Milk 
(powder) 63 2 scoops = 70 g 
32 g   
CytoSport 
Muscle Milk 
RTD (liquid) 94 14 fl. oz 
25 g   
Designer Whey 83 24 g 18 g   
Dymatize 
Xpand 13 18.5 g 
1 g of glutamine 
fusion 
1 g of glutamine 
fusion 
Dymatize Elite 
Whey Protein 92 1 scoop = 31 g 
24 g   
EAS Betagen 
HP 11 2 scoops = 10.57 g 
no total protein 




2 g  
EAS L-
Glutamine 21  1.5 teaspoons = 5 g 





Armor 16 30 g 
no total protein 
amount in grams on 
label 
15.5 g of JUVEN 
TECHNOLOGY of 
which an unstated 
amount of glutamine is 
part of. 
EAS Whey 
Protein 55 1 scoop = 30 g 
23 g   
GNC 50 gram 
slam 73 1 can = 15 fl. oz 
 




Sports Meal 100 1 packet = 82 g 
40 g  5 g  
GNC 
MassXXX 39 1 scoop = 50g 





3000 84 3 tablets = 3.015 g 
 




Glutamine 38 2 capsules = 1.5 g 
1.5 g of L- Glutamine 
in this product. This is 
a purely glutamine 
product. 
1.5 g of L-Glutamine 
in this product. This is 





(powder) 38 1 scoop = 5 g 
5 g of L-Glutamine in 
this product. This is a 
purely glutamine 
product. 
5 g of L-Glutamine in 





Mega Whey 85 1/3 cup = 35 g 
24 g  
GNC Pro 
Performance 
Weight Gainer 37 3 cups = 390 g 




aka GNC 100% 
Whey Protein 35 1 scoop = 31 g 
 






Protein 77 1 scoop = 33.81 g 
 
25 g  
 
Gold Standard 
Whey Protein 69 29.4 g  







Glutamine) 20 1 teaspoon = 4.5 g 
4.5 g of L-Glutamine 
in this product. This is 
a purely glutamine 
product. 
4.5 g of L-Glutamine 
in this product. This is 




Glutamine 23 1 teaspoon = 4.5 g 
4.5 g of L-Glutamine 
in this product. Pure.  
4.5 g of L-Glutamine 
in this product. Pure. 
IDS L-
Glutamine with 
MSM 19 1 scoop = 5.5 g 
no total protein 




Gainer 18 2 scoops = 165g 
51 g   
Isopure 75 2 scoops = 65 g 50 g   
LA Weightloss 
Protein Bar 78 1 bar = 47.14 g 
8 g   
Met-Rx protein 
booster 57 1 scoop = 31 g 
8 g   
Met-Rx protein 
plus bar 93 1 bar = 85 g 
32 g   
Muscle Tech 












Hardcore 4 1 scoop = 28.5 g 
 







Mass Tech 14 
5 scoops =  
227 g  
40 g   
Myoplex Light 61  1 packet = 54 g 25 g   
Naked Juice 
Protein Zone 52 8 fl. oz  
17 g   
Nature's Best 
Isopure 8 87 g 
50 g   
NOW L-
Glutamine 26 1 capsule = 1g 
1 g of L-Glutamine in 
this product. This is a 
purely glutamine 
product. 
1 g of L-Glutamine in 




Plasmavol 7 2 tablespoons = 40 g 
  
Optimum 
Glutamine  24 1 teaspoon= 5 g 
5 g of L-Glutamine  5 g of L-Glutamine  
Optimum 
NATURAL 
100% Whey 86 1 scoop = 32.4 g 
 




Standard  53 1 scoop = 32 g 
24 g  
Optimum 
Nutrition Whey 
Protein 40 1 scoop = 32 g 
24 g   
Optimum Pro-
Complex 96 1 scoop = 37 g 
30 g   
PermaLean 90 1 scoop = 30 g 20 g   
Power Bar 
Protein Plus 59 1 bar = 78 g 
23 g   
Prolab N-Large 
II 72 4 scoops = 152g 
 







GlutaForm 30 1 scoop = 5 g 
5 g of L-Glutamine. 
This is a purely 
glutamine product. 
5 g of L-Glutamine in 





Powder 22 1 teaspoon = 4.5 g 
4.5 grams of L- 
Glutamine in this 
product. This is a 
purely glutamine 
product. 
4.5 grams of L- 
Glutamine in this 





4 scoops =  
152 g 
 
52 g  
 
Protein Blitz 56 20 fl. oz  30 g   
Protein Booster 
C from the 
Smoothie Shop 41 
  




14 g  
 
Pure Protein 
Bar 62 1 bar = 78 g 
32 g   
PureForm L-
Glutamine Pro 32 1 serving size = 5 g 
5 g of L-Glutamine in 
this product. This is a 
purely glutamine 
product. 
5 g of L-Glutamine in 




(Generic) 74 1 scoop = 31 g 
20 g  
Ripped Fuel 
(powder) 81 .47825 g 
 




gainer 95 292 g 
36.8 g   
S.A.N. V-12 








Xtend 6 2 scoops = 13 g 
 2.5 g 
Smoothie King 
Gladiator 91 
1 serving size = 
47.151 g 
 




Bar 80 1 bar = 35 g 
10 g   
Textrbolk 
Protein Shake 65 






Glutamine Fuel 33 2 capsules = 1.5 g 
1.5 g of L-Glutamine 
in this product. This is 
a purely glutamine 
product. 
1.5 g of L-Glutamine 
in this product. This is 




Glutapure 34 5 g 
5 g of L-Glutamine in 
this product. This is a 
purely glutamine 
product. 
5 g of L-Glutamine in 









Whey Protein 50 1 scoop = 24 g 
18 g   
VP2 76 1 scoop = 28 g 23.5 g   
Weider L-
Glutamine 28 1 teaspoon = 1.5 g 
1.5 g of L-Glutamine 
in this product. Pure.  
1.5 g of L-Glutamine 
in this product. Pure.  
Xyience XM2 17 2 scoops = 78.003 g 
 
32 g  
 
Xyience NOX-
CG3 2 1 scoop = 13 g 
 1.5 g of Tri-Glutamine 
complex. 






A.1.5 Recommended Daily Allowance Calculations 
*Assume our participants have the average body mass found in literature (Johnson, 
1999):  
 
72.1 kg  
 
*Assume our participants have the average American dietary protein intake found in 
literature (Eisenstein et. al., 2002):  
 
1.2 g protein/kg of body mass/day 
 
*Use recommended daily allowance found in literature (Eisenstein et. al., 2002): 
 
 0.8 g protein/kg of body mass/day 
 
Average weekly RDA: 
 
 (0.8 g/kg/d) * (72.1 kg) * (7 d/wk) = 403.76 g/wk for a 72.1 kg individual 
 
Average participant dietary intake: 
 
 (1.2 g/kg/d) * (72.1 kg) * (7 d/wk) = 605.64 g/wk for a 72.1 kg individual 
 
Average participant supplementary intake: 
 





Total weekly participant intake: 
 
 605.64 g/wk + 183.4 g/wk = 789.04 g/wk for a 72.1 kg participant taking protein 
 
% RDA participant protein intake: 
 




% increase in protein intake from supplementation (assuming average American dietary 
intake): 
 





A.2 Biochemical Analysis Appendix 
A.2.1 Data From Biochemical Analysis 




























% Rec  
(Y-int=0) 
JU16-
7A 52.51 1.0502 0.02431 13.90728 26194.55 26005.1 267.9135 1.030234 0.045399 0.047175 4.322878 4.491956 
JU16-
7B 52.51 1.0502 0.02431 13.89617 25815.66        
JU16-
8A 55.37 1.1074 0.025634 13.9029 28216.74 28120.68 135.8487 0.483092 0.049246 0.051012 4.447008 4.606491 
JU16-
8B 55.37 1.1074 0.025634 13.90485 28024.62        
JU16-
9A 66.28 1.3256 0.030685 13.90324 103380.3 102885.6 699.5848 0.679964 0.185211 0.18664 13.97186 14.07963 
JU16-
9B 66.28 1.3256 0.030685 13.88344 102391        
JU16-
10A 52.27 1.0454 0.024199 13.91345 20437.37 20491.93 77.14839 0.376482 0.035373 0.037173 3.383661 3.555898 
JU16-






11A 51.48 1.0296 0.023833 13.91467 25349.04 24797.84 779.5137 3.143474 0.043203 0.044984 4.196132 4.369123 
JU16-
11B 51.48 1.0296 0.023833 13.9101 24246.64        
JU16-
12A 49.73 0.9946 0.023023 13.83493 20689.06 20785.37 136.1979 0.655258 0.035906 0.037706 3.610138 3.791038 
JU16-
12B 49.73 0.9946 0.023023 13.84832 20881.67        
JU16-
13A 51.08 1.0216 0.023648 13.90469 30428.87 30353.15 107.0796 0.352779 0.053306 0.055062 5.2179 5.38979 
JU16-
13B 51.08 1.0216 0.023648 13.90044 30277.44        
JU16-
14A 50.49 1.0098 0.023375 13.90269 26012.64 25999.91 18.00102 0.069235 0.045389 0.047165 4.494892 4.670738 
JU16-
14B 50.49 1.0098 0.023375 13.90017 25987.19        
JU16-
15A 51.32 1.0264 0.023759 13.86154 16819.41 16766.92 74.2284 0.442707 0.028599 0.030416 2.786305 2.963368 
JU16-
15B 51.32 1.0264 0.023759 13.83344 16714.43        
JU16-






16B 51.106 1.02212 0.02366 14.02676 562472.1        
JU16-
17A 50.59 1.0118 0.023421 13.81088 2885.863 3185.961 424.4016 13.32099 0.003901 0.005779 0.38553 0.571209 
JU16-
17B 50.59 1.0118 0.023421 13.81424 3486.058        
JU16-
18A 102.263 2.04526 0.047344 14.03736 10660.58 10527.94 187.5892 1.781823 0.017253 0.019098 0.843543 0.933778 
JU16-
18B 102.263 2.04526 0.047344 14.03311 10395.29        
JU16-
19A 52.98 1.0596 0.024528 13.81742 8600.695 9846.491 1761.822 17.89289 0.016013 0.017862 1.511268 1.685732 
JU16-
19B 52.98 1.0596 0.024528 13.82508 11092.29        
JU16-
20A 50.44 1.0088 0.023352 13.80114 19601.44 24099.08 6360.627 26.39365 0.041933 0.043717 4.156684 4.333555 
JU16-
20B 51.185 1.0237 0.023697 14.02412 28596.72        
JU16-
21A 49.6 0.992 0.022963 13.81353 8190.296 9320.399 1598.207 17.14741 0.015057 0.016908 1.517808 1.704401 
JU16-






22A 53.19 1.0638 0.024625 13.81064 9117.352 9765.263 916.2849 9.383105 0.015866 0.017715 1.491415 1.665225 
JU16-
22B 53.19 1.0638 0.024625 13.82777 10413.17        
JU16-
23A 51.104 1.02208 0.023659 14.02969 547221.3 557161.4 14057.52 2.523061 1.011341 1.010718 98.94925 98.88835 
JU16-
23B 51.104 1.02208 0.023659 14.03774 567101.6        
JU19-
1A 50.158 1.00316 0.023221 14.04874 549727.8 564132 20370.61 3.610965 1.024017 1.023363 102.0791 102.0139 
JU19-
1B 50.158 1.00316 0.023221 14.04205 578536.2        
JU19-
2A 51.75 1.035 0.023958 13.83453 327682.9 304118.3 33325.37 10.95803 0.551165 0.551685 53.2527 53.30294 
JU19-
2B 51.75 1.035 0.023958 13.83711 280553.7        
JU19-
3A 52 1.04 0.024074 13.83895 277528.7 276889.6 903.7727 0.326402 0.501648 0.502291 48.23542 48.29724 
JU19-










































2A 51.2 1.024 0.023704 14.16448 564240.2 554835.5 13300.24 2.397151 1.007111 1.006499 98.35065 98.29088 53.30294 
JU19-
2B 51.2 1.024 0.023704 14.15224 545430.8          
JU19-
3A 51.03 1.0206 0.023625 14.16953 568480.5 570559 2939.422 0.515183 1.035705 1.035022 101.48 101.4131 48.29724 
JU19-
3B 51.03 1.0206 0.023625 14.16171 572637.5         
JU16-
7A 26.27 1.0508 0.024324 14.15023 22043.78 22265.72 313.8664 1.40964 0.038599 0.040391 3.673253 3.843842 4.491956 
JU16-
7B 26.27 1.0508 0.024324 14.16306 22487.65         
JU16-
8A 25.5 1.02 0.023611 14.15409 22854.63 22983.73 182.5785 0.794381 0.039904 0.041694 3.912187 4.087609 4.606491 
JU16-
8B 25.5 1.02 0.023611 14.14901 23112.84         
JU16-






9B 26.24 1.0496 0.024296 14.15687 76904.72         
JU16-
10A 25.04 1.0016 0.023185 14.14513 17106.39 17512.21 573.9212 3.277262 0.029954 0.031768 2.990615 3.171726 3.555898 
JU16-
10B 25.04 1.0016 0.023185 14.15684 17918.04         
JU16-
17A 24.95 0.998 0.023102 14.15892 22202.92 22063.99 196.4866 0.890531 0.038232 0.040025 3.83083 4.010536 0.571209 
JU16-
17B 24.95 0.998 0.023102 14.14792 21925.05         
JU16-
22A 25.42 1.0168 0.023537 14.16078 23052.66 23095.83 61.05299 0.264346 0.040108 0.041897 3.944548 4.120473 1.665225 
JU16-
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A.3.5 IRB Renewal August 4, 2008 
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